
<html lang="en"     class="pb-page"  data-request-id="34733f85-2745-42a0-8619-e6af85fdcaac"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm901811v;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2010.53.issue-5;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="1-Alkyl-4-phenyl-6-alkoxy-1H-quinazolin-2-ones: A Novel Series of Potent Calcium-Sensing Receptor Antagonists" /></meta><meta name="dc.Creator" content="Leo  Widler" /></meta><meta name="dc.Creator" content="Eva  Altmann" /></meta><meta name="dc.Creator" content="René  Beerli" /></meta><meta name="dc.Creator" content="Werner  Breitenstein" /></meta><meta name="dc.Creator" content="Rochdi  Bouhelal" /></meta><meta name="dc.Creator" content="Thomas  Buhl" /></meta><meta name="dc.Creator" content="Rainer  Gamse" /></meta><meta name="dc.Creator" content="Marc  Gerspacher" /></meta><meta name="dc.Creator" content="Christine  Halleux" /></meta><meta name="dc.Creator" content="Markus R.  John" /></meta><meta name="dc.Creator" content="Hansjoerg  Lehmann" /></meta><meta name="dc.Creator" content="Oskar  Kalb" /></meta><meta name="dc.Creator" content="Michaela  Kneissel" /></meta><meta name="dc.Creator" content="Martin  Missbach" /></meta><meta name="dc.Creator" content="Irene R.  Müller" /></meta><meta name="dc.Creator" content="Sibylle  Reidemeister" /></meta><meta name="dc.Creator" content="Johanne  Renaud" /></meta><meta name="dc.Creator" content="Agnes  Taillardat" /></meta><meta name="dc.Creator" content="Ruben  Tommasi" /></meta><meta name="dc.Creator" content="Sven  Weiler" /></meta><meta name="dc.Creator" content="Romain M.  Wolf" /></meta><meta name="dc.Creator" content="Klaus  Seuwen" /></meta><meta name="dc.Description" content="Parathyroid hormone (PTH) is an effective bone anabolic agent. However, only when administered by daily sc injections exposure of short duration is achieved, a prerequisite for an anabolic response..." /></meta><meta name="Description" content="Parathyroid hormone (PTH) is an effective bone anabolic agent. However, only when administered by daily sc injections exposure of short duration is achieved, a prerequisite for an anabolic response..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 16, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm901811v" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm901811v" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm901811v" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm901811v" /></link>
        
    
    

<title>1-Alkyl-4-phenyl-6-alkoxy-1H-quinazolin-2-ones: A Novel Series of Potent Calcium-Sensing Receptor Antagonists | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm901811v" /></meta><meta property="og:title" content="1-Alkyl-4-phenyl-6-alkoxy-1H-quinazolin-2-ones: A Novel Series of Potent Calcium-Sensing Receptor Antagonists" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0007.jpeg" /></meta><meta property="og:description" content="Parathyroid hormone (PTH) is an effective bone anabolic agent. However, only when administered by daily sc injections exposure of short duration is achieved, a prerequisite for an anabolic response. Instead of applying exogenous PTH, mobilization of endogenous stores of the hormone can be envisaged. The secretion of PTH stored in the parathyroid glands is mediated by a calcium sensing receptor (CaSR) a GPCR localized at the cell surface. Antagonists of CaSR (calcilytics) mimic a state of hypocalcaemia and stimulate PTH release to the bloodstream. Screening of the internal compound collection for inhibition of CaSR signaling function afforded 2a. In vitro potency could be improved &gt;1000 fold by optimization of its chemical structure. The binding mode of our compounds was predicted based on molecular modeling and confirmed by testing with mutated receptors. While the compounds readily induced PTH release after iv application a special formulation was needed for oral activity. The required profile was achieved by using microemulsions. Excellent PK/PD correlation was found in rats and dogs. High levels of PTH were reached in plasma within minutes which reverted to baseline in about 1−2 h in both species." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm901811v"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm901811v">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm901811v&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm901811v&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm901811v&amp;href=/doi/10.1021/jm901811v" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 2250-2263</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm901788j" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm901852f" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">1-Alkyl-4-phenyl-6-alkoxy-1<i>H</i>-quinazolin-2-ones: A Novel Series of Potent Calcium-Sensing Receptor Antagonists</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Leo++Widler">Leo Widler</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eva++Altmann">Eva Altmann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ren%C3%A9++Beerli">René Beerli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Werner++Breitenstein">Werner Breitenstein</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rochdi++Bouhelal">Rochdi Bouhelal</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Buhl">Thomas Buhl</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rainer++Gamse">Rainer Gamse</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marc++Gerspacher">Marc Gerspacher</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine++Halleux">Christine Halleux</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Markus+R.++John">Markus R. John</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hansjoerg++Lehmann">Hansjoerg Lehmann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Oskar++Kalb">Oskar Kalb</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michaela++Kneissel">Michaela Kneissel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Missbach">Martin Missbach</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Irene+R.++M%C3%BCller">Irene R. Müller</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sibylle++Reidemeister">Sibylle Reidemeister</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Johanne++Renaud">Johanne Renaud</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Agnes++Taillardat">Agnes Taillardat</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ruben++Tommasi">Ruben Tommasi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sven++Weiler">Sven Weiler</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Romain+M.++Wolf">Romain M. Wolf</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Klaus++Seuwen">Klaus Seuwen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Novartis Institutes for BioMedical Research, 400 Technology Square, Cambridge, MA</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Pharmaceutical Development, Novartis Pharma AG, Basel, Switzerland</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: +41 61 696 57 86. Fax: +41 61 696 82 13. E-mail: <a href="/cdn-cgi/l/email-protection#b2ded7dd9cc5dbd6ded7c0f2dcddc4d3c0c6dbc19cd1dddf"><span class="__cf_email__" data-cfemail="b0dcd5df9ec7d9d4dcd5c2f0dedfc6d1c2c4d9c39ed3dfdd">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm901811v&amp;href=/doi/10.1021%2Fjm901811v" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 2250–2263</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 16, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>8 December 2009</li><li><span class="item_label"><b>Published</b> online</span>16 February 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 March 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm901811v" title="DOI URL">https://doi.org/10.1021/jm901811v</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2250%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DLeo%2BWidler%252C%2BEva%2BAltmann%252C%2BRen%25C3%25A9%2BBeerli%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D5%26contentID%3Djm901811v%26title%3D1-Alkyl-4-phenyl-6-alkoxy-1H-quinazolin-2-ones%253A%2BA%2BNovel%2BSeries%2Bof%2BPotent%2BCalcium-Sensing%2BReceptor%2BAntagonists%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2263%26publicationDate%3DMarch%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm901811v"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2237</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">29</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm901811v" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;1-Alkyl-4-phenyl-6-alkoxy-1H-quinazolin-2-ones: A Novel Series of Potent Calcium-Sensing Receptor Antagonists&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Leo&quot;,&quot;last_name&quot;:&quot;Widler&quot;},{&quot;first_name&quot;:&quot;Eva&quot;,&quot;last_name&quot;:&quot;Altmann&quot;},{&quot;first_name&quot;:&quot;René&quot;,&quot;last_name&quot;:&quot;Beerli&quot;},{&quot;first_name&quot;:&quot;Werner&quot;,&quot;last_name&quot;:&quot;Breitenstein&quot;},{&quot;first_name&quot;:&quot;Rochdi&quot;,&quot;last_name&quot;:&quot;Bouhelal&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Buhl&quot;},{&quot;first_name&quot;:&quot;Rainer&quot;,&quot;last_name&quot;:&quot;Gamse&quot;},{&quot;first_name&quot;:&quot;Marc&quot;,&quot;last_name&quot;:&quot;Gerspacher&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;Halleux&quot;},{&quot;first_name&quot;:&quot;Markus&quot;,&quot;last_name&quot;:&quot;R. John&quot;},{&quot;first_name&quot;:&quot;Hansjoerg&quot;,&quot;last_name&quot;:&quot;Lehmann&quot;},{&quot;first_name&quot;:&quot;Oskar&quot;,&quot;last_name&quot;:&quot;Kalb&quot;},{&quot;first_name&quot;:&quot;Michaela&quot;,&quot;last_name&quot;:&quot;Kneissel&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Missbach&quot;},{&quot;first_name&quot;:&quot;Irene&quot;,&quot;last_name&quot;:&quot;R. Müller&quot;},{&quot;first_name&quot;:&quot;Sibylle&quot;,&quot;last_name&quot;:&quot;Reidemeister&quot;},{&quot;first_name&quot;:&quot;Johanne&quot;,&quot;last_name&quot;:&quot;Renaud&quot;},{&quot;first_name&quot;:&quot;Agnes&quot;,&quot;last_name&quot;:&quot;Taillardat&quot;},{&quot;first_name&quot;:&quot;Ruben&quot;,&quot;last_name&quot;:&quot;Tommasi&quot;},{&quot;first_name&quot;:&quot;Sven&quot;,&quot;last_name&quot;:&quot;Weiler&quot;},{&quot;first_name&quot;:&quot;Romain&quot;,&quot;last_name&quot;:&quot;M. Wolf&quot;},{&quot;first_name&quot;:&quot;Klaus&quot;,&quot;last_name&quot;:&quot;Seuwen&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;2250-2263&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm901811v&quot;},&quot;abstract&quot;:&quot;Parathyroid hormone (PTH) is an effective bone anabolic agent. However, only when administered by daily sc injections exposure of short duration is achieved, a prerequisite for an anabolic response. Instead of applying exogenous PTH, mobilization of endogenous stores of the hormone can be envisaged. The secretion of PTH stored in the parathyroid glands is mediated by a calcium sensing receptor (CaSR) a GPCR localized at the cell surface. Antagonists of CaSR (calcilytics) mimic a state of hypocalcaemia and stimulate PTH release to the bloodstream. Screening of the internal compound collection for inhibition of CaSR signaling function afforded 2a. In vitro potency could be improved &gt;1000 fold by optimization of its chemical structure. The binding mode of our compounds was predicted based on molecular modeling and confirmed by testing with mutated receptors. While the compounds readily induced PTH release after iv application a special formulation was needed for oral activity. The required profile was achieved b&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901811v&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901811v" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901811v&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901811v" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901811v&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901811v" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm901811v&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901811v&amp;href=/doi/10.1021/jm901811v" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm901811v" /></input><a href="/doi/pdf/10.1021/jm901811v" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm901811v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm901811v%26sid%3Dliteratum%253Aachs%26pmid%3D20158186%26genre%3Darticle%26aulast%3DWidler%26date%3D2010%26atitle%3D1-Alkyl-4-phenyl-6-alkoxy-1H-quinazolin-2-ones%253A%2BA%2BNovel%2BSeries%2Bof%2BPotent%2BCalcium-Sensing%2BReceptor%2BAntagonists%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D5%26spage%3D2250%26epage%3D2263%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Parathyroid hormone (PTH) is an effective bone anabolic agent. However, only when administered by daily sc injections exposure of short duration is achieved, a prerequisite for an anabolic response. Instead of applying <i>exogenous</i> PTH, mobilization of <i>endogenous</i> stores of the hormone can be envisaged. The secretion of PTH stored in the parathyroid glands is mediated by a calcium sensing receptor (CaSR) a GPCR localized at the cell surface. Antagonists of CaSR (calcilytics) mimic a state of hypocalcaemia and stimulate PTH release to the bloodstream. Screening of the internal compound collection for inhibition of CaSR signaling function afforded <b>2a</b>. In vitro potency could be improved >1000 fold by optimization of its chemical structure. The binding mode of our compounds was predicted based on molecular modeling and confirmed by testing with mutated receptors. While the compounds readily induced PTH release after iv application a special formulation was needed for oral activity. The required profile was achieved by using microemulsions. Excellent PK/PD correlation was found in rats and dogs. High levels of PTH were reached in plasma within minutes which reverted to baseline in about 1−2 h in both species.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61160" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61160" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Osteoporosis is a systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue that leads to bone fragility and increased risk of fractures. The disease is associated with high cost for the health care system and substantial morbidity and mortality especially after hip fractures. In osteoporotic individuals the delicate equilibrium between bone formation by osteoblasts and resorption by osteoclasts is out of balance leading to progressive bone loss. Osteoporosis could largely be prevented by treatment with one of the commercially available resorption inhibitors (e.g., a bisphosphonate). However, many patients are only diagnosed at a time when they have already lost a considerable amount of bone mass. There is consequently a clear need for bone anabolic agents which can rebuild lost bone. The only bone anabolics currently on the market are based on the natural hormone parathyroid hormone (PTH<a class="ref internalNav" href="#fn1" aria-label="a">a</a><div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: 7TM, seven-transmembrane; BMD, bone mineral density; CaSR, calcium sensing receptor; DMEU, 1,3-dimethyl-2-imidazolidinone; EDTA, ethylenediaminetetraacetic acid; FLIPR, fluorimetric calcium assay; GPCR, G-protein-coupled receptor; iv, intravenous; MEPC, microemulsion preconcentrate; PAMPA, parallel artificial membrane permeability; PD, pharmacodynamic; PK, pharmacokinetic; po, oral; PTH, parathyroid hormone; SAR, structure−activity-relationship; sc, subcutaneous; TFA, trifluoroacetic acid; h, hour; rt, room temperature; mp, melting point; HV, high vacuum; equiv, equivalent, quint, 5-line system, hex, 6-line system, hept, 7-line system.</p></div>), a polypeptide consisting of 84 amino acids. The N-terminal fragment PTH(1−34) (teriparatide) is approved in the U.S. as well as in Europe while the full length peptide PTH(1−84) is only available in Europe. Administration of these peptides is so far only possible by daily subcutaneous (sc) injections which is not ideal for a chronic therapy.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Stimulation of the release of <i>endogenous</i> PTH from parathyroid glands therefore would provide an attractive alternative.</div><div class="NLM_p">PTH secretion is controlled by a calcium-sensing receptor (CaSR), a member of the GPCR family 3, expressed on the surface of parathyroid cells.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Extracellular Ca<sup>2+</sup> concentrations below the normal physiological level stimulate PTH release, while at high [Ca<sup>2+</sup>] little or no PTH is secreted. With a CaSR modulator PTH levels can be controlled independently of extracellular [Ca<sup>2+</sup>]. Calcimimetic compounds (agonists of CaSR) activate the receptor and inhibit PTH secretion, while calcilytics (antagonists) mimic a state of hypocalcaemia and thus stimulate the release of endogenous PTH.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> However, it is well documented that elevated levels of PTH only result in higher bone mass if they are transient, i.e., they do not persist for more than about 2−4 h.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Elevated PTH levels sustained for several hours activate not only osteoblasts but also osteoclasts leading to an increase in bone turnover instead of higher bone mass.</div><div class="NLM_p">Cinacalcet, a calcimimetic, was approved several years ago for the treatment of secondary hyperparathyroidism.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The first calcilytic studied in some detail was <b>1a</b> (NPS 2143)<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> with a β-amino-alcohol partial structure (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Daily oral administration of <b>1a</b> to ovariectomized rats resulted in elevated PTH levels sustained for several hours (>4 h). Higher bone turnover was consequently observed rather than an anabolic net increase in bone mass. Only by blocking the increased bone resorption with the antiresorptive agent 17β-estradiol a gain in bone mineral density (BMD) could be achieved. The follow-up compound <b>1b</b> (Ronacaleret; SB-751689)<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> with a similar structure but a more appropriate PK profile was clinically tested (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Proof of concept was achieved by showing significant increases in bone formation markers in postmenopausal women, while resorption markers remained at baseline levels.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> More recently, other structural series of calcilytics have also been reported.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12">(9-12)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of calcilytics <b>1a</b> and <b>1b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The starting point for our calcilytics project was compound <b>2a</b> found by screening the internal Novartis compound collection for inhibition of CaSR signaling function using a fluorimetric assay for intracellular calcium (FLIPR). The structure is related to Proquazone<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> developed at Sandoz in the early 1980s as an analgesic (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). The compound had an IC<sub>50</sub> of 1.45 μM and was an interesting starting point for lead optimization being a close analogue of a marketed compound.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of lead compound <b>2a</b> and Proquazone.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72884" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72884" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> outlines the synthesis of the lead compound <b>2a</b>. The commercially available 5-hydroxy-2-nitrobenzaldehyde was <i>O</i>-methylated and then treated with 4-isopropyl-phenyl-magnesium bromide at low temperature to yield the secondary alcohol <b>4</b>. Jones oxidation followed by catalytic reduction afforded the amino-ketone <b>5</b>. The synthesis was completed by monoalkylation of the aniline nitrogen followed by cyclization to the target compound <b>2a</b> by treatment with sodium cyanate in glacial acetic acid.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0010.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 1-Isopropyl-4-(4-isopropyl-phenyl)-6-methoxy-1<i>H</i>-quinazolin-2-one<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) methyl iodide, K<sub>2</sub>CO<sub>3</sub>, DMF, rt, 12 h; (b) 4-isopropyl-phenyl-magnesium bromide, THF; −78 °C, 2 h; (c) (i) Jones-reagent; acetone, 0 °C, 1 h, (ii) H<sub>2</sub>, RaNi, rt, atmospheric pressure, MeOH/THF 1:1; (d) isopropyl iodide, K<sub>2</sub>CO<sub>3</sub>, 110 °C, 48 h; (e) sodium cyanate, AcOH, rt, overnight.</p></p></figure><div class="NLM_p">Derivatives with various 4-substituents at the phenyl group (cf. Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) were easily accessible using the same synthetic sequence employing the appropriate Grignard reagents.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR of the <i>p</i>-Substituent of the 4-Phenyl Group</div></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0015.gif" alt="" id="fx1" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Average of two or more runs. Standard deviation of assay is generally less than ±40%.</p></div></div></div><div class="NLM_p">The methylether of <b>2a</b> could be cleaved with boron tribromide to the give <b>7a</b> with a free phenol group. Alkylation with a range of bromides in DMEU (1,3-dimethyl-2-imidazolidinone) in the presence of cesium carbonate gave easy access to a range of analogues with different ether functionalities (cf. Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0011.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Modification of the Ether Functionality<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h; (b) R<sup>1</sup>-Br, Cs<sub>2</sub>CO<sub>3</sub>, DMEU, rt, 18 h.</p></p></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of the 6-Alkoxy Substituent</div></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0016.gif" alt="" id="fx2" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Average of two or more runs. Standard deviation of assay is generally less than ±40%.</p></div></div></div><div class="NLM_p">1-Benzyl-4-(4-isopropyl-phenyl)-6-propargyloxy-(1<i>H</i>)-quinazolin-2-ones (<b>10</b>, cf. Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) were prepared similarly to the reaction sequence depicted in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> starting from 2-nitro-5-hydroxy-benzaldehyde (cf. <a class="ref internalNav" href="#sec4" aria-label="Experimental Procedures">Experimental Procedures</a>). For the reduction of the nitro group iron powder in acetic acid was used instead of catalytic hydrogenation to preserve the alkyne moiety. The N-(1) substituent was introduced either by alkylation of <b>8</b> with an appropriately substituted benzyl bromide or by reductive amination with the corresponding benzaldehyde (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Cyclization to the quinazolinone heterocycles <b>10</b> was accomplished by reaction with sodium cyanate. Thio analogues <b>11</b> were prepared by ring closure with benzoyl isothiocyanate.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0012.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 1-Benzyl-4-(4-isopropyl-phenyl)-6-propargyloxy-1<i>H</i>-quinazolin-2-ones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Huenig’s base, 1.4-dioxane, 100 °C; (a′) NaB(OAc)<sub>3</sub>H/CH<sub>2</sub>Cl<sub>2</sub> or NaCNBH<sub>3</sub>/MeOH, rt; (b) sodium cyanate, AcOH, rt; (c) benzoyl isothiocyanate, THF, rt.</p></p></figure><div class="NLM_p">The synthesis of quinazolinones with 6-amino groups started with 2-chloro-5-nitro-benzaldehyde (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Standard treatment with 4-isopropyl-phenyl magnesium bromide and Jones oxidation led to the ketone <b>12</b>. The chlorine was then replaced by isopropyl amine to afford <b>13</b>, which was cyclized with chlorosulfonyl isocyanate to <b>14</b>. Catalytic reduction with Raney nickel to aniline <b>15</b> and mono- or dialkylation completed the synthesis of derivatives <b>16</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0013.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 6-Amino-4-(4-isopropyl-phenyl)-1-isopropyl-1<i>H</i>-quinazolin-2-one<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-isopropyl-phenyl-magnesium bromide, THF; −75 °C → rt, 3 h; (b) Jones reagent; acetone, 0 °C; (c) isopropyl amine, 65 °C, 10 h; (d) chlorosulfonyl isocyanate, 0 °C; (e) H<sub>2</sub>, Ra−Ni, EtOH/THF; (f) cf. <a class="ref internalNav" href="#sec4" aria-label="Experimental Procedures">Experimental Procedures</a> below.</p></p></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR of Substituted <i>N</i>(1)-Benzyl Derivatives</div></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0017.gif" alt="" id="fx3" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Average of two or more runs. Standard deviation of assay is generally less than ±40%.</p></div></div></div><div class="NLM_p">When the aniline <b>17</b> was treated at 180 °C in a water/DMEU mixture under microwave conditions, sigmatropic rearrangement took place giving rise to phenol <b>18a</b> with a 2-allyl group (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). The regioselectivity observed can be rationalized by the push pull system caused through the electron donating capacity of the amino group and the electron withdrawing character of the carbonyl moiety. Compound <b>18a</b> was benzylated (<b>19a</b>) and cyclized to the quinazolinone <b>20a</b>. Alternatively, the allyl group was derivatized, e.g., by hydrogenation (<b>19b</b>) prior to cyclization to <b>20b</b>. Pd catalyzed cyclopropanation of <b>18a</b> furnished <b>18c</b>, which was analogously transformed to <b>20c</b>.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0014.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of 6-Hydroxy-1<i>H</i>-quinazolin-2-ones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) autoclave, DMEU/water, 165 °C, 48 h or microwave, 180 °C (small scale); (b) benzaldehyde, sodium cyanoborohydride, AcOH/CH<sub>2</sub>Cl<sub>2</sub>, rt; (c) sodium cyanate, AcOH, rt, overnight; (d) H<sub>2</sub>, Ra−Ni, rt, 2 h; (e) diazomethane, Pd(II)acetate, rt, 16 h.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43771" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43771" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> From Hit to Potent Calcilytics (SAR)</h3><div class="NLM_p">A fluorimetric assay was used as a primary screen to determine inhibitory potency of the compounds against the CaSR. The assay measures calcium mobilization in hamster fibroblasts transfected with the human receptor.</div><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> shows that the 4-isopropyl group at the phenyl residue is important for antagonistic activity. Both the hydrogen (<b>2b</b>) or the methyl (<b>2c</b>) analogues show only marginal activity. However, 4-isopropyl may be replaced by other alkyl substituents, such as an ethyl (<b>2d</b>), cyclopropyl (<b>2e</b>) or <i>t</i>-butyl (<b>2f</b>) group without affecting potency significantly. A phenyl group is somewhat tolerated (<b>2g</b>) but not residues containing functional groups such as an ester (<b>2i</b>) or an acid (<b>2j</b>). An isopropoxy substituent (<b>2h</b>) is similarly detrimental to potency. A short lipophilic substituent is thus preferred in this position. The <i>p</i>-isopropyl group was moved to the <i>m</i>- and <i>o</i>-positions, but this resulted in clearly less potent compounds (data not shown). Addition of a second substituent on the phenyl ring had little or no effect (data not shown).</div><div class="NLM_p">The nature of the alkoxy substituent in the 6-position was found to have a pronounced effect on potency. While the analogue with a free phenolic group (<b>7a</b>) was about 10 times less potent than the lead <b>2a</b> short alkoxy groups with up to a C<sub>4</sub>-alkyl chain all showed similar IC<sub>50</sub> values (see compounds <b>7b</b>−<b>e</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Improved potencies were obtained for the allyloxy and especially the propargyloxy derivative (see <b>7f</b> and <b>7h</b>, respectively). These groups seem to fit  into a specific apolar binding pocket very tightly because already slightly larger groups such as methallyl (<b>7g</b>) or 2-butynyl (<b>7i</b>) caused some loss in activity. Small substituents (like H or Me) seem to lack the required attractive van der Waals forces while large and/or polar groups are not tolerated in this position. Replacement of the propargyl group by common C−C triple bond replacers was not successful (data not shown in the table). Such derivatives were either less potent (analogues with an <i>O</i>-benzyl moiety) or had unfavorable PK properties (replacement of the propargyl by an acetonitrile group).</div><div class="NLM_p">The part of the molecule which was tolerant to a wide range of structural variations was the <i>N</i>(1)-substituent. Isopropyl could be replaced by a large variety of alkyl groups which may be substituted further by additional functionalities. The most potent compounds, however, were those with a <i>N</i>(1)-benzyl group. A representative selection is presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. With respect to the unsubstituted benzyl derivative <b>10a</b>, additional substituents in the <i>m</i>- or <i>p</i>-position increased the potency by a factor of 2−5. Little difference was found between the <i>m</i>- and <i>p</i>-subseries as long as the substituents were small. However, with growing length of the residues <i>m</i>-substitution was increasingly preferred (data not shown). Ortho substituents, on the other hand, were detrimental for potency. The addition of polar groups resulted in a substantial reduction of potency. However, most of the in vitro activity was maintained by linking such residues via a spacer as in derivatives <b>10g</b> and <b>10l</b> (cf. also <a class="ref internalNav" href="#sec3" aria-label="Results and Discussion">Results and Discussion</a> below for structures <b>21</b>). Unfortunately, our expectations that the increased polarity of <b>10l</b> would be beneficial for in vivo potency was not met (data not shown).</div><div class="NLM_p">Replacement of the carbonyl group of the quinazolinone core by a thiocarbonyl unit resulted in the most potent derivatives of the series. Compound <b>11m</b> showed an IC<sub>50</sub> of 0.4 nM, an increase by a factor of nearly 20 compared to its oxygen analogue <b>10m</b>. Overall, we have succeeded to improve the micromolar IC<sub>50</sub> of our initial hit roughly by a factor of 1000 to arrive at derivatives with nanomolar potencies. The glycol moiety in compounds <b>10m</b> and <b>11m</b> was introduced to increase aqueous solubility of the very lipophilic structure (cf. <a class="ref internalNav" href="#sec3" aria-label="Results and Discussion">Results and Discussion</a> below).</div><div class="NLM_p last">Structural modifications of the core were not very successful, e.g., replacement of one of the ring nitrogens by a carbon atom leading to quinolinones reduced potency substantially. The same was found for derivatives with an enlarged heterocycle (diazepinones) or a smaller one (indoles, benzimidazolones or indazoles).</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Improving Aqueous Solubility</h3><div class="NLM_p">As pointed out previously a calcilytic must not only be a potent antagonist of the CaSR but most importantly its PK profile must be appropriate in order to elicit a bone anabolic effect. The required parameters are high <i>C</i><sub>max</sub> at an early time point (<i>T</i><sub>max</sub>) and a short terminal half-life to ensure expeditious return of exposure and PTH levels to baseline.</div><div class="NLM_p">All of the quinazolinone structures described so far are highly lipophilic (high clogP). It was therefore not surprising that only low exposure levels were observed after oral dosing with protracted return to baseline (cf. below). For an early <i>C</i><sub>max</sub> the gastrointestinal dissolution/absorption rate of the compounds had to be increased. The most straightforward method to achieve this is by way of improving their aqueous solubility. Unfortunately polar and/or solubilizing groups are not tolerated at most sites. This may be rationalized in terms of the assumed binding mode of our compounds. The local environment in the binding pocket is very lipophilic thus precluding the accommodation of polar residues without significant loss in antagonistic potency.</div><div class="NLM_p">All efforts to introduce polar groups at the 4-phenyl substituent only led to derivatives with much decreased potency. In contrast, replacement of the 6-alkoxy substituent by mono- or dialkylamino groups (cf. Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) was tolerated. Similar SAR was found to the one established in the parent ether series (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). <i>N</i>,<i>N</i>-Disubstituted derivatives are generally a little less potent compared to the monosubstituted ones, except for <b>16b</b> with two small ethyl groups. The best derivative was the one with a single <i>N</i>-propargyl substituent (<b>16g</b>; IC<sub>50</sub> 30 nM) corroborating the SAR of the alkoxy series (cf. <b>7h</b> IC<sub>50</sub> 9 nM). However, aqueous solubility of this subclass was still very limited because the anilinic nitrogen is only a very weak base. Derivative <b>16e</b> was tested in a PK experiment in rats. Only minimal exposure levels were found, mainly due to its high clearance.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR of 6-Amino-Substituted Quinazolinones</div></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0018.gif" alt="" id="fx4" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Average of two or more runs. Standard deviation of assay is generally less than ±40%.</p></div></div></div><div class="NLM_p">Analogues with a free phenol group are accessible from the precursor <b>17</b> by thermal regioselective sigmatropic rearrangement of the 6-allyl group (cf. chemistry section). The 6-hydroxy-quinazolinones <b>20a</b>−<b>c</b> are very potent with IC<sub>50</sub> values of 3.9 (<b>20a</b>), 6.6 (<b>20b</b>), and 2.5 nM (<b>20c</b>). Interestingly propargylation of the phenolic OH-group of <b>20a</b> decreased potency by almost a factor of 100 in the fluorimetric calcium assay (FLIPR).</div><div class="NLM_p">Unfortunately, polarity and hence aqueous solubility of these compounds were still not much improved. Not surprisingly, pharmacokinetic experiments of the most potent derivative <b>20c</b> again showed low exposure and low <i>C</i><sub>max</sub> values, believed to be mainly the consequence of high clearance caused by fast phase II metabolism of the free phenol group.</div><div class="NLM_p">As already pointed out, the best site for modifications is the position at <i>N</i>(1). Substituents attached to the <i>m</i>- or <i>p</i>-position of the <i>N</i>(1)-benzyl group point toward the hydrophilic outside of the cell membrane according to the binding mode proposed in the modeling section. Thus it was envisaged that polar residues could be tolerated there without affecting calcilytic potency significantly. Out of a large series of derivatives containing basic amine groups attached to the benzyl moiety via different linkers and spacers of varying length, compounds of structure <b>21</b> were among the most promising ones (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Their clogP values, however, are not much different from that of <b>7h</b> (cf. Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). While <b>21a</b> and <b>21b</b> still only exhibited acceptable solubility at low pH derivative <b>21c</b> with an additional dimethyl-amino group did so even under neutral conditions. To our disappointment, however, the substantially improved aqueous solubility was not reflected in a better PK profile. On the contrary, pharmacokinetic measurements in the rat showed better oral bioavailability (ca. 20%) for <b>7h</b> than for all the piperazines <b>21</b> (only 1−2% for <b>21a</b> and <b>b</b> and about 8% for <b>21c</b>). <i>C</i><sub>max</sub> remained low for <b>21a</b> and <b>b</b>, but <i>T</i><sub>max</sub> was short and the return to baseline swift as desired for calcilytics. Peak levels for the third piperazine <b>21c</b> were higher, but elimination rather slow such that substantial exposure persisted throughout the measuring period of 6 h. The increased size of compounds <b>21</b> and the unequal distribution of polar surface area might offer an explanation for their poor oral bioavailability. Also, permeability was found to be reduced with respect to <b>7h</b> in an in vitro test system using artificial membranes<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> (PAMPA). These results made it rather obvious that simple addition of solubilizing polar groups may not be sufficient to make the current series of calcilytics orally active.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Quinazolinones with Basic Benzyl Side Chains</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0019.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="left">R<sup>7</sup></th><th align="center"> </th><th align="center">Me</th><th align="center">(CH<sub>2</sub>)<sub>2</sub>OMe</th><th align="center">(CH<sub>2</sub>)<sub>3</sub>NMe<sub>2</sub></th></tr></thead><tbody><tr valign="top"><td align="left">compound</td><td align="left"><b>7h</b></td><td align="left"><b>21a</b></td><td align="left"><b>21b</b></td><td align="left"><b>21c</b></td></tr><tr valign="top"><td align="left">FLIPR assay IC<sub>50</sub> [nM]<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td align="left">8.8</td><td align="left">2.4</td><td align="left">13</td><td align="left">8.1</td></tr><tr valign="top"><td align="left">clogP</td><td align="left">5.6</td><td align="left">4.8</td><td align="left">5.0</td><td align="left">5.3</td></tr><tr valign="top"><td align="left">solubility [mg/mL] @ pH 6.8</td><td align="left">0.02</td><td align="left">0.02</td><td align="left">0.02</td><td align="left">0.1</td></tr><tr valign="top"><td align="left">solubility [mg/mL] @ pH 1.0</td><td align="left">0.02</td><td align="left">>0.2</td><td align="left">>0.2</td><td align="left">>0.2</td></tr><tr valign="top"><td align="left">PAMPA permeability<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></td><td align="left">high</td><td align="left">medium</td><td align="left">low</td><td align="left">low</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Average of two or more runs. Standard deviation of assay is generally less than ±40%.</p></div></div></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Docking of Compound <b>10a</b> into a Homology Model of the Human CaSR</h3><div class="NLM_p">Various homology models for the calcium-sensing receptor (CaSR) have been proposed over the past few years.<a onclick="showRef(event, 'ref16 ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19 ref20">(16-20)</a> While they all use the 7TM region of the crystal structure of bovine rhodopsin as a template, they differ in the primary sequence alignment for some TM helices. Despite the resulting differences in the detailed 3D structures, the models help to understand the consequences of mutations of residues considered relevant for ligand binding. Importantly, the combination of detailed models and point mutations clearly suggested that calcimimetics and calcilytics both bind in the 7TM domain and not in the extracellular part of the receptor.</div><div class="NLM_p">Our initial homology model<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> had already suggested<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> that ligands with the quinazolinone core structure described in this work bind to a different region of the receptor than compounds like <b>1a</b>.</div><div class="NLM_p">The binding mode shown in Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> was obtained with our latest CaSR model,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> docking compound <b>10a</b> manually into the receptor, after analyzing possible cavities large enough to accommodate this type of ligand. The comlex was then adjusted by simple energy refinement (conjugate gradient minimization using the Amber force field with parameter sets <i>parm03</i><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> for the protein and <i>gaf</i><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> for the ligand were used).</div><div class="NLM_p">The result is in agreement with mutation studies on the four residues shown in red or orange in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0020.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Proposed binding mode for <b>10a</b> (top view, from the extracellular area into the receptor). In red W818 (TM6) and Y825 (TM6) mutations, both of which affect the interactions with quinazolinone-type ligands; in yellow E837 (TM7), R680 (TM3), I841 (TM7), and F668 (TM2), which do not seem to be involved in binding of this type of ligands but clearly interfere with compounds like <b>1a</b>; in orange F684 (TM3) and F688 (TM3), which are supposed to interact with both types of ligands. (Figure made with PyMOL<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0021.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Side view of binding site (extracellular region on top). The ligand <b>10a</b> is represented in green, see Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> and text for the further color coding. (Figure made with PyMOL<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In our studies,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> mutations of the red residues W818 (TM6) and Y825 (TM6) only affect the binding of quinazolinone-type ligands. Mutations of the yellow residues E837 (TM7), R680 (TM3), I841 (TM7), and F668 (TM2) have no effect on this type of ligand but have a strong negative effect for compounds like <b>1a</b>.<a onclick="showRef(event, 'ref16 ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19 ref20">(16-20)</a> E837 in particular seems to be the major anchor point for positively charged ligands of that type. The orange F684 (TM3) and F688 (TM3) have both been found to affect the binding of the quinazolinone derivatives reported here as well as the amino-alcohol structures of the <b>1a</b> type compounds, i.e., they are at the boundary (or intersection) of distinct binding sites for these two different types of compounds.</div><div class="NLM_p last">In conclusion, the binding site for the compound class presented here is clearly distinct from the one suggested previously for <b>1a</b> and analogues. Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> shows the clear separation of the residues interacting with <b>1a</b> (shown in yellow) from those that do with ligand <b>10a</b> (green).</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> In Vivo PTH Release</h3><div class="NLM_p">For a first in vivo proof of concept study, rats were dosed intravenously to avoid potential problems associated to slow and/or poor gastrointestinal absorption which could drastically reduce <i>C</i><sub>max</sub> and preclude significant PTH release. As anticipated all compounds tested triggered short and sharp PTH peaks and  good in vitro/in vivo correlation was observed (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0001.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Correlation between in vitro and in vivo iv potency.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The first oral tests were made by administering the compounds in a mixture of ethanol/corn oil to dissolve the highly lipophilic compounds. When 3 mg/kg of <b>7h</b> was given to rats, the compound was quickly detected in the blood but only at low levels which persisted for more than 6h (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). Absorption is protracted under these conditions and the resulting PK profile not suitable to achieve a bone anabolic effect.</div><div class="NLM_p">Major factors influencing <i>C</i><sub>max</sub> and peak width in the time−concentration diagram are dissolution/absorption rates and tissue distribution/elimination. The absorption profile and especially the maximal blood/plasma concentration (<i>C</i><sub>max</sub>) of compounds which can easily penetrate GI epithelia but which show limited solubility/slow dissolution rate can often be improved significantly by an optimized pharmaceutical formulation. Molecules with such physicochemical properties are classified as class II compounds (according to the Biopharmaceutics Classification System of the FDA)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and the calcilytics of our lead series are typical examples.</div><div class="NLM_p">Derivative <b>7h</b> was selected to be tested in rats using a range of different formulations known to improve PK behavior of class II compounds. Microemulsions were found to result in the best PK profiles, and this formulation principle was subsequently used for all further oral experiments. In striking contrast to the exposure curve obtained with the EtOH/corn oil formulation, a pronounced and early peak was obtained with <b>7h</b> in the microemulsion and <i>C</i><sub>max</sub> was at least 5-fold higher. Furthermore, one hour after oral administration, drug levels had already dropped to values below 20% of their maximum levels (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).</div><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0002.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Comparison of blood levels of <b>7h</b> in rats after 3 mg/kg po administration using EtOH/corn oil or a microemulsion formulation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The same microemulsion formulation was used for a single dose pharmacodynamic (PD) experiment in rats. While a dose of 10 mg/kg of <b>7h</b> was too low to induce PTH release, a sharp PTH peak with a <i>C</i><sub>max</sub> of ca. 150 pg·equiv/mL resulted with the higher dose of 30 mg/kg (cf. Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).</div><figure id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0003.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Plasma and bioactive parathyroid hormone (PTH, expressed as human PTH equivalents) levels after oral administration of a microemulsion formulation of <b>7h</b> at a dose of 10 and 30 mg/kg to rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>7h</b> was also tested in dogs. Similar to what was previously seen in rats not only PK but also PD (PTH release) showed a perfectly sharp peak (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). The PK and PD curves are almost super imposable. Baseline for PTH levels in the experiment was around 50 pg·equiv/mL and was reached again 2 h post dosing. However, after oral dosing of 30 mg per dog (ca. 3 mg/kg), exposure was considerably higher than that observed in rats at the same dose (data not shown).</div><figure id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0004.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Plasma levels and bioactive parathyroid hormone (PTH, expressed as human PTH equivalents) after oral administration of a microemulsion formulation of <b>7h</b> at a dose of 30 mg per dog.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In vitro, the most potent calcilytics of our series were those with a thiocarbonyl group (<b>11</b>, cf. Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). As an example, <b>11m</b> with subnanomolar potency was selected to be tested in vivo in rats and dogs. In the rat, a 10× lower dose (3 mg/kg) resulted in a peak similar in shape to that obtained with <b>7h</b> at 30 mg/kg reaching a PTH <i>C</i><sub>max</sub> of ca. 280 pg·equiv/mL (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>).</div><figure id="fig9" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0005.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Plasma levels and bioactive parathyroid hormone (PTH, expressed as human PTH equivalents) after oral administration of a microemulsion formulation of <b>11m</b> at a dose of 1 and 3 mg/kg to rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The superior potency of <b>11m</b> was also seen in the dog in which a dose of 3 mg/dog (approximately 0.3 mg/kg) was sufficient for a PTH <i>C</i><sub>max</sub> of around 300 pg·equiv/mL (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>). In both species, rat and dog, <b>11m</b> was thus 10 times more potent than <b>7h</b>.</div><figure id="fig10" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0006.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Plasma levels of PTH and of parent compound <b>11m</b> after oral administration of 3 mg/dog (ca. 0.3 mg/kg) in a microemulsion formulation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In summary, a highly potent and novel series of calcilytics was discovered. Optimization by classical medicinal chemistry led to compound <b>11m</b>, which showed a sharp PTH release peak in rats and dogs provided that a microemulsion formulation is used. The maximum PTH levels achieved as well as the sharp profile suggest that compounds such as <b>11m</b> should have an anabolic effect on bone. Data from long-term in vivo studies of a derivative of the current lead series will be reported shortly elsewhere.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Procedures</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60005" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60005" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Assay for Intracellular Free Calcium</h3><div class="NLM_p last">Antagonism at the CaSR was determined by measuring the inhibition of intracellular calcium transients stimulated by extracellular calcium. CCL39 fibroblasts stably transfected with human CaSR were seeded at 40000 cells/well into 96-well Viewplates and incubated for 24 h. Medium was then removed and replaced with fresh medium containing 2 μM Fluo-3 AM (Molecular Probes, Leiden, The Netherlands). In routine experiments, cells were incubated at 37 °C, 5% CO<sub>2</sub> for 1 h. Afterward, plates were washed twice with mHBS and wells were refilled with 100 μL of mHBS containing the test compounds. Incubation was continued at room temperature for 15 min. To record changes of intracellular free calcium, plates were transferred to a fluorescence-imaging plate reader (FLIPR, Molecular Devices, Sunnyvale, CA). A baseline consisting in five measurements of 0.4 s each (laser excitation 488 nm) was recorded. Cells were then stimulated with calcium (2.5 mM final), and fluorescence changes were recorded over a period of 3 min.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Compositions of Microemulsion Preconcentrates</h3><div class="NLM_p">The microemulsion preconcentrates were prepared as follows: After heating Cremophor RH40 to 65 °C with stirring, the other components were added at the weight ratios indicated in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>. This mixture was stirred for 1 h. The clear solution obtained (microemulsion preconcentrate; MEPC) was mixed with the test compound, and the resulting mixture was stirred at ambient temperature for 8−12 h. Complete dissolution in the microemulsion preconcentrate was assessed by crossed polarized light microscopy.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Composition of Microemulsion Preconcentrates (%, w/w)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="left">component</th><th align="center" char=".">MEPC A</th><th align="center" char=".">MEPC B</th></tr></thead><tbody><tr valign="top"><td align="left">Cremophor RH40</td><td align="char" char=".">45.0</td><td align="char" char=".">58.1</td></tr><tr valign="top"><td align="left">corn oil gylcerides (LCTG)</td><td align="char" char=".">36.0</td><td align="char" char="."> </td></tr><tr valign="top"><td align="left">Labrafil M2125 CS</td><td align="char" char="."> </td><td align="char" char=".">16.9</td></tr><tr valign="top"><td align="left">propylene glycol</td><td align="char" char=".">9.0</td><td align="char" char=".">8.3</td></tr><tr valign="top"><td align="left">EtOH</td><td align="char" char=".">10.0</td><td align="char" char=".">16.7</td></tr></tbody></table></div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> In Vivo Experiments</h3><div id="sec5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Measurement of Parathyroid Hormone (PTH) Release in Anesthetized Rats after Single iv Dosing</h4><div class="NLM_p">In male Wistar rats (300−350 g body weight), one of the carotid arteries (for rapid blood sampling) and one of the jugular veins (for iv drug administration) were cannulated under anesthesia. Blood samples were collected immediately before (0 min) and after iv bolus drug administration, and serum was separated from blood cells by a centrifugation step. Serum samples were stored for a maximum of 2 weeks until determination of PTH and compound levels.</div><div class="NLM_p last">Immunoreactive PTH in rat serum samples was determined using the Nichols Institute rat PTH (IRMA) kit (Immutopics Inc., San Clemente, CA).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Absorption Profile in Conscious Rats after Single po Dosing</h4><div class="NLM_p last">Conscious rats (<i>n</i> = 4), permanently cannulated at the femoral artery, were treated with 3 mg/kg of <b>7h</b> by gavage, using a 1% solution in MEPC A diluted with deionized water to 2.5 mL final volume. Blood samples were taken at 0, 5, 15, 30, 60, 120, 180, 240, 360, 480, and 1440 min after administration.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Measurement of Parathyroid Hormone (PTH) Release in Rats after Single po Dosing</h4><div class="NLM_p last">Three-month-old female Wistar rats were administered orally with the test compound or vehicle (microemulsion) alone. The microemulsions used were prepared starting with 2% w/w solution of the compounds in MEPC B, which were subsequently diluted with deionized water according to the doses applied (application volume 5 mL/kg). Animals were sacrificed by decapitation 5, 15, 30, 60, and 240 min after application. A group receiving vehicle alone before sacrifice served as baseline control. Trunk blood was taken at necropsy. EDTA plasma was collected for determination of PTH levels (rat PTH IRMA, Immutopics Inc., USA).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Measurement of Parathyroid Hormone (PTH) Release in Dogs after Single po Dosing</h4><div class="NLM_p last">Fasted male beagle dogs (aged 2−9 years; <i>n</i> = 3 per group) weighing about 10 kg were dosed as follows: A solution of  30 mg of <b>7h</b> in 3.0 g MEPC  A was diluted 10-fold with deionized water to a final volume of 30 mL, mixed well, and administered by gavage with a subsequent rinse with 15 mL of tap water. 3 mg of compound <b>11k</b> were dissolved in 0.5 g of MEPC B, diluted with deionized water to a final volume of 15 mL, mixed well, and administered by gavage with a subsequent rinse with 25 mL of tap water. Blood samples from conscious dogs were taken into EDTA-coated tubes at 0, 5, 10, 15, 30, 45, 60, 90, 120, 180, 360, 600, and 1440 min post administration. Plasma concentrations of parent compound were determined using a specific HPLC/MS-MS method, and levels of bioactive parathyroid hormone (hPTH) were determined with an intact PTH radioimmunoassay.</div></div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> General</h3><div class="NLM_p">Reagents and solvents were used as purchased without further purification. Flash chromatography was carried out on a Flash Master II system with E. Merck Kieselgel 60 (230−400 mesh) silica gel or a Combi Flash Companion system using prepacked columns. Reactions were monitored either by TLC (E. Merck Silica Gel 60 F 254 thin layer plates) or by LC/MS (Agilent 1100 series with a G1946 D mass spectrometer using atmospheric pressure chemical ionization (APCI), which was also used for all MS data provided. The purity of all compounds for biological testing was determined by high performance liquid chromatography. Method A: Agilent 1100 HPLC with diode array detection in the range of λ = 210−250 nm, column: Waters XTerra MS C<sub>18</sub> 50 mm × 4.6 mm ⌀̷ 3.5 μm pore size, flux: 4 mL/min containing 0.1 % TFA with a linear gradient going form 90% water/10% acetonitrile to 5% water/95% acetonitrile in 8.3 min. Method B: the same as method A but with a Waters XTerra Phenyl (50 mm × 2.1 mm ⌀̷3.5 μm pore size) column and a flux of 2 mL/min. All compounds analyzed by these methods possessed purities equal to or greater than 95%, with the exception of <b>21a</b> (100% using method A and 94% method B).</div><div class="NLM_p last">Nuclear magnetic resonance spectra were recorded at 300 or 400 MHz using Varian Gemini or Mercury instruments. Chemical shifts are given in ppm.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 5-Methoxy-2-nitro-benzaldehyde (<b>3</b>)</h3><div class="NLM_p last">A mixture of 5.0 g (29.9 mmol) 5-hydroxy-2-nitro-benzaldehyde, 2.05 mL (32.9 mmol) of iodomethane, and 4.14 g (29.9 mmol) of potassium carbonate in 50 mL of DMF was stirred for 12 h at rt. The resulting yellow suspension was taken up in water and ethyl acetate. The crude product was recrystallized from a mixture of ethyl acetate/petroleum ether to yield 4.57 g (84%) of compound <b>3</b> in the form of a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 10.49 (s, 1H), 8.16 (d, 1H), 7.33 (d, 1H), 7.15 (dd, 1H), 3.96 (s, 3H).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (4-Isopropyl-phenyl)-(5-methoxy-2-nitro-phenyl)-methanol (<b>4</b>)</h3><div class="NLM_p last">A suspension of 486 mg (20.0 mmol) of magnesium in 2 mL of THF was treated with 100 mg of 4-isopropyl-bromobenzene (in 0.5 mL of THF). The Grignard reaction was started by gentle heating and the rest of the bromide (diluted with 8 mL of THF) was added within 10 min (total amount 2.39 g; 12 mmol). After heating to reflux for <sup>1</sup>/<sub>2</sub> h, the resulting mixture was added dropwise to a suspension of 1.81 g (10.0 mmol) of <b>3</b> in 30 mL of THF at −70 °C. After 2 h at this temperature, the reaction was quenched by the addition of satd ammonium chloride solution and the product was extracted with ethyl acetate. The yellow oily product was purified by flash-chromatography (hexanes/ethyl acetate). Yield: 1.65 g (55%) of <b>4</b> as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.08 (d, 1H), 7.35 (d, 1H), 7.25 (d, 2H), 7.18 (d, 2H), 6.89 (dd, 1H), 6.52 (broad s, 1H), 3.90 (s, 3H), 2.88 (hept, 1H), 2.71 (broad, OH), 1.22 (d, 6H). MS: 284 (M − OH)<sup>+</sup>.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (2-Amino-5-methoxy-phenyl)-(4-isopropyl-phenyl)-methanone (<b>5</b>)</h3><div class="NLM_p">The alcohol <b>4</b> (1.6 g; 5.31 mmol) prepared in the step above was dissolved in 5 mL of acetone, cooled to 0 °C, and treated dropwise with 3 mL of a 2.6 M solution of Jones reagent.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The mixture turned immediately dark. After stirring for 1 h, the chromium salts were separated and washed several times with acetone. After stripping off the acetone in vacuo, the filtrate was extracted with water/ethyl acetate. Evaporation of the organic layers afforded 1.47 g (92%) of crude (4-isopropyl-phenyl)-(5-methoxy-2-nitro-phenyl)-methanone. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.24 (d, 1H), 7.69 (d, 2H), 7.29 (d, 2H), 7.07 (dd, 1H), 6.87 (d, 1H), 3.92 (s, 3H), 2.96 (hept, 1H), 1.26 (d, 6H).</div><div class="NLM_p last">The nitro group of the material obtained above was catalytically hydrogenated at atmospheric pressure and rt with Ra−Ni (0.5 g) in 30 mL of MeOH/THF 1:1. Some over-reduction to the amino alcohol was observed. This material was separated by chromatography (hexanes/ethyl acetate) to yield 550 mg (42%) of <b>5</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.63 (d, 2H), 7.31 (d, 2H), 7.01 (d, 1H), 6.98 (dd, 1H), 6.72 (d, 1H), 3.68 (s, 3H), 2.98 (hept, 1H), 1.29 (d, 6H). MS: 270 (M + 1)<sup>+</sup>.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (2-Isopropyl-amino-5-methoxy-phenyl)-(4-isopropyl-phenyl)-methanone (<b>6</b>)</h3><div class="NLM_p last">A mixture of the amine <b>5</b> (500 mg; 1.86 mmol) and 308 mg (2.23 mmol) of potassium carbonate in 33 mL of 2-iodopropane was stirred for two days at 110 °C. The mixture was distributed between ethyl acetate and water, the layers were separated, and the organics concentrated in vacuo. Flash-chromatography (ethyl acetate/hexanes) yielded 530 mg of a yellow oil, which was a mixture of the desired monoalkylated <b>6</b> and some dialkylated material (8%). This mixture was used for the next cyclization step without further purification.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 1-Isopropyl-4-(4-isopropyl-phenyl)-6-methoxy-1H-quinazolin-2-one (<b>2a</b>)</h3><div class="NLM_p last">A solution of 250 mg (0.80 mmol) of <b>6</b> in 5 mL of glacial acetic acid was treated at rt with 81 mg (1.2 mmol) of sodium cyanate. Workup after stirring overnight afforded a yellow oil, which was purified by chromatography (petroleum ether/ethyl acetate) to give a yellow solid. After recrystallization, 150 mg (56%) of <b>2a</b> were obtained; mp 159−162 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.70 (d, 2H), 7.54 (d, 1H), 7.29−7.40 (m, 4H), 5.21 (broad, 1H), 3.78 (s, 3H), 3.00 (broad hept, 1H), 1.69 (d, 6H), 1.30 (d, 6H). MS: 337 (M + 1)<sup>+</sup>.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 4-(4-<i>tert</i>-Butyl-phenyl)-1-isopropyl-6-methoxy-1<i>H</i>-quinazolin-2-one (<b>2f</b>)</h3><div class="NLM_p"><b>2f</b> was prepared according to the method described by Houlihan et al.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> A suspension of 200 mg (0.96 mmol) of 1-isopropyl-1-(4-methoxy-phenyl)-urea, 192 μL (1.15 mmol) of 4-<i>tert</i>-butylbenzaldehyde, and 32 μL (0.49 mmol) of methanesulfonic acid in 1 mL of diglyme was heated at 130 °C overnight. The reaction mixture was poured into water and extracted with ethyl acetate. The crude product was purified by preparative HPLC to yield 163 mg (0.46 mmol, 48%) of the intermediate 4-(4-<i>tert</i>-butyl-phenyl)-1-isopropyl-6-methoxy-3,4-dihydro-1<i>H</i>-quinazolin-2-one.</div><div class="NLM_p last">The whole amount of this intermediate was dissolved in 3 mL of 1,4-dioxane and treated at 10 °C with a solution of 88 mg (0.56 mmol) of KMnO<sub>4</sub> in 2 mL of water followed by the addition of 37 μL (0.48 mmol) of 36% formalin solution. After 20 min, the reaction mixture was filtered and the filtrate was evaporated. The residue was purified by chromatography (ethyl acetate/hexanes) to yield 84 mg (52%) of <b>2f</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.71 (d, 2H), 7.54 (d, 1H), 7.35−7.31 (m, 4H), 5.21 (hept, 1H), 3.79 (s, 3H), 1.69 (d, 6H), 1.38 (s, 9H). MS: 351 (M + 1)<sup>+</sup>.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 6-Hydroxy-1-isopropyl-4-(4-isopropyl-phenyl)-1<i>H</i>-quinazolin-2-one (<b>7a</b>)</h3><div class="NLM_p last">To a solution of 5.0 g (14.9 mmol) of <b>2a</b> in 20 mL of CH<sub>2</sub>Cl<sub>2</sub>, 29.8 mL (29.8 mmol) of 1 M solution of BBr<sub>3</sub> in CH<sub>2</sub>Cl<sub>2</sub> were added dropwise, causing a slight exotherm. After stirring for 3 h at rt, the reaction mixture was poured into water and extracted with CH<sub>2</sub>Cl<sub>2</sub>. Crystallization from diethyl ether afforded 3.66 g (76%) of <b>7a</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 300 MHz): δ 8.00 (d, 1H), 7.76 (d, 2H), 7.74 (dd, 1H), 7.65 (d, 2H), 7.28 (d, 1H), 5.34 (m, 1H), 3.12 (hept, 1H), 1.72 (d, 6H), 1.36 (d, 6H). MS: 323 (M + 1)<sup>+</sup>.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 6-Allyloxy-1-isopropyl-4-(4-isopropyl-phenyl)-1<i>H</i>-quinazolin-2-one (<b>7f</b>)</h3><div class="NLM_p last">To a solution of 3.66 g (11.4 mmol) of <b>7a</b> in 20 mL of DMEU, 5.57 g (17.1 mmol) of cesium carbonate were added, followed by 2.76 g (22.8 mmol) of allyl bromide. After stirring for 18 h at rt, water was added and the product was extracted with diethyl ether. Chromatography (hexanes/ethyl acetate) afforded 2.96 g (72%) of <b>7f</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 300 MHz): δ 7.68 (dt, 2H), 7.52 (d, 1H), 7.38−7.32 (m, 4H), 6.00 (ddt, 1H), 5.37 (dq, 1H), 5.31 (dq, 1H), 5.20 (hept, 1H), 4.50 (dt, 2H), 3.00 (hept, 1H), 1.69 (d, 6H), 1.31 (d, 6H). MS: 363 (M + 1)<sup>+</sup>.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (2-Benzyl-amino-5-propargyloxy-phenyl)-(4-isopropyl-phenyl)-methanone (<b>9a</b>)</h3><div class="NLM_p last">A mixture of 1.00 g (3.41 mmol) (2-amino-5-proparyloxy-phenyl)-(4-isopropyl-phenyl)-methanone (<b>8</b>), 0.49 mL (4.10 mmol) of benzyl bromide, and 0.70 mL (4.09 mmol) of Huenig’s base in 10 mL of 1,4-dioxane was stirred for 7 h at 100 °C. The crude product obtained after extraction with ethyl acetate was purified by flash chromatography (ethyl acetate/hexanes) to yield 1.23 g (88%) of <b>9a</b> in the form of a yellow oil. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD): δ 7.58 (d, 2H), 7.39−7.31 (m, 6H), 7.27−7.22 (m, 1H), 7.13−7.08 (m, 2H), 6.78 (d, 1H), 4.53 (s, 2H), 4.48 (s, 2H), 3.00 (hept, 1H), 2.91 (s, 1H), 1.30 (d, 6H). MS: 384 (M + 1)<sup>+</sup>.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 1-Benzyl-4-(4-isopropyl-phenyl)-6-propargyloxy-1<i>H</i>-quinazolin-2-one (<b>10a</b>)</h3><div class="NLM_p last">A solution of 0.5 g (1.15 mmol) of <b>9a</b> and 78 mg (1.15 mmol) of sodium cyanate in 12 mL of glacial acetic acid was stirred for 4 h. After careful neutralization with 0.1 N NaOH solution, the reaction mixture was extracted with ethyl acetate. The crude product was purified by flash-chromatography (ethyl acetate/hexanes). After recrystallization, 240 mg (36%) of <b>10a</b> was obtained as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.75 (d, 2H), 7.49 (s, 1H), 7.39 (d, 2H), 7.23−7.34 (m, 7H), 5.56 (s, 2H), 4.63 (s, 2H), 3.02 (hept, 1H), 2.53 (s, 1H), 1.32 (d, 6H). MS: 409 (M + 1)<sup>+</sup>.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> {2-[3-(2-Hydroxy-ethoxy)-benzylamino]-5-propargyloxy-phenyl}-(4-isopropyl-phenyl)-methanone (<b>9m</b>)</h3><div class="NLM_p last">A solution of 4.00 g (13.6 mmol) of the aniline <b>8</b> in 50 mL of dichloromethane was treated at rt with 2.43 g (14.3 mmol) of 3-(2-hydroxyethoxy)benzaldehyde and 3.35 g (15.0 mmol) of sodium triacetoxyborohydride. After stirring overnight at rt, another 0.3 equiv of the aldehyde and the hydride was added to drive the reaction to completion. Workup was done after a further 8 h by pouring the orange reaction mixture into 100 mL of water and extraction with dichloromethane. The crude yellow oil was purified by chromatography (ethyl acetate/hexanes) to yield 3.6 g (60%) of {2-[3-(2-hydroxy-ethoxy)-benzylamino]-5-propargyloxy-phenyl}-(4-isopropyl-phenyl) methanone (<b>9m</b>). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.58 (broad, OH), 7.59 (d, 2H), 7.29 (d, 2H), 7.26 (t, 1H), 7.20−7.22 (m, 1H), 7.08 (dd, 1H), 6.97 (d, 1H), 6.94 (s, 1H), 6.80 (d, 1H), 6.66 (d, 1H), 4.52 (d, 2H), 4.43 (s, 2H), 4.03−4.08 (m, 2H), 3.91−3.94 (m, 2H), 2.98 (hept, 1H), 2.48 (t, 1H), 1.31 (d, 6H).</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 1-[3-(2-Hydroxy-ethoxy)-benzyl]-4-(4-isopropyl-phenyl)-6-propargyloxy-1<i>H</i>-quinazolin-2-one (<b>10m</b>)</h3><div class="NLM_p last">A solution of 2.50 g (5.64 mmol) of <b>9m</b> and 748 mg (11.3 mmol) of sodium cyanate in 45 mL of glacial acetic acid was stirred for 1 h at rt. After concentration in vacuo, the residue was poured into 100 mL of water and extracted with ethyl acetate. The organic layers were washed with 1 M aqueous potassium carbonate solution and brine to give a yellow foam on concentration in vacuo. The crude product was triturated with hexane to yield 2.1 g (80%) of the target compound <b>10m</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.76 (d, 2H), 7.50 (d, 1H), 7.39 (d, 2H), 7.32 (dd, 1H), 7.23−7.28 (m, 2H), 6.93 (d, 1H), 6.89 (s, 1H), 6.81 (dd, 1H), 5.52 (broad s, 2H), 4.64 (d, 2H), 4.04 (t, 2H), 3.92 (t, 2H), 3.02 (hept, 1H), 2.54 (t, 1H), 1.32 (d, 6H). MS: 469 (M + 1)<sup>+</sup>.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 1-[3-(2-Hydroxy-ethoxy)-benzyl]-4-(4-isopropyl-phenyl)-6-propargyloxy-1<i>H</i>-quinazolin-2-thione (<b>11m</b>)</h3><div class="NLM_p last">A solution of 2.10 g (4.73 mmol) <b>9m</b> in 20 mL of THF was treated with 700 μL (5.2 mmol) of benzoyl isothiocyanate. After stirring for 2 h at rt, 654 mg (4.73 mmol) of potassium carbonate and 20 mL of methanol were added. The reaction was complete after a further 2 h and worked up by quenching with 200 mL of a brine/water mixture. Extraction with dichloromethane and concentration of the organic layers afforded an orange crude product, which was purified by chromatography (ethyl acetate/hexanes), resulting in 1.66 g of <b>11m</b> in the form of an orange foam. The product was further purified by trituration with diethyl ether. Yield: 1.23 g (50%); mp 84−86 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.82 (d, 2H), 7.52 (m, 1H), 7.20−7.42 (m, 5H), 6.76−6.94 (m, 3H), 6.18 (broad s, 2 H), 4.66 (d, 2 H), 4.03 (t, 2H), 3.92 (t, 2H), 3.00 (hept, 1H), 2.56 (t, 1H), 1.30 (d, 6H). MS: 485 (M + 1)<sup>+</sup>.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (2-Chloro-5-nitro-phenyl)-4-isopropoxy-phenyl)-methanone (<b>12</b>)</h3><div class="NLM_p">A solution of 11.1 g (60 mmol) of 2-chloro-5-nitrobenzaldehyde in 140 mL of anhydrous THF was treated at −75 °C dropwise with 86 mL (61.9 mmol) of 0.72 M 4-isopropyl-phenyl-magnesium bromide. After complete addition, the mixture was allowed to come to rt. Extractive workup with diluted HCl solution/ethyl acetate resulted in 20.0 g of a dark oil, which was purified by flash-chromatography (hexanes/ethyl acetate) to give 15.0 g (81%) of (2-chloro-5-nitro-phenyl)-(4-isopropyl-phenyl)-methanol in the form of a yellow oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.71 (d, 1H), 8.10 (dd, 1H), 7.49 (d, 1H), 7.31 (d, 2H), 7.22 (d, 2H), 6,17 (d, 1H), 2.90 (hept, 1H), 2.88 (d, OH), 1.24 (d, 6H).</div><div class="NLM_p last">A solution of 1.2 g (3.92 mmol) of the alcohol prepared in the previous step in 10 mL of acetone was treated at 0 °C with 1.8 mL (4.79 mmol) of 2.66 M Jones reagent. Stirring was continued overnight at rt. The acetone was removed in vacuo, followed by extractive workup with ethyl acetate/water to result in 1.09 g (92%) of <b>12</b> in the form of a yellow solid; mp 86−89 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.29 (dd, 1H), 8.23 (d, 1H), 7.73 (d, 2H), 7.67 (d, 1H), 7.36 (d, 2H), 3.00 (hept, 1H), 1.29 (d, 6H). MS: 274 [(M + 1)<sup>+</sup> − 30].</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (2-Isopropylamino-5-nitro-phenyl)-(4-isopropyl-phenyl)-methanone (<b>13</b>)</h3><div class="NLM_p last">A mixture of 300 mg (0.95 mmol) of <b>12</b> in 15 mL of isopropylamine was heated to 65 °C for 10 h in a sealed tube. The excess of amine was stripped off in vacuo. Extraction of the residue with ethyl acetate/water gave a quantitative yield of <b>13</b> in the form of a yellow resin, which was used without purification in the next step. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 9.24 (broad d, NH), 8.54 (d, 1H), 8.23 (dd, 1H), 7.57 (d, 2H), 7.35 (d, 2H), 6.78 (d, 1H), 3.88 (8-line system, 1H), 3.00 (hept, 1H), 1.36 (d, 6H), 1.31 (d, 6H). MS: 327 (M + 1)<sup>+</sup>.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 1-Isopropyl-4-(4-isopropyl-phenyl)-6-nitro-1<i>H</i>-quinazolin-2-one (<b>14</b>)</h3><div class="NLM_p last">The crude benzophenone derivative <b>13</b> was taken up into 10 mL of benzene and treated slowly with 0.10 mL (1.2 mmol) of chlorosulfonyl isocyanate (diluted with 2 mL of benzene). After stirring 1 h at rt, extractive workup with ethyl acetate/water afforded the crude product, which was purified by chromatography (petroleum ether/ethyl acetate). Yield (after recrystallization from diethyl ether): 140 mg (40%) of <b>14</b> in the form of a slightly yellow solid; mp 208−209 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.79 (d, 1H), 8.53 (dd, 1H), 7.71 (d, 2H), 7.67 (d, 1H), 7.43 (d, 2H), 5.14 (hept, 1H), 3.03 (hept, 1H), 1.73 (d, 6H), 1.33 (d, 6H). MS: 352 (M + 1)<sup>+</sup>.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 6-Amino-1-isopropyl-4-(4-isopropyl-phenyl)-1<i>H</i>-quinazolin-2-one (<b>15</b>)</h3><div class="NLM_p last">Catalytic hydrogenation of a solution of 4.05 g (11.5 mmol) of <b>14</b> in 150 mL ethanol/50 mL THF over Raney nickel (1 g) at rt and normal pressure resulted in a quantitative yield of <b>15</b> as a red solid, which was used for further transformations without purification; mp 218−220 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.65 (d, 2H), 7.42 (d, 1H), 7.34 (d, 2H), 7.08−7.13 (m, 2H), 5.18 (broad hept, 1H), 3.67 (broad, NH<sub>2</sub>), 2.99 (hept, 1H), 1.67 (d, 6H), 1.30 (d, 6H). MS: 322 (M + 1)<sup>+</sup>.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 6-Allylamino-1-isopropyl-4-(4-isopropyl-phenyl)-1<i>H</i>-quinazolin-2-one (<b>16e</b>)</h3><div class="NLM_p last">To a solution of 40 mg (0.124 mmol) of <b>15</b> and 50 μL (0.29 mmol) of <i>N</i>,<i>N</i>-diisopropylethyl amine (in 2 mL of dichloromethane), 16 μL (0.13 mmol) of trimethylchlorosilane were added dropwise at rt. After stirring for 1 h at 50 °C, 1 equiv of allyl bromide (11 μL; 0.13 mmol) was added. The reaction was kept for 6 h at that temperature. The crude product obtained after extractive workup with ethyl acetate/water was purified by flash chromatography (ethyl acetate/hexanes) to give 10 mg (33%) of <b>16e</b>; mp 209−211 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.67 (d, 2H), 7.43 (d, 1H), 7.33 (d, 2H), 7.07 (dd, 1H), 6.99 (d, 1H), 5.80−5.94 (m, 1H), 5.13−5.26 (m, 3H), 3.89 (broad s, NH), 3.72 (broad d, 2H), 2.98 (hept, 1H), 1.66 (d, 6H), 1.29 (d, 6H). MS: 362 (M + 1)<sup>+</sup>.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 6-Dipropargylamino-1-isopropyl-4-(4-isopropyl-phenyl)-1<i>H</i>-quinazolin-2-one (<b>16h</b>)</h3><div class="NLM_p last">A mixture of 200 mg (0.622 mmol) of the aniline <b>15</b> in 2 mL of DMF and 260 mg (1.87 mmol) of potassium carbonate was treated with 0.14 mL (1.57 mmol) of propargyl bromide. The mixture was heated in a sealed tube for 12 h at 90 °C. Extraction with ethyl acetate/water resulted in a dark oil, which was purified by chromatography (petroleum ether/ethyl acetate). Yield: 120 mg (48%) as a yellow foam. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7,75 (d, 2H), 7.56 (d, 1H), 7.41−7.47 (m, 2H), 7.36 (d, 2H), 5.21 (broad hept, 1H), 4.06 (d, 4H), 3.00 (hept, 1H), 2.28 (broad t, 2H), 1.69 (d, 6H), 1.31 (d, 6H). MS: 398 (M + 1)<sup>+</sup>.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (2-Allyl-6-amino-3-hydroxy-phenyl)-(4-isopropyl-phenyl)-methanone (<b>18a</b>)</h3><div class="NLM_p">A mixture of 10.0 g (34.0 mmol) of <b>17</b> (prepared analogously to <b>8</b>), 100 mL of DMEU, and 50 mL of water was heated in an autoclave for 48 h at a interior temperature of 165 °C. Water was evaporated in vacuo. The remaining DMEU solution was put on a reversed phase C<sub>18</sub> column, and the DMEU was washed down with water. The eluent was changed to MeOH to collect the crude product, which was purified by chromatography (hexanes/ethyl acetate) to yield 6.87 g (69%) of <b>18a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.79 (d, 2H), 7.30 (d, 2H), 6.81 (d, 1H), 6.60 (d, 1H), 5.80 (ddt, 1H), 5.03 (dq, 1H), 5.01 (dq, 1H), 3.16 (dt, 2H), 2.97 (hept, 1H), 1.28 (d, 6H). MS: 296 (M + 1)<sup>+</sup>.</div><div class="NLM_p last">On smaller scale, heating <b>17</b> in a DMEU water mixture by microwave radiation to 180 °C for 30 min afforded <b>18a</b> readily.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (2-Allyl-6-benzylamino-3-hydroxy-phenyl)-(4-isopropyl-phenyl)-methanone (<b>19a</b>)</h3><div class="NLM_p last">To a solution of 500 mg (1.69 mmol) of <b>18a</b> in 3 mL of CH<sub>2</sub>Cl<sub>2</sub>, 171 μL (1.69 mmol) of benzaldehyde, 148 mg (2.37 mmol) of NaCNBH<sub>3</sub>, and 96 μL (1.69 mmol) of glacial acetic acid were added. After stirring at rt for 150 min, 1 M aqueous HCl was added to quench the excess of hydride. The mixture was made basic by the addition of 1 M NaOH followed by extraction with CH<sub>2</sub>Cl<sub>2</sub>. Chromatography (hexanes/ethyl acetate) afforded 472 mg (72%) of <b>19a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.78 (d, 2H), 7.31 (d, 2H), 7.28−7.16 (m, 5H), 6.82 (d, 1H), 6.56 (d, 1H), 5.79 (ddt, 1H), 5.02 (dd, 1H), 5.01 (dd, 1H), 4.22 (s, 2H), 3.17 (d, 2H), 2.99 (hept, 1H), 1.30 (d, 6H). MS: 386 (M + 1)<sup>+</sup>.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 5-Allyl-1-benzyl-6-hydroxy-4-(4-isopropyl-phenyl)-1<i>H</i>-quinazolin-2-one (<b>20a</b>)</h3><div class="NLM_p last">A solution of 53.8 mg (140 μmol) of <b>19a</b> and 9.1 mg (140 μmol) of sodium cyanate in 0.8 mL of glacial acetic acid was stirred at rt for 18 h. Saturated sodium bicarbonate solution was added, and the product was extracted with CH<sub>2</sub>Cl<sub>2</sub> to yield 42 mg (73%) of <b>20a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.48 (d, 2H), 7.33−7.24 (m, 8H), 7.14 (d, 1H), 5.65 (ddt, 1H), 5.52 (s, 2H), 5.10 (dd, 1H), 4.95 (dd, 1H), 3.20 (d, 2H), 2.97 (hept, 1H), 1.28 (d, 6H). MS: 411 (M + 1)<sup>+</sup>.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 1-Benzyl-6-hydroxy-4-(4-isopropyl-phenyl)-5-propyl-1<i>H</i>-quinazolin-2-one (<b>20b</b>)</h3><div class="NLM_p last">A solution of 200 mg (519 μmol) of <b>19a</b> in 6 mL of methanol was hydrogenated in the presence of Raney nickel during 2 h at normal pressure and rt. The catalyst was filtered off, and the filtrate was evaporated to yield 183.5 mg (91%) of <b>19b</b>. As described above for <b>20a</b>, <b>19b</b> was cyclized with NaOCN to afford <b>20b</b> in 87% yield. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.58 (s, 1H), 7.41−7.16 (m, 11H), 5.43 (s, 2H), 2.99 (hept, 1H), 2.19 (m, 2H), 1.25 (d, 6H), 1.18 (m, 2H), 0.36 (t, 3H). MS: 413 (M + 1)<sup>+</sup>.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (6-Amino-2-cyclopropylmethyl-3-hydroxy-phenyl)-(4-isopropyl-phenyl)methanone (<b>18c</b>)</h3><div class="NLM_p last">A diazomethane solution was freshly prepared by adding 515 mg (5 mmol) of <i>N</i>-nitroso-<i>N</i>-methylurea in small portions to a stirred mixture of 50 mL of diethyl ether and 17.5 mL of 40% aq potassium hydroxide solution at 5 °C. Ten minutes after the last addition, the organic layer was separated off and dried over solid potassium hydroxide. This diazomethane solution was added to a concentrated solution of 1.00 g (3.39 mmol) of <b>18a</b> in diethyl ether containing 152 mg (0.68 mmol) of Pd(OAc)<sub>2</sub>. After stirring for 16 h at rt, the reaction mixture was filtered, evaporated to dryness, and purified by chromatography (hexanes/ethyl acetate) to yield 590 mg (56%) of <b>18c</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.78 (d, 2H), 7.29 (d, 2H), 6.77 (d, 1H), 6.55 (d, 1H), 4.70 (s, 1H), 3.40 (broad, 2H), 2.96 (hept, 1H), 2.35 (d, 2H), 1.27 (d, 6H), 0.88 (m, 1H), 0.38 (m, 2H), 0.09 (m, 2H). MS: 310 (M + 1)<sup>+</sup>.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 1-Benzyl-5-cyclopropylmethyl-6-hydroxy-4-(4-isopropyl-phenyl)-1<i>H</i>-quinazolin-2-one (<b>20c</b>)</h3><div class="NLM_p last"><b>20c</b> was prepared from <b>18c</b> by reductive amination followed by treatment with NaOCN as described for <b>19a</b> and <b>20a</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.00 (broad 1H), 7.47 (d, 2H), 7.29−7.22 (m, 8H), 7.01 (d, 1H), 5.49 (s, 2H), 2.96 (hept, 1H), 2.36 (d, 2H), 1.27 (d, 6H), 0.69 (m, 1H), 0.17 (m, 2H), −0.18 (m, 2H). MS: 425 (M + 1)<sup>+</sup>.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> <i>N</i>-{3-[4-(4-Isopropyl-pheny)-2-oxo-6-propargyloxy-2<i>H</i>-quinazolin-1-ylmethyl]-phenyl}-2-[4-(2-methoxy-ethyl)piperazin-1-yl]-acetamide (<b>21b</b>)</h3><div class="NLM_p">A suspension of 9.00 g (19.8 mmol) of 4-(4-isopropyl-phenyl)-1-(3-nitro-benzyl-6-propargyloxy-1<i>H</i>-quinazolin-2-one (prepared analogously to compound <b>10a</b>) and 10 g (180 mmol) of iron powder in 180 mL of glacial acetic acid was stirred at 45 °C for 30 h. After 6 and 15 h, additional batches of 10 g of iron powder were added. The mixture was filtered through Hyflo and distributed between water and dichloromethane. The crude product was obtained as a yellow foam, which was purified by chromatography (ethyl acetate/petroleum ether) to yield 5.05 g (61%) of 1-(3-amino-benzyl)-4-(4-isopropyl-phenyl)-6-prop-2-ynyloxy-1<i>H</i>-quinazolin-2-one. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.75 (d, 2H), 7.48 (s, 1H), 7.39 (d, 2H), 7.30 (s, 2H), 7.11 (t, 1H), 6.73 (d, 1H), 6.62 (s, 1H), 6.57 (d, 1H), 5.46 (broad s, 2H), 4.64 (d, 2H), 3.65 (broad s, NH<sub>2</sub>), 3.02 (hept, 1H), 2.54 (t, 1H), 1.32 (d, 6H).</div><div class="NLM_p">The aniline (13.60 g; 32.0 mmol) obtained above was dissolved in 200 mL of dichloromethane and 5.4 mL (38.5 mmol) of triethylamine and was treated at −5 °C dropwise with 2.74 mL (35.2 mmol) of chloroacetyl chloride. After completed addition, the cooling bath was removed and the suspension allowed to come to rt. Workup was done after stirring for 2 h at rt by the addition of water and additional dichloromethane. A quantitative crude yield (16.0 g) of 2-chloro-<i>N</i>-{3-[4-(4-isopropyl-phenyl)-2-oxo-6-prop-2-ynyloxy-2<i>H</i>-quinazolin-1-ylmethyl]-phenyl}-acetamide was obtained in the form of dark-green crystals which were used without purification for the next step. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 8.34 (broad, NH), 7.72 (d, 2H), 7.60 (d, 1H), 7.49 (d, 1H), 7.46 (s, 1H), 7.37 (d, 2H), 7.27−7.35 (m, 3H), 7.12 (d, 1H), 5.53 (broad, 2H), 4.64 (d, 2H), 4.16 (s, 2H), 3.01 (hept, 1H), 2.55 (t, 1H), 1.32 (d, 6H).</div><div class="NLM_p last">A DMEU solution (25 mL) of 11.0 g (33.3 mmol) of the chloroacetyl derivative obtained above was treated with potassium carbonate (6.1 g; 44 mmol) and 1-(2-methoxyethyl)-piperazine (4.75 g; 33.0 mmol). The mixture was heated to 65 °C for 2 h. The yellow product was filtered off from the resulting suspension and washed with water. Furthermore, the filtrate was extracted with ethyl acetate, and the organic layers were concentrated in vacuo to give additional material. The combined crude material was purified by chromatography (dichloromethane/methanol). Yield: 14.0 g (98%) <b>21b</b>; mp 199−200 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 9.05 (broad, NH), 7.75 (d, 2H), 7.58 (s, 1H), 7.53 (d, 1H), 7.49 (d, 1H), 7.39 (d, 2H), 7.27−7.35 (m, 3H), 7.05 (d, 1H), 5.53 (broad s, 2H), 4.64 (s, 2H), 3.55 (broad t, 2H), 3.35 (s, 3H), 3.13 (s, 2H), 3.02 (hept, 1H), 2.75−2.56 (broad, 10H), 2.54 (t, 1H), 1.32 (d, 6H). MS: 608 (M + 1)<sup>+</sup>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i55"><a href="/doi/suppl/10.1021/jm901811v">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11058" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11058" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental information on synthetic preparation and analytical data of compounds <b>2b</b>−<b>2e</b>, <b>2g</b>−<b>2j</b>, <b>7b</b>−<b>7e</b>, <b>7g</b>−<b>7i</b>, <b>8</b>, <b>10b</b>−<b>10l</b>, <b>16a</b>−<b>16d</b>, <b>16f</b>, <b>16g</b>, <b>16i</b>, <b>21a</b>, and <b>21c</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm901811v/suppl_file/jm901811v_si_001.pdf">jm901811v_si_001.pdf (82.93 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm901811v" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67568" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67568" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leo Widler</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#620e070d4c150b060e0710220c0d140310160b114c010d0f"><span class="__cf_email__" data-cfemail="deb2bbb1f0a9b7bab2bbac9eb0b1a8bfacaab7adf0bdb1b3">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eva Altmann</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">René Beerli</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Werner Breitenstein</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rochdi Bouhelal</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Buhl</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rainer Gamse</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marc Gerspacher</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine Halleux</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Markus R. John</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hansjoerg Lehmann</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Oskar Kalb</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Development, Novartis Pharma AG, Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michaela Kneissel</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Missbach</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Irene R. Müller</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sibylle Reidemeister</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Development, Novartis Pharma AG, Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Johanne Renaud</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Agnes Taillardat</span> - <span class="hlFld-Affiliation affiliation">Pharmaceutical Development, Novartis Pharma AG, Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruben Tommasi</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, 400 Technology Square, Cambridge, MA</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sven Weiler</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Romain M. Wolf</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Klaus Seuwen</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i54">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25817" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25817" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Prof. Gerda Breitwieser (Syracuse University, NY) for providing us with point mutations of CaSR to investigate the binding mode of our compounds. Expert technical assistance of the following colleagues is gratefully acknowledged. Chemistry: Sandra Ammon Vetter, Nadine Braendlin, Pascale Fille, Bernard Flueckiger, Hansjoerg Haas, Doris Huerzeler, Sabine Kimmel, Michael Kindler, Rémy Klein, Patrick Lerch, Uzel Nilufer, Esther Roehn-Carnemolla, Karin Ryffel, Gerard Schreiber, Ivan Trkulja. Prep lab: Dominik Wiss, Thomas Ruppen, Martin Roggwiller. HTS: Laurent Tenaillon, Jochen Wyss. Biology: Heinz Anklin, Margot Bruederlin, Reto Cortesi, Lilian Hartmann, Marcel Merdes, Roger Vuille, Barbara Wilmering-Wetter. PK/PD: Valérie Cordier, Lothar Dillo, Paul Hernandez, Laura Pedrini, Jean-Louis Runser, Esther Scheidegger, Hans Zihlmann. We thank Angela Mackay for proofreading and correcting the manuscript.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i56">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72683" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72683" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 25 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_contrib-group">Bodenner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggs, A.</span><span> </span><span class="NLM_article-title">Teriparatide in the management of osteoporosis</span> <span class="citation_source-journal">Clin. Interventions Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">499</span><span class="NLM_x">–</span> <span class="NLM_lpage">507</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=18225450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1ejsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=499-507&author=D.+Bodennerauthor=C.+Redmannauthor=A.+Riggs&title=Teriparatide+in+the+management+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Teriparatide in the management of osteoporosis</span></div><div class="casAuthors">Bodenner, Donald; Redman, Carolyn; Riggs, Ann</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Interventions in Aging</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">499-507</span>CODEN:
                <span class="NLM_cas:coden">CIALBC</span>;
        ISSN:<span class="NLM_cas:issn">1176-9092</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  Fracture of the hip is frequently a catastrophic event in the elderly, often resulting in death within a year and of the survivors, few regain pre-fracture quality of life.  Although less appreciated, fractures of the spine result in significant morbidity and are also assocd. with increased mortality compared with individuals without a fracture.  In recent years there has been an explosion in the development of new drugs for the treatment of osteoporosis.  Recombinant human parathyroid hormone (1-34) (20 μg/day) is a recent addn. to this armamentarium with a novel mechanism of action, which was approved by the US FDA for the treatment of postmenopausal osteoporosis and male osteoporosis secondary to hypogonadism in Nov. 2002.  It is the first osteoporosis treatment that leads to the formation of new bone with architecture similar to normal bone.  Intense efforts have been made to understand the effect of teriparatide on antiresorptive therapy and vice versa.  Although these relationships are not completely understood, the results of recent studies allow clinicians to begin to optimize therapeutic gains in bone mineral d. and improve anti-fracture efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoah_3atunqZbVg90H21EOLACvtfcHk0liDJQCmz_Udxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1ejsb4%253D&md5=ce7b8894f61d7d67e2e83b9fd03c0520</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBodenner%26aufirst%3DD.%26aulast%3DRedmann%26aufirst%3DC.%26aulast%3DRiggs%26aufirst%3DA.%26atitle%3DTeriparatide%2520in%2520the%2520management%2520of%2520osteoporosis%26jtitle%3DClin.%2520Interventions%2520Aging%26date%3D2007%26volume%3D2%26spage%3D499%26epage%3D507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_contrib-group">Bilezikian, J. P.</span><span> </span><span class="NLM_article-title">Anabolic therapy for osteoporosis</span> <span class="citation_source-journal">Women’s Health</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.2217%2F17455057.3.2.243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit12qtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=243-253&author=J.+P.+Bilezikian&title=Anabolic+therapy+for+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Anabolic therapy for osteoporosis</span></div><div class="casAuthors">Bilezikian, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Women's Health</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">243-253</span>CODEN:
                <span class="NLM_cas:coden">WHOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1745-5057</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Antiresorptive agents for osteoporosis are a cornerstone of therapy, but anabolic drugs have recently increased our options.  By directly stimulating bone formation, anabolic agents reduce fracture incidence by improving bone qualities as well as increasing bone mass.  The anabolic agent currently approved for osteoporosis, teriparatide (recombinant human parathyroid hormone[1-34]), has emerged as a major approach for selected patients with osteoporosis.  Parathyroid hormone(1-84) is also available in Europe.  Teriparatide increases bone d. and bone turnover, improves microarchitecture and changes bone size.  The incidence of vertebral and nonvertebral fractures is reduced.  A current concept in the mechanism of teriparatide action is related to its effect of stimulating processes assocd. with bone formation before processes assocd. with bone resorption.  This sequence of events has led to the concept of the anabolic window, the period of time when teriparatide is maximally anabolic.  Newer approaches to the use of teriparatide alone and in combination with antiresorptive agents has led to ways in which the anabolic window can be expanded.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKC2jWx9LbarVg90H21EOLACvtfcHk0liDJQCmz_Udxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit12qtL0%253D&md5=2e26b6931f831f63477e2f9a8d5f2042</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.2217%2F17455057.3.2.243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252F17455057.3.2.243%26sid%3Dliteratum%253Aachs%26aulast%3DBilezikian%26aufirst%3DJ.%2BP.%26atitle%3DAnabolic%2520therapy%2520for%2520osteoporosis%26jtitle%3DWomen%25E2%2580%2599s%2520Health%26date%3D2007%26volume%3D3%26spage%3D243%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_contrib-group">Girotra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilezikian, J. P.</span><span> </span><span class="NLM_article-title">The use of parathyroid hormone in the treatment of osteoporosis</span> <span class="citation_source-journal">Rev. Endocrinol. Metab. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1007%2Fs11154-006-9007-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=17043762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12lsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=113-121&author=M.+Girotraauthor=M.+R.+Rubinauthor=J.+P.+Bilezikian&title=The+use+of+parathyroid+hormone+in+the+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The use of parathyroid hormone in the treatment of osteoporosis</span></div><div class="casAuthors">Girotra, Monica; Rubin, Mishaela R.; Bilezikian, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in Endocrine & Metabolic Disorders</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">113-121</span>CODEN:
                <span class="NLM_cas:coden">REMDCG</span>;
        ISSN:<span class="NLM_cas:issn">1389-9155</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Anabolic skeletal agents have recently broadened our therapeutic options for osteoporosis.  By directly stimulating bone formation, they reduce fracture incidence by improving bone qualities in addn. to increasing bone mass.  Teriparatide [recombinant human parathyroid hormone(1-34)], the only anabolic agent currently approved in the United States for osteoporosis, has emerged as a major therapeutic approach to selected patients with osteoporosis.  Teriparatide is approved for both postmenopausal women and men with osteoporosis who are at high risk for fracture.  With the use of this anabolic agent, bone d. and bone turnover increase, microarchitecture improves, and bone size is beneficially altered.  The incidence of vertebral and nonvertebral fractures is reduced with teriparatide use.  Combination therapy with parathyroid hormone and an antiresorptive does not appear to offer definitive advantages over the use of PTH or an antiresorptive alone, although recent ideas about combining these agents may offer new insights.  In order to maintain increases in bone d. acquired during PTH therapy, it is important to follow its use with an antiresorptive agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgHX2PVm7hELVg90H21EOLACvtfcHk0liDJQCmz_Udxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12lsg%253D%253D&md5=2c3c9d800f166a7236c3314a6730ad79</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1007%2Fs11154-006-9007-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11154-006-9007-z%26sid%3Dliteratum%253Aachs%26aulast%3DGirotra%26aufirst%3DM.%26aulast%3DRubin%26aufirst%3DM.%2BR.%26aulast%3DBilezikian%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520use%2520of%2520parathyroid%2520hormone%2520in%2520the%2520treatment%2520of%2520osteoporosis%26jtitle%3DRev.%2520Endocrinol.%2520Metab.%2520Disord.%26date%3D2006%26volume%3D7%26spage%3D113%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1d"><span><span class="NLM_contrib-group">Rubin, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilezikian, J. P.</span><span> </span><span class="NLM_article-title">Parathyroid hormone as an anabolic skeletal therapy</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">2481</span><span class="NLM_x">–</span> <span class="NLM_lpage">2498</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=2481-2498&issue=17&author=M.+R.+Rubinauthor=J.+P.+Bilezikian&title=Parathyroid+hormone+as+an+anabolic+skeletal+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRubin%26aufirst%3DM.%2BR.%26aulast%3DBilezikian%26aufirst%3DJ.%2BP.%26atitle%3DParathyroid%2520hormone%2520as%2520an%2520anabolic%2520skeletal%2520therapy%26jtitle%3DDrugs%26date%3D2005%26volume%3D65%26issue%3D17%26spage%3D2481%26epage%3D2498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1e"><span><span class="NLM_contrib-group">Rubin, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilezikan, J. P.</span><span> </span><span class="NLM_article-title">The anabolic effects of parathyroid hormone</span> <span class="citation_source-journal">Osteoporosis Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1007%2Fs001980200026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=12030541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFWjt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=267-277&author=M.+R.+Rubinauthor=F.+Cosmanauthor=R.+Lindsayauthor=J.+P.+Bilezikan&title=The+anabolic+effects+of+parathyroid+hormone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1eR"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The anabolic effects of parathyroid hormone</span></div><div class="casAuthors">Rubin, M. R.; Cosman, F.; Lindsay, R.; Bilezikian, J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Osteoporosis International</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">267-277</span>CODEN:
                <span class="NLM_cas:coden">OSINEP</span>;
        ISSN:<span class="NLM_cas:issn">0937-941X</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag London Ltd.</span>)
        </div><div class="casAbstract">A review discusses animal and human data indicating the potential of parathyroid hormone as an anabolic agent for osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqMEj9nk-hg7Vg90H21EOLACvtfcHk0lgFTe_bq9eVmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFWjt70%253D&md5=ede19e4982006206a511e3bed09274b8</span></div><a href="/servlet/linkout?suffix=cit1e&amp;dbid=16384&amp;doi=10.1007%2Fs001980200026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs001980200026%26sid%3Dliteratum%253Aachs%26aulast%3DRubin%26aufirst%3DM.%2BR.%26aulast%3DCosman%26aufirst%3DF.%26aulast%3DLindsay%26aufirst%3DR.%26aulast%3DBilezikan%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520anabolic%2520effects%2520of%2520parathyroid%2520hormone%26jtitle%3DOsteoporosis%2520Int.%26date%3D2002%26volume%3D13%26spage%3D267%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1f"><span><span class="NLM_contrib-group">Compston, J.</span><span> </span><span class="NLM_article-title">Recombinant parathyroid hormone in the management of osteoporosis</span> <span class="citation_source-journal">Calcif. Tissue Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1f&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1007%2Fs00223-005-0012-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1f&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=16059774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1f&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFant7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2005&pages=65-71&issue=2&author=J.+Compston&title=Recombinant+parathyroid+hormone+in+the+management+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1fR"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Recombinant parathyroid hormone in the management of osteoporosis</span></div><div class="casAuthors">Compston, J.</div><div class="citationInfo"><span class="NLM_cas:title">Calcified Tissue International</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">65-71</span>CODEN:
                <span class="NLM_cas:coden">CTINDZ</span>;
        ISSN:<span class="NLM_cas:issn">0171-967X</span>.
    
            (<span class="NLM_cas:orgname">Springer Science+Business Media, Inc.</span>)
        </div><div class="casAbstract">A review.  Although the observation that injections of parathyroid hormone (PTH) ext. could increase bone mineral d. was first made in 1929, it was not until nearly 90 yr later that the 1-34 peptide of PTH became approved as a treatment for postmenopausal osteoporosis.  The checkered career of PTH as a treatment for osteoporosis has been recounted in detail previously; however, today it provides an exciting new addn. to our armamentarium of therapies.  This review considers the evidence for efficacy of recombinant human PTH 1-34 (teriparatide) in the prevention of osteoporotic fractures and discusses its positioning among other available interventions.  Studies with other PTH peptides are also discussed with respect to combination therapy, sequential therapy, and prevention of glucocorticoid-induced osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKP0lqJnWTUbVg90H21EOLACvtfcHk0lgFTe_bq9eVmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFant7nF&md5=0f5e6499ef0ba5bdac28adcdbdd714e1</span></div><a href="/servlet/linkout?suffix=cit1f&amp;dbid=16384&amp;doi=10.1007%2Fs00223-005-0012-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00223-005-0012-0%26sid%3Dliteratum%253Aachs%26aulast%3DCompston%26aufirst%3DJ.%26atitle%3DRecombinant%2520parathyroid%2520hormone%2520in%2520the%2520management%2520of%2520osteoporosis%26jtitle%3DCalcif.%2520Tissue%2520Int.%26date%3D2005%26volume%3D77%26issue%3D2%26spage%3D65%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1g"><span><span class="NLM_contrib-group">Eriksen, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, D. A.</span><span> </span><span class="NLM_article-title">Teriparatide: a bone formation treatment for osteoporosis</span> <span class="citation_source-journal">Drugs Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">935</span><span class="NLM_x">–</span> <span class="NLM_lpage">948</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1g&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1358%2Fdot.2004.40.11.872582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1g&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVSksbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2004&pages=935-948&author=E.+F.+Eriksenauthor=D.+A.+Robins&title=Teriparatide%3A+a+bone+formation+treatment+for+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1gR"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">TERIPARATIDE: A bone formation treatment for osteoporosis</span></div><div class="casAuthors">Eriksen, Erik F.; Robins, Deborah A.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of Today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">935-948</span>CODEN:
                <span class="NLM_cas:coden">MDACAP</span>;
        ISSN:<span class="NLM_cas:issn">0025-7656</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Teriparatide is the recombinant human N-terminal fragment (1-34) of endogenous human parathyroid hormone, and it is the first bone anabolic agent for the treatment of osteoporosis.  When given as once-daily s.c. injections, teriparatide can reverse the course of osteoporosis by stimulating formation of new bone and restoring lost architecture.  Teriparatide (20 μg) treatment of osteoporosis in postmenopausal women rapidly increased markers of bone formation and reduced the incidence of vertebral fractures by 65% and of nonvertebral fragility fractures by 53%.  In addn., treatment with this compd. increased spine bone mineral d. by 10% and hip bone mineral d. by 3% at study endpoint.  Teriparatide is well tolerated and is not assocd. with any serious side effects.  The compd. has been approved in Europe and in the US for the treatment of osteoporosis.  Duration of treatment is 18-24 mo and the dose does not need to be adjusted for age or gender.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1JIdWJtTLw7Vg90H21EOLACvtfcHk0lgFTe_bq9eVmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVSksbs%253D&md5=636570477d27ee584bc02ce954ecee68</span></div><a href="/servlet/linkout?suffix=cit1g&amp;dbid=16384&amp;doi=10.1358%2Fdot.2004.40.11.872582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdot.2004.40.11.872582%26sid%3Dliteratum%253Aachs%26aulast%3DEriksen%26aufirst%3DE.%2BF.%26aulast%3DRobins%26aufirst%3DD.%2BA.%26atitle%3DTeriparatide%253A%2520a%2520bone%2520formation%2520treatment%2520for%2520osteoporosis%26jtitle%3DDrugs%2520Today%26date%3D2004%26volume%3D40%26spage%3D935%26epage%3D948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1h"><span><span class="NLM_contrib-group">Hodsman, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dempster, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanley, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendler, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClung, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olszynski, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orwoll, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuen, C. K.</span><span> </span><span class="NLM_article-title">Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">688</span><span class="NLM_x">–</span> <span class="NLM_lpage">703</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1h&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1210%2Fer.2004-0006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1h&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=15769903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1h&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXps1Kit7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=688-703&issue=5&author=A.+B.+Hodsmanauthor=D.+C.+Bauerauthor=D.+W.+Dempsterauthor=L.+Dianauthor=D.+A.+Hanleyauthor=S.+T.+Harrisauthor=D.+L.+Kendlerauthor=M.+R.+McClungauthor=P.+D.+Millerauthor=W.+P.+Olszynskiauthor=E.+Orwollauthor=C.+K.+Yuen&title=Parathyroid+hormone+and+teriparatide+for+the+treatment+of+osteoporosis%3A+a+review+of+the+evidence+and+suggested+guidelines+for+its+use"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1hR"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Parathyroid hormone and teriparatide for the treatment of osteoporosis: A review of the evidence and suggested guidelines for its use</span></div><div class="casAuthors">Hodsman, Anthony B.; Bauer, Douglas C.; Dempster, David W.; Dian, Larry; Hanley, David A.; Harris, Steven T.; Kendler, David L.; McClung, Michael R.; Miller, Paul D.; Olszynski, Wojciech P.; Orwoll, Eric; Yuen, Chui Kin</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">688-703</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  All therapies currently recommended for the management of osteoporosis act mainly to inhibit bone resorption and reduce bone remodeling.  PTH and its analog, teriparatide [recombinant human PTH(1-34)], represent a new class of anabolic therapies for the treatment of severe osteoporosis, having the potential to improve skeletal microarchitecture.  Significant redns. in both vertebral and appendicular fracture rates have been demonstrated in the phase III trial of teriparatide, involving elderly women with at least one prevalent vertebral fracture before the onset of therapy.  However, there is as yet no evidence that the antifracture efficacy of PTH will be superior to the bisphosphonates, whereas cost-utility ests. suggest that teriparatide is significantly more expensive.  Teriparatide should be considered as treatment for post-menopausal women and men with severe osteoporosis, as well as for patients with established glucocorticoid-induced osteoporosis who require long-term steroid treatment.  Teriparatide should also be considered for the management of individuals at particularly high risk for fractures, including subjects who are younger than age 65 and who have particularly low bone mineral d. measurements (T scores ≤ 3.5).  Teriparatide therapy is not recommended for more than 2 yr, based, in part, on the induction of osteosarcoma in a rat model of carcinogenicity.  Total daily calcium intake from both supplements and dietary sources should be limited to 1500 mg together with adequate vitamin D intake (≤1000 U/d).  Monitoring of serum calcium may be safely limited to measurement after 1 mo of treatment; mild hypercalcemia may be treated by withdrawing dietary calcium supplements, reducing the dosing frequency of PTH, or both.  At present, concurrent therapy with antiresorptive therapy, particularly bisphosphonates, should be avoided, although sequential therapy with such agents may consolidate the beneficial effects upon the skeleton after PTH is discontinued.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7Er5Z7BfgdbVg90H21EOLACvtfcHk0ljoQ1KaP9lxzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXps1Kit7g%253D&md5=a0d06328df9dff668e76699719ae02ac</span></div><a href="/servlet/linkout?suffix=cit1h&amp;dbid=16384&amp;doi=10.1210%2Fer.2004-0006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2004-0006%26sid%3Dliteratum%253Aachs%26aulast%3DHodsman%26aufirst%3DA.%2BB.%26aulast%3DBauer%26aufirst%3DD.%2BC.%26aulast%3DDempster%26aufirst%3DD.%2BW.%26aulast%3DDian%26aufirst%3DL.%26aulast%3DHanley%26aufirst%3DD.%2BA.%26aulast%3DHarris%26aufirst%3DS.%2BT.%26aulast%3DKendler%26aufirst%3DD.%2BL.%26aulast%3DMcClung%26aufirst%3DM.%2BR.%26aulast%3DMiller%26aufirst%3DP.%2BD.%26aulast%3DOlszynski%26aufirst%3DW.%2BP.%26aulast%3DOrwoll%26aufirst%3DE.%26aulast%3DYuen%26aufirst%3DC.%2BK.%26atitle%3DParathyroid%2520hormone%2520and%2520teriparatide%2520for%2520the%2520treatment%2520of%2520osteoporosis%253A%2520a%2520review%2520of%2520the%2520evidence%2520and%2520suggested%2520guidelines%2520for%2520its%2520use%26jtitle%3DEndocr.%2520Rev.%26date%3D2005%26volume%3D26%26issue%3D5%26spage%3D688%26epage%3D703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1i"><span><span class="NLM_contrib-group">Hodsman, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanley, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ettinger, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognese, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalfe, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsay, R.</span><span> </span><span class="NLM_article-title">Efficacy and safety of human parathyroid hormone-(1−84) in increasing bone mineral density in postmenopausal osteoporosis</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">5212</span><span class="NLM_x">–</span> <span class="NLM_lpage">5220</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1i&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1210%2Fjc.2003-030768" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1i&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=14602752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1i&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptVyns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2003&pages=5212-5220&issue=11&author=A.+B.+Hodsmanauthor=D.+A.+Hanleyauthor=M.+P.+Ettingerauthor=M.+A.+Bologneseauthor=J.+Foxauthor=A.+J.+Metcalfeauthor=R.+Lindsay&title=Efficacy+and+safety+of+human+parathyroid+hormone-%281%E2%88%9284%29+in+increasing+bone+mineral+density+in+postmenopausal+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1iR"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of human parathyroid hormone-(1-84) in increasing bone mineral density in postmenopausal osteoporosis</span></div><div class="casAuthors">Hodsman, Anthony B.; Hanley, David A.; Ettinger, Mark P.; Bolognese, Michael A.; Fox, John; Metcalfe, Anna J.; Lindsay, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5212-5220</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Daily s.c. injections of N-terminal analogs of PTH increase bone mass and decrease fractures in osteoporotic women.  We investigated the efficacy and safety of human PTH-(1-84) (full-length PTH) in the treatment of postmenopausal osteoporosis in a double-blind, placebo-controlled study.  The women (n = 50-53/group) self-administered PTH (50, 75, or 100 μg) or placebo by daily s.c. injection for 12 mo.  PTH treatment induced time- and dose-related increases in lumbar spine bone mineral d. (BMD).  The 100-μg dose increased BMD significantly at 3 mo (+2.0%) and 12 mo (+7.8%).  BMD underestimated the anabolic effect of PTH in lumbar spine (bone mineral content, +10.0%) because bone area increased significantly (+2.0%).  A nonsignificant decrease (-0.9%) in total hip BMD occurred during the first 6 mo with the 100-μg dose, but this trend reversed (+1.6%) during the second 6 mo.  Bone turnover markers increased during the first half of the study and were maintained at elevated levels during the second 6 mo.  Protocol compliance was excellent (95-98%), and treatment was generally safe and well tolerated.  Dose-related incidences of transient hypercalcemia occurred, but only one patient (100-μg group) was withdrawn because of repeated hypercalcemia.  Thus, full-length PTH was efficacious and safe over 12 mo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9JUuh11mAhrVg90H21EOLACvtfcHk0ljoQ1KaP9lxzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptVyns7k%253D&md5=97c1f6be416d744473dcd5dc0acb0b2a</span></div><a href="/servlet/linkout?suffix=cit1i&amp;dbid=16384&amp;doi=10.1210%2Fjc.2003-030768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2003-030768%26sid%3Dliteratum%253Aachs%26aulast%3DHodsman%26aufirst%3DA.%2BB.%26aulast%3DHanley%26aufirst%3DD.%2BA.%26aulast%3DEttinger%26aufirst%3DM.%2BP.%26aulast%3DBolognese%26aufirst%3DM.%2BA.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DMetcalfe%26aufirst%3DA.%2BJ.%26aulast%3DLindsay%26aufirst%3DR.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520human%2520parathyroid%2520hormone-%25281%25E2%2588%259284%2529%2520in%2520increasing%2520bone%2520mineral%2520density%2520in%2520postmenopausal%2520osteoporosis%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2003%26volume%3D88%26issue%3D11%26spage%3D5212%26epage%3D5220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_contrib-group">Trivedi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mithal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chattopadhyay, N.</span><span> </span><span class="NLM_article-title">Recent updates on the calcium-sensing receptor as a drug target</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">178</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.2174%2F092986708783330601" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=18220773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVyisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=178-186&issue=2&author=R.+Trivediauthor=A.+Mithalauthor=N.+Chattopadhyay&title=Recent+updates+on+the+calcium-sensing+receptor+as+a+drug+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Recent updates on the calcium-sensing receptor as a drug target</span></div><div class="casAuthors">Trivedi, Ritu; Mithal, Ambrish; Chattopadhyay, Naibedya</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">178-186</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Parathyroid hormone (PTH) secreted from parathyroid cells is a key regulator of circulating levels of calcium ion, which is maintained within a narrow physiol. range mainly by the action of a cell surface Ca2+-sensing receptor (CaSR) residing on parathyroid cells.  The CaSR belongs to the family C of G-protein-coupled receptors (GPCRs), all members of which have a large extra cellular domain called Venus flytrap, akin to bacterial nutrient sensor.  Promiscuity of the CaSR is reflected in its binding to several physiol. relevant di- or polyvalent cations that could elicit cellular signaling, yet the ligand specificity remains poor.  This problem has been circumvented by the discovery of calcimimetics, the pos. allosteric modulators of the CaSR that activate the CaSR on parathyroid cells, immediately suppressing PTH secretion.  Out of several small mols. that act as calcimimetics, cinacalcet is the most extensively studied.  The discovery of the CaSR and these specific agonists provides important insights into the discovery of new drugs that will be discussed in this review from the perspective of their structure-activity relationship.  The calcimimetic compd. cinacalcet has obtained regulatory approval for the treatment of hyperparathyroidism and is the first pos. allosteric modulator of any GPCR to reach the market.  It has other important uses in dialysis patients with end-stage renal disease, in whom it decreases Ca × P product.  Pharmaceutically converse to calcimimetics are calcilytic compds., which antagonize parathyroid CaSR and stimulate PTH secretion.  Antagonism of the CaSR has the potential to yield an anabolic therapy for osteoporosis that awaits clin. validation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuFmI3kGSesbVg90H21EOLACvtfcHk0ljoQ1KaP9lxzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVyisro%253D&md5=cea967bc7042aa21177bd11638da8d50</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.2174%2F092986708783330601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986708783330601%26sid%3Dliteratum%253Aachs%26aulast%3DTrivedi%26aufirst%3DR.%26aulast%3DMithal%26aufirst%3DA.%26aulast%3DChattopadhyay%26aufirst%3DN.%26atitle%3DRecent%2520updates%2520on%2520the%2520calcium-sensing%2520receptor%2520as%2520a%2520drug%2520target%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2008%26volume%3D15%26issue%3D2%26spage%3D178%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_contrib-group">Brown, E. M.</span><span> </span><span class="NLM_article-title">The calcium-sensing receptor: physiology, pathophysiology and CaR-based therapeutics</span> <span class="citation_source-journal">Subcell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1007%2F978-1-4020-6191-2_6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=18193637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A280%3ADC%252BD1c%252FktVahtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2007&pages=139-165&author=E.+M.+Brown&title=The+calcium-sensing+receptor%3A+physiology%2C+pathophysiology+and+CaR-based+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The calcium-sensing receptor: physiology, pathophysiology and CaR-based therapeutics</span></div><div class="casAuthors">Brown E M</div><div class="citationInfo"><span class="NLM_cas:title">Sub-cellular biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">139-67</span>
        ISSN:<span class="NLM_cas:issn">0306-0225</span>.
    </div><div class="casAbstract">The extracellular calcium (Ca(o)2+)-sensing receptor (CaR) enables the parathyroid glands and other CaR-expressing cells to sense alterations in the level of Ca(o)2+ and to respond with changes in function that are directed at normalizing the blood calcium concentration.  In addition to the parathyroid gland, the kidney is a key site for Ca(o)2(+)-sensing that enables it to make physiologically relevant alterations in divalent cation and water metabolism.  Several disorders of Ca(o)2(+)-sensing arise from inherited or acquired abnormalities that "reset" the serum calcium concentration upward or downward.  Inactivating mutations produce a benign form of hypercalcemia when present in the heterozygous state, termed Familial Hypocalciuric Hypercalcemia (FHH), while homozygous mutations produce a much more severe hypercalcemic disorder resulting from marked hyperparathyroidism, called Neonatal Severe Hyperparathyroidism (NSHPT).  Activating mutations cause a hypocalcemic syndrome of varying severity, termed autosomal dominant hypocalcemia or hypoparathyroidism.  Inactivating or activating antibodies directed at the CaR produce the expected hyper- or hypocalcemic syndromes, respectively. "Calcimimetic" CaR activators and "calcilytic" CaR antagonists have been developed.  The calcimimetics are currently in use for controlling severe hyperparathyroidism in patients receiving dialysis treatment for end stage renal disease or with parathyroid cancer.  Calcilytics are being evaluated as a means of inducing a "pulse" in the circulating parathyroid hormone (PTH) concentration, which would mimic that resulting from injection of PTH, an established anabolic form of treatment for osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8IqdjdhC4Am52AMpI4GK2fW6udTcc2eZUni-BQtg6Fbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c%252FktVahtQ%253D%253D&md5=efb4412b5755168f5433ee1f034cd934</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1007%2F978-1-4020-6191-2_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4020-6191-2_6%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DE.%2BM.%26atitle%3DThe%2520calcium-sensing%2520receptor%253A%2520physiology%252C%2520pathophysiology%2520and%2520CaR-based%2520therapeutics%26jtitle%3DSubcell.%2520Biochem.%26date%3D2007%26volume%3D45%26spage%3D139%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2c"><span><span class="NLM_contrib-group">Brown, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLeod, R. J.</span><span> </span><span class="NLM_article-title">Extracellular calcium sensing and extracellular calcium signaling</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1152%2Fphysrev.2001.81.1.239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=11152759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitV2ktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2001&pages=239-297&author=E.+M.+Brownauthor=R.+J.+MacLeod&title=Extracellular+calcium+sensing+and+extracellular+calcium+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular calcium sensing and extracellular calcium signaling</span></div><div class="casAuthors">Brown, Edward M.; MacLeod, R. John</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">239-297</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review, with 481 refs.  The cloning of a G protein-coupled extracellular Ca2+ (Cao2+)-sensing receptor (CaR) has elucidated the mol. basis for many of the previously recognized effects of Cao2+ on tissues that maintain systemic Cao2+ homeostasis, esp. parathyroid chief cells and several cells in the kidney.  The availability of the cloned CaR enabled the development of DNA and antibody probes for identifying the CaR's mRNA and protein, resp., within these and other tissues.  It also permitted the identification of human diseases resulting from inactivating or activating mutations of the CaR gene and the subsequent generation of mice with targeted disruption of the CaR gene.  The characteristic alterations in parathyroid and renal function in these patients and in the mice with knockout of the CaR gene have provided valuable information on the CaR's physiol. roles in these tissues participating in mineral ion homeostasis.  Nevertheless, relatively little is known about how the CaR regulates other tissues involved in systemic Cao2+ homeostasis, particularly bone and intestine.  Moreover, there is evidence that addnl. Cao2+ sensors may exist in bone cells that mediate some or even all of the known effects of Cao2+ on these cells.  Even more remains to be learned about the CaR's function in the rapidly growing list of cells that express it but are uninvolved in systemic Cao2+ metab.  Available data suggest that the receptor serves numerous roles outside of systemic mineral ion homeostasis, ranging from the regulation of hormonal secretion and the activities of various ion channels to the longer term control of gene expression, programmed cell death (apoptosis), and cellular proliferation.  In some cases, the CaR on these non-homeostatic cells responds to local changes in Cao2+ taking place within compartments of the extracellular fluid (ECF) that communicate with the outside environment (e.g., the gastrointestinal tract).  In others, localized changes in Cao2+ within the ECF can originate from several mechanisms, including fluxes of calcium ions into or out of cellular or extracellular stores or across epithelium that absorb or secrete Ca2+.  In any event, the CaR and other receptors/sensors for Cao2+ and probably for other extracellular ions represent versatile regulators of numerous cellular functions and may serve as important therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6uGVgKVIQybVg90H21EOLACvtfcHk0ljst_wlw9KwKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitV2ktLo%253D&md5=bdaf576fbde7255da389eb9fa0d84823</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.2001.81.1.239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.2001.81.1.239%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DE.%2BM.%26aulast%3DMacLeod%26aufirst%3DR.%2BJ.%26atitle%3DExtracellular%2520calcium%2520sensing%2520and%2520extracellular%2520calcium%2520signaling%26jtitle%3DPhysiol.%2520Rev.%26date%3D2001%26volume%3D81%26spage%3D239%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2d"><span><span class="NLM_contrib-group">Brown, E. M.</span><span> </span><span class="NLM_article-title">Extracellular Ca<sup>2+</sup> sensing, regulation of parathyroid cell function, and role of Ca<sup>2+</sup> and other ions as extracellular (first) messengers</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1991&pages=371-411&author=E.+M.+Brown&title=Extracellular+Ca2%2B+sensing%2C+regulation+of+parathyroid+cell+function%2C+and+role+of+Ca2%2B+and+other+ions+as+extracellular+%28first%29+messengers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DE.%2BM.%26atitle%3DExtracellular%2520Ca2%252B%2520sensing%252C%2520regulation%2520of%2520parathyroid%2520cell%2520function%252C%2520and%2520role%2520of%2520Ca2%252B%2520and%2520other%2520ions%2520as%2520extracellular%2520%2528first%2529%2520messengers%26jtitle%3DPhysiol.%2520Rev.%26date%3D1991%26volume%3D71%26spage%3D371%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2e"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span> </span><span class="NLM_article-title">Calcium receptor-dependent regulation of cellular functions</span> <span class="citation_source-journal">News Physiol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADyaK2MXkslequ7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1995&pages=1-5&author=E.+F.+Nemeth&title=Calcium+receptor-dependent+regulation+of+cellular+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2eR"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Ca2+ receptor-dependent regulation of cellular functions</span></div><div class="casAuthors">Nemeth, Edward F.</div><div class="citationInfo"><span class="NLM_cas:title">News in Physiological Sciences</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">Feb.</span>),
    <span class="NLM_cas:pages">1-5</span>CODEN:
                <span class="NLM_cas:coden">NEPSEY</span>;
        ISSN:<span class="NLM_cas:issn">0886-1714</span>.
    </div><div class="casAbstract">A review, with 15 refs.  A cell-surface Ca2+ receptor enables parathyroid cells to detect and respond to extracellular Ca2+.  The recent cloning of a G protein-coupled Ca2+ receptor solidifies this view.  Ca2+ receptors regulate the activity of various cells and provide novel mol. targets for new pharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmAYKq3zbA7LVg90H21EOLACvtfcHk0ljst_wlw9KwKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXkslequ7g%253D&md5=5c0358f59bb52230ca313049fa647144</span></div><a href="/servlet/linkout?suffix=cit2e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26atitle%3DCalcium%2520receptor-dependent%2520regulation%2520of%2520cellular%2520functions%26jtitle%3DNews%2520Physiol.%2520Sci.%26date%3D1995%26volume%3D10%26spage%3D1%26epage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_contrib-group">Steddon, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, J.</span><span> </span><span class="NLM_article-title">Calcimimetics and calcilytics−fooling the calcium receptor</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">365</span><span class="NLM_x"> (</span><span class="NLM_issue">9478</span><span class="NLM_x">) </span> <span class="NLM_fpage">2237</span><span class="NLM_x">–</span> <span class="NLM_lpage">2239</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2005&pages=2237-2239&issue=9478&author=S.+J.+Steddonauthor=J.+Cunningham&title=Calcimimetics+and+calcilytics%E2%88%92fooling+the+calcium+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSteddon%26aufirst%3DS.%2BJ.%26aulast%3DCunningham%26aufirst%3DJ.%26atitle%3DCalcimimetics%2520and%2520calcilytics%25E2%2588%2592fooling%2520the%2520calcium%2520receptor%26jtitle%3DLancet%26date%3D2005%26volume%3D365%26issue%3D9478%26spage%3D2237%26epage%3D2239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brauner-Osborne, H.</span><span> </span><span class="NLM_article-title">Allosteric modulation of the calcium-sensing receptor</span> <span class="citation_source-journal">Curr. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">180</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.2174%2F157015907781695982" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=19305800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKqsLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=180-186&issue=3&author=A.+A.+Jensenauthor=H.+Brauner-Osborne&title=Allosteric+modulation+of+the+calcium-sensing+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulation of the calcium-sensing receptor</span></div><div class="casAuthors">Jensen, Anders A.; Brauner-Osborne, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">180-186</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1570-159X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The calcium (Ca2+)-sensing receptor (CaR) belongs to family C of the G-protein coupled receptors (GPCRs).  The receptor is activated by physiol. levels of Ca2+ (and Mg2+) and pos. modulated by a range of proteinogenic L-α-amino acids.  Recently, several synthetic allosteric modulators of the receptor have been developed, which either act as pos. modulators (termed calcimimetics) or neg. modulators (termed calcilytics).  These ligands do not activate the wild-type receptor directly, but rather shift the concn.-response curves of Ca2+ to the left or right, resp.  Like other family C GPCRs, the CaR contains a large amino-terminal domain and a 7-transmembrane domain.  Whereas the endogenous ligands for the receptor, Ca2+, Mg2+ and the L-α-amino acids, bind to the amino-terminal domain, most if not all of the synthetic modulators published so far bind to the 7-transmembrane domain.  The most prominent physiol. function of the CaR is to maintain the extracellular Ca2+ level in a very tight range via control of secretion of parathyroid hormone (PTH).  Influence on e.g. secretion of calcitonin from thyroid C-cells and direct action on the tubule of the kidney also contribute to the control of the extracellular Ca2+ level.  This control over PTH and Ca2+ levels is partially lost in patients suffering from primary and secondary hyperparathyroidism.  The perspectives in CaR as a therapeutic target have been underlined by the recent approval of the calcimimetic cinacalcet for the treatment of certain forms of primary and secondary hyperparathyroidism.  Cinacalcet is the first clin. administered allosteric modulator acting on a GPCR, and thus the compd. constitutes an important proof-of-concept for future development of allosteric modulators on other GPCR drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGKZ6YylvnSLVg90H21EOLACvtfcHk0ljst_wlw9KwKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKqsLnJ&md5=2cfbaaea96ba8f4ef1c9119bff0b6207</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.2174%2F157015907781695982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157015907781695982%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DBrauner-Osborne%26aufirst%3DH.%26atitle%3DAllosteric%2520modulation%2520of%2520the%2520calcium-sensing%2520receptor%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2007%26volume%3D5%26issue%3D3%26spage%3D180%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_contrib-group">Dobnig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R. T.</span><span> </span><span class="NLM_article-title">The effects of programmed administration of human parathyroid hormone fragment (1−34) on bone histomorphometry and serum chemistry in rats</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">4607</span><span class="NLM_x">–</span> <span class="NLM_lpage">4612</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=1997&pages=4607-4612&issue=11&author=H.+Dobnigauthor=R.+T.+Turner&title=The+effects+of+programmed+administration+of+human+parathyroid+hormone+fragment+%281%E2%88%9234%29+on+bone+histomorphometry+and+serum+chemistry+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDobnig%26aufirst%3DH.%26aulast%3DTurner%26aufirst%3DR.%2BT.%26atitle%3DThe%2520effects%2520of%2520programmed%2520administration%2520of%2520human%2520parathyroid%2520hormone%2520fragment%2520%25281%25E2%2588%259234%2529%2520on%2520bone%2520histomorphometry%2520and%2520serum%2520chemistry%2520in%2520rats%26jtitle%3DEndocrinology%26date%3D1997%26volume%3D138%26issue%3D11%26spage%3D4607%26epage%3D4612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_contrib-group">Frolik, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cain, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satterwhite, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown-Augsburger, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hock, J. M.</span><span> </span><span class="NLM_article-title">Anabolic and catabolic bone effects of human parathyroid hormone (1−34) are predicted by duration of hormone exposure</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">372</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2003&pages=372-379&author=C.+A.+Frolikauthor=E.+C.+Blackauthor=R.+L.+Cainauthor=J.+H.+Satterwhiteauthor=P.+L.+Brown-Augsburgerauthor=M.+Sataauthor=J.+M.+Hock&title=Anabolic+and+catabolic+bone+effects+of+human+parathyroid+hormone+%281%E2%88%9234%29+are+predicted+by+duration+of+hormone+exposure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrolik%26aufirst%3DC.%2BA.%26aulast%3DBlack%26aufirst%3DE.%2BC.%26aulast%3DCain%26aufirst%3DR.%2BL.%26aulast%3DSatterwhite%26aufirst%3DJ.%2BH.%26aulast%3DBrown-Augsburger%26aufirst%3DP.%2BL.%26aulast%3DSata%26aufirst%3DM.%26aulast%3DHock%26aufirst%3DJ.%2BM.%26atitle%3DAnabolic%2520and%2520catabolic%2520bone%2520effects%2520of%2520human%2520parathyroid%2520hormone%2520%25281%25E2%2588%259234%2529%2520are%2520predicted%2520by%2520duration%2520of%2520hormone%2520exposure%26jtitle%3DBone%26date%3D2003%26volume%3D33%26spage%3D372%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_contrib-group">Onyia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helvering, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbert, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dow, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotinun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halladay, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miles, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrose, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frolik, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R. T.</span><span> </span><span class="NLM_article-title">Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: An analysis of DNA microarray</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">418</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2005&pages=403-418&author=J.+E.+Onyiaauthor=L.+M.+Helveringauthor=L.+Gelbertauthor=T.+Weiauthor=S.+Huangauthor=P.+Chenauthor=E.+R.+Dowauthor=A.+Maranauthor=M.+Zhangauthor=S.+Lotinunauthor=X.+Linauthor=D.+L.+Halladayauthor=R.+R.+Milesauthor=N.+H.+Kulkarniauthor=E.+M.+Ambroseauthor=Y.+L.+Maauthor=C.+A.+Frolikauthor=M.+Satoauthor=H.+U.+Bryantauthor=R.+T.+Turner&title=Molecular+profile+of+catabolic+versus+anabolic+treatment+regimens+of+parathyroid+hormone+%28PTH%29+in+rat+bone%3A+An+analysis+of+DNA+microarray"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOnyia%26aufirst%3DJ.%2BE.%26aulast%3DHelvering%26aufirst%3DL.%2BM.%26aulast%3DGelbert%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DDow%26aufirst%3DE.%2BR.%26aulast%3DMaran%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DLotinun%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DHalladay%26aufirst%3DD.%2BL.%26aulast%3DMiles%26aufirst%3DR.%2BR.%26aulast%3DKulkarni%26aufirst%3DN.%2BH.%26aulast%3DAmbrose%26aufirst%3DE.%2BM.%26aulast%3DMa%26aufirst%3DY.%2BL.%26aulast%3DFrolik%26aufirst%3DC.%2BA.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DBryant%26aufirst%3DH.%2BU.%26aulast%3DTurner%26aufirst%3DR.%2BT.%26atitle%3DMolecular%2520profile%2520of%2520catabolic%2520versus%2520anabolic%2520treatment%2520regimens%2520of%2520parathyroid%2520hormone%2520%2528PTH%2529%2520in%2520rat%2520bone%253A%2520An%2520analysis%2520of%2520DNA%2520microarray%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2005%26volume%3D95%26spage%3D403%26epage%3D418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_contrib-group">Messa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfieri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brezzi, B.</span><span> </span><span class="NLM_article-title">Cinacalcet: pharmacological and clinical aspects</span> <span class="citation_source-journal">Expert Opin. Drug Metabol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1551</span><span class="NLM_x">–</span> <span class="NLM_lpage">1560</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1517%2F17425250802587017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=19040330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVent7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=1551-1560&issue=12&author=P.+Messaauthor=C.+Alfieriauthor=B.+Brezzi&title=Cinacalcet%3A+pharmacological+and+clinical+aspects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Cinacalcet: pharmacological and clinical aspects</span></div><div class="casAuthors">Messa, Piergiorgio; Alfieri, Carlo; Brezzi, Brigida</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1551-1560</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The calcium sensing receptor (CaSR) is expressed in cells secreting calcium-regulating hormones, in cells involved in calcium transport and in many other tissues, with an as yet not completely defined role.  In parathyroid cells, the CaSR stimulation inhibits parathyroid hormone (PTH) secretion, synthesis and parathyroid cell proliferation.  Cinacalcet belongs to calcimimetic type II compds. that can interact with CaSR, increasing its affinity for calcium.  Clin. studies have proved cinacalcet to be effective in reducing calcium and PTH levels in primary hyperparathyroidism and in reducing PTH, calcium and phosphate in patients with secondary hyperparathyroidism owing to chronic renal failure, with a relatively safe profile, the only reported adverse events being hypocalcemia and gastrointestinal symptoms.  However, though calcimimetics do represent a real advancement in the field of the treatment of PTH secretion disturbances, there is a need for clin. trials, which should aim to demonstrate that a better control of biochem. parameters is also matched with better clin. outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphrPY0-n5eq7Vg90H21EOLACvtfcHk0lg-VAFSit6Uow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVent7zP&md5=c0bbe83dc845e72b2d1a1f41a05ce025</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1517%2F17425250802587017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425250802587017%26sid%3Dliteratum%253Aachs%26aulast%3DMessa%26aufirst%3DP.%26aulast%3DAlfieri%26aufirst%3DC.%26aulast%3DBrezzi%26aufirst%3DB.%26atitle%3DCinacalcet%253A%2520pharmacological%2520and%2520clinical%2520aspects%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metabol.%2520Toxicol.%26date%3D2008%26volume%3D4%26issue%3D12%26spage%3D1551%26epage%3D1560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_contrib-group">Kebig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, K.</span><span> </span><span class="NLM_article-title">Cinacalcet−an allosteric enhancer at the Ca<sup>2+</sup>-receptor</span> <span class="citation_source-journal">Dtsch. Med. Wochenschr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x"> (</span><span class="NLM_issue">33</span><span class="NLM_x">) </span> <span class="NLM_fpage">1681</span><span class="NLM_x">–</span> <span class="NLM_lpage">1683</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1055%2Fs-0028-1082785" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=18661462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2008&pages=1681-1683&issue=33&author=A.+Kebigauthor=K.+Mohr&title=Cinacalcet%E2%88%92an+allosteric+enhancer+at+the+Ca2%2B-receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Cinacalcet - an allosteric enhancer at the Ca2+-receptor</span></div><div class="casAuthors">Kebig, A.; Mohr, K.</div><div class="citationInfo"><span class="NLM_cas:title">Deutsche Medizinische Wochenschrift</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">1681-1683</span>CODEN:
                <span class="NLM_cas:coden">DMWOAX</span>;
        ISSN:<span class="NLM_cas:issn">0012-0472</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">A review on the mode of action, indications, dosing, intake, pharmacokinetics, undesired drug effects, therapy control, efficacy in clin. studies, and evaluation of cinacalcet, an allosteric enhancer at the Ca2+ receptor.  Treatment is discussed of secondary hyperparathyroidism with the calcimimetic agent cinacalcet.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxhY4OdWKgYbVg90H21EOLACvtfcHk0lg-VAFSit6Uow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsrnN&md5=8b8497eaca38aa31529a43c1274bbcf0</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1055%2Fs-0028-1082785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0028-1082785%26sid%3Dliteratum%253Aachs%26aulast%3DKebig%26aufirst%3DA.%26aulast%3DMohr%26aufirst%3DK.%26atitle%3DCinacalcet%25E2%2588%2592an%2520allosteric%2520enhancer%2520at%2520the%2520Ca2%252B-receptor%26jtitle%3DDtsch.%2520Med.%2520Wochenschr.%26date%3D2008%26volume%3D133%26issue%3D33%26spage%3D1681%26epage%3D1683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_contrib-group">Harrington, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotsch, C.</span><span> </span><span class="NLM_article-title">Calcium sensing receptor activators: Calcimimetics</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">28</span><span class="NLM_x">) </span> <span class="NLM_fpage">3027</span><span class="NLM_x">–</span> <span class="NLM_lpage">3034</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.2174%2F092986707782794096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=18220738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlSrs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=3027-3034&issue=28&author=P.+Harringtonauthor=C.+Fotsch&title=Calcium+sensing+receptor+activators%3A+Calcimimetics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium sensing receptor activators: calcimimetics</span></div><div class="casAuthors">Harrington, Paul E.; Fotsch, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">3027-3034</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The calcium sensing receptor (CaR) is a G protein-coupled receptor (GPCR) that plays a fundamental role in serum calcium homeostasis.  The CaR is expressed on the chief cells of the parathyroid gland and is responsible for controlling the secretion of parathyroid hormone (PTH).  PTH acts on several organs including the bone, kidney, and intestine to tightly regulate the concn. of serum calcium.  Substances other than calcium that activate the CaR are referred to as calcimimetics.  Calcimimetics that bind to the CaR as agonists are referred to as type I.  Type II calcimimetics bind to a site that is distinct from the physiol. ligand and function as pos. allosteric modulators of the CaR.  Type II calcimimetics amplify the sensitivity of the CaR to serum calcium and are thus able to lower the concn. of serum PTH.  Calcimimetics are being pursued as therapeutics for the treatment of disorders that are characterized by elevated levels of PTH such as primary and secondary hyperparathyroidism (primary HPT and secondary HPT).  In this review, we provide an overview of key results in the discovery of cinacalcet HCl (Sensipar in the US, Mimpara in Europe).  In addn., other recently disclosed type II calcimimetics are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBRgBPKixE4rVg90H21EOLACvtfcHk0ljwXVdnGI5a8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlSrs7Y%253D&md5=7f519dd21f377ef76af4a43c722206f8</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.2174%2F092986707782794096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986707782794096%26sid%3Dliteratum%253Aachs%26aulast%3DHarrington%26aufirst%3DP.%26aulast%3DFotsch%26aufirst%3DC.%26atitle%3DCalcium%2520sensing%2520receptor%2520activators%253A%2520Calcimimetics%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2007%26volume%3D14%26issue%3D28%26spage%3D3027%26epage%3D3034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_contrib-group">Marquis, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lago, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee Trout, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DelMar, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Wagenen, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roethke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, P.</span><span> </span><span class="NLM_article-title">Antagonists of the Calcium Receptor I. Amino Alcohol-Based Parathyroid Hormone Secretagogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">3982</span><span class="NLM_x">–</span> <span class="NLM_lpage">3993</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900364m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3982-3993&issue=13&author=R.+W.+Marquisauthor=A.+M.+Lagoauthor=J.+F.+Callahanauthor=R.+E.+Lee+Troutauthor=M.+Gowenauthor=E.+G.+DelMarauthor=B.+C.+Van+Wagenenauthor=S.+Loganauthor=S.+Shimizuauthor=J.+Foxauthor=E.+F.+Nemethauthor=Z.+Yangauthor=T.+Roethkeauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=J.+Leeauthor=R.+M.+Keenanauthor=P.+Bhatnagar&title=Antagonists+of+the+Calcium+Receptor+I.+Amino+Alcohol-Based+Parathyroid+Hormone+Secretagogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1021%2Fjm900364m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900364m%26sid%3Dliteratum%253Aachs%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DLago%26aufirst%3DA.%2BM.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DLee%2BTrout%26aufirst%3DR.%2BE.%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DDelMar%26aufirst%3DE.%2BG.%26aulast%3DVan%2BWagenen%26aufirst%3DB.%2BC.%26aulast%3DLogan%26aufirst%3DS.%26aulast%3DShimizu%26aufirst%3DS.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DRoethke%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DKeenan%26aufirst%3DR.%2BM.%26aulast%3DBhatnagar%26aufirst%3DP.%26atitle%3DAntagonists%2520of%2520the%2520Calcium%2520Receptor%2520I.%2520Amino%2520Alcohol-Based%2520Parathyroid%2520Hormone%2520Secretagogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D13%26spage%3D3982%26epage%3D3993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroup, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodds, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Votta, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lago, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DelMar, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span> </span><span class="NLM_article-title">Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1595</span><span class="NLM_x">–</span> <span class="NLM_lpage">1604</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2000&pages=1595-1604&issue=11&author=M.+Gowenauthor=G.+B.+Stroupauthor=R.+A.+Doddsauthor=I.+E.+Jamesauthor=B.+J.+Vottaauthor=B.+R.+Smithauthor=P.+K.+Bhatnagarauthor=A.+M.+Lagoauthor=J.+F.+Callahanauthor=E.+G.+DelMarauthor=M.+A.+Millerauthor=E.+F.+Nemethauthor=J.+Fox&title=Antagonizing+the+parathyroid+calcium+receptor+stimulates+parathyroid+hormone+secretion+and+bone+formation+in+osteopenic+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DStroup%26aufirst%3DG.%2BB.%26aulast%3DDodds%26aufirst%3DR.%2BA.%26aulast%3DJames%26aufirst%3DI.%2BE.%26aulast%3DVotta%26aufirst%3DB.%2BJ.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DBhatnagar%26aufirst%3DP.%2BK.%26aulast%3DLago%26aufirst%3DA.%2BM.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DDelMar%26aufirst%3DE.%2BG.%26aulast%3DMiller%26aufirst%3DM.%2BA.%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DFox%26aufirst%3DJ.%26atitle%3DAntagonizing%2520the%2520parathyroid%2520calcium%2520receptor%2520stimulates%2520parathyroid%2520hormone%2520secretion%2520and%2520bone%2520formation%2520in%2520osteopenic%2520rats%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2000%26volume%3D105%26issue%3D11%26spage%3D1595%26epage%3D1604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delmar, E:G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleason, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span> </span><span class="NLM_article-title">Calcilytic compounds: potent and selective Ca<sup>2+</sup> receptor antagonists that stimulate secretion of parathyroid hormone</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=11561095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntFWltbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2001&pages=323-331&issue=1&author=E.+F.+Nemethauthor=E%3AG.+Delmarauthor=W.+L.+Heatonauthor=M.+A.+Millerauthor=L.+D.+Lambertauthor=R.+L.+Conklinauthor=M.+Gowenauthor=J.+G.+Gleasonauthor=P.+K.+Bhatnagarauthor=J.+Fox&title=Calcilytic+compounds%3A+potent+and+selective+Ca2%2B+receptor+antagonists+that+stimulate+secretion+of+parathyroid+hormone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Calcilytic compounds: potent and selective Ca2+ receptor antagonists that stimulate secretion of parathyroid hormone</span></div><div class="casAuthors">Nemeth, Edward F.; Delmar, Eric G.; Heaton, William L.; Miller, Michael A.; Lambert, Lyssa D.; Conklin, Rebecca L.; Gowen, Maxine; Gleason, John G.; Bhatnagar, Pradip K.; Fox, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">323-331</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Despite the discovery of many ions and mols. that activate the Ca2+ receptor, there are no known ligands that block this receptor.  Reported here are the pharmacodynamic properties of a small mol., NPS 2143, which acts as an antagonist at the Ca2+ receptor.  This compd. blocked (IC50 of 43 nM) increases in cytoplasmic Ca2+ concns. [Ca2+]i elicited by activating the Ca2+ receptor in HEK 293 cells expressing the human Ca2+ receptor.  NPS 2143, even when tested at much higher concns. (3 μM), did not affect the activity of a no. of other G protein-coupled receptors, including those most structurally homologous to the Ca2+ receptor.  NPS 2143 stimulated parathyroid hormone (PTH) secretion from bovine parathyroid cells (EC50 of 41 nM) over a range of extracellular Ca2+ concns. and reversed the effects of the calcimimetic compd. NPS R-467 on [Ca2+]i and on secretion of PTH.  When infused i.v. in normal rats, NPS 2143 caused a rapid and large increase in plasma levels of PTH.  Ca2+ receptor antagonists are termed calcilytics and NPS 2143 is the first substance (either at. or mol.) shown to possess such activity.  The pharmacodynamic properties of NPS 2143 together with the recently demonstrated effects of this compd. on bone formation support the view that orally active calcilytic compds. might provide a novel anabolic therapy for osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5irxzzwLOvbVg90H21EOLACvtfcHk0ljwXVdnGI5a8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntFWltbk%253D&md5=14cedbe167bc3f0de96cec16d9ce73b4</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DDelmar%26aufirst%3DE%253AG.%26aulast%3DHeaton%26aufirst%3DW.%2BL.%26aulast%3DMiller%26aufirst%3DM.%2BA.%26aulast%3DLambert%26aufirst%3DL.%2BD.%26aulast%3DConklin%26aufirst%3DR.%2BL.%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DGleason%26aufirst%3DJ.%2BG.%26aulast%3DBhatnagar%26aufirst%3DP.%2BK.%26aulast%3DFox%26aufirst%3DJ.%26atitle%3DCalcilytic%2520compounds%253A%2520potent%2520and%2520selective%2520Ca2%252B%2520receptor%2520antagonists%2520that%2520stimulate%2520secretion%2520of%2520parathyroid%2520hormone%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D299%26issue%3D1%26spage%3D323%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6d"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span> </span><span class="NLM_article-title">The search for calcium receptor antagonists (calcilytics)</span> <span class="citation_source-journal">J. Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1677%2Fjme.0.0290015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=12200226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD38XmvFOhu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2002&pages=15-21&issue=1&author=E.+F.+Nemeth&title=The+search+for+calcium+receptor+antagonists+%28calcilytics%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6dR"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The search for calcium receptor antagonists (calcilytics)</span></div><div class="casAuthors">Nemeth, E. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-21</span>CODEN:
                <span class="NLM_cas:coden">JMLEEI</span>;
        ISSN:<span class="NLM_cas:issn">0952-5041</span>.
    
            (<span class="NLM_cas:orgname">Society for Endocrinology</span>)
        </div><div class="casAbstract">A review.  The Ca2+ receptor on the surface of parathyroid cells is the primary mol. entity regulating secretion of parathyroid hormone (PTH).  Because of this, it is a particularly appealing target for new drugs intended to increase or decrease circulating levels of PTH.  Calcilytic compds. are Ca2+ receptor antagonists which increase the secretion of PTH.  The first reported calcilytic compd. was NPS 2143, an orally active mol. which elicits rapid, 3- to 4-fold increases in circulating levels of PTH.  These rapid changes in plasma PTH levels are sufficient to increase bone turnover in ovariectomized, osteopenic rats.  When administered together with an antiresorptive agent (estradiol), NPS 2143 causes an increase in trabecular bone vol. and bone mineral d. in osteopenic rats.  The magnitude of these changes are far in excess of those caused by estradiol alone and are comparable with those achieved by daily administration of PTH or a peptide analog.  These anabolic effects of NPS 2143 on bone are not assocd. with hyperplasia of the parathyroid glands.  Calcilytic compds. can increase endogenous levels of circulating PTH to an extent that stimulates new bone formation.  Such compds. could replace the use of exogenous PTH or its peptide fragments in treating osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQAkcwwkiwrrVg90H21EOLACvtfcHk0liERWmMGjaeTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmvFOhu7o%253D&md5=e2836d11c306172c2a209df996ee5cea</span></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.1677%2Fjme.0.0290015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252Fjme.0.0290015%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26atitle%3DThe%2520search%2520for%2520calcium%2520receptor%2520antagonists%2520%2528calcilytics%2529%26jtitle%3DJ.%2520Mol.%2520Endocrinol.%26date%3D2002%26volume%3D29%26issue%3D1%26spage%3D15%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6e"><span><span class="NLM_contrib-group">Doggrell, S. A.; Del Fresno, M.; Castaner, J.</span> NPS - 2143.  <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span>),  <span class="NLM_fpage">140</span>− <span class="NLM_lpage">142</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1358%2Fdof.2002.027.02.656406" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD38Xkt1Shsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Doggrell%2C+S.+A.%3B+Del+Fresno%2C+M.%3B+Castaner%2C+J.+NPS+-+2143.+Drugs+Future+2002%2C+27+%282%29%2C+140%E2%88%92142."target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6eR"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">NPS-2143</span></div><div class="casAuthors">Doggrell, Sheila A.; Del Fresno, M.; Castaner, J.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">140-142</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Efforts to discover new treatments for osteoporosis led to the identification of the potent and selective, small-mol. calcium receptor antagonist NPS-2143.  NPS-2143 is the prototype calcilytic drug, designed to act on calcium receptors on the surface of parathyroid glands, stimulating the release of the body's own stores of native parathyroid hormone (PTH).  In osteopenic ovariectomized rats, daily oral administration of NPS-2143 resulted in moderate but sustained increases in plasma PTH levels and marked increases in bone formation and resorption, with no net bone gain or loss.  The combination of NPS-2143 and estrogen increases bone formation and d. to a greater extent than either agent alone.  These results suggest that NPS-2143 may be useful in the treatment of established osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9khiVRdE9nLVg90H21EOLACvtfcHk0liERWmMGjaeTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xkt1Shsb0%253D&md5=e306314807d368de4a1c9e023dc36885</span></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=10.1358%2Fdof.2002.027.02.656406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2002.027.02.656406%26sid%3Dliteratum%253Aachs%26aulast%3DDoggrell%26aufirst%3DS.%2BA.%26jtitle%3DDrugs%2520Future%26date%3D2002%26volume%3D27%26issue%3D2%26spage%3D140%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_contrib-group">Marquis, R. W.; Ramanjulu, J. M.; Casillas, L. N.</span><span> </span><span class="NLM_article-title">Preparation of acyloxy-amino-functionalized-aromatic carboxy compounds as calcilytic compounds useful against bone and mineral diseases</span>. Patent WO 2005077886,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=R.+W.+Marquis&author=J.+M.+Ramanjulu&author=L.+N.+Casillas&title=Preparation+of+acyloxy-amino-functionalized-aromatic+carboxy+compounds+as+calcilytic+compounds+useful+against+bone+and+mineral+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26atitle%3DPreparation%2520of%2520acyloxy-amino-functionalized-aromatic%2520carboxy%2520compounds%2520as%2520calcilytic%2520compounds%2520useful%2520against%2520bone%2520and%2520mineral%2520diseases%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_contrib-group">Marquis, R. W.; Casillas, L. N.; Ramanjulu, J. M.; Callahan, J. F.</span><span> </span><span class="NLM_article-title">Preparation of phenylalkanoic acids as calcilytic compounds</span>. Patent WO 200404775,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=R.+W.+Marquis&author=L.+N.+Casillas&author=J.+M.+Ramanjulu&author=J.+F.+Callahan&title=Preparation+of+phenylalkanoic+acids+as+calcilytic+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26atitle%3DPreparation%2520of%2520phenylalkanoic%2520acids%2520as%2520calcilytic%2520compounds%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_contrib-group">Balan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castrodad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healy, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphries, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapinos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khot, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarra, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neagu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piotrowski, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paralkar, V. M.</span><span> </span><span class="NLM_article-title">The discovery of novel calcium sensing receptor negative allosteric modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3328</span><span class="NLM_x">–</span> <span class="NLM_lpage">3332</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3328-3332&issue=12&author=G.+Balanauthor=J.+Baumanauthor=S.+Bhattacharyaauthor=M.+Castrodadauthor=D.+R.+Healyauthor=M.+Herrauthor=P.+Humphriesauthor=S.+Jenningsauthor=A.+S.+Kalgutkarauthor=B.+Kapinosauthor=V.+Khotauthor=K.+Lazarraauthor=M.+Liauthor=Y.+Liauthor=C.+Neaguauthor=R.+Oliverauthor=D.+W.+Piotrowskiauthor=D.+Priceauthor=H.+Qiauthor=H.+A.+Simmonsauthor=J.+Southersauthor=L.+Weiauthor=Y.+Zhangauthor=V.+M.+Paralkar&title=The+discovery+of+novel+calcium+sensing+receptor+negative+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBalan%26aufirst%3DG.%26aulast%3DBauman%26aufirst%3DJ.%26aulast%3DBhattacharya%26aufirst%3DS.%26aulast%3DCastrodad%26aufirst%3DM.%26aulast%3DHealy%26aufirst%3DD.%2BR.%26aulast%3DHerr%26aufirst%3DM.%26aulast%3DHumphries%26aufirst%3DP.%26aulast%3DJennings%26aufirst%3DS.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKapinos%26aufirst%3DB.%26aulast%3DKhot%26aufirst%3DV.%26aulast%3DLazarra%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DNeagu%26aufirst%3DC.%26aulast%3DOliver%26aufirst%3DR.%26aulast%3DPiotrowski%26aufirst%3DD.%2BW.%26aulast%3DPrice%26aufirst%3DD.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DSimmons%26aufirst%3DH.%2BA.%26aulast%3DSouthers%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DParalkar%26aufirst%3DV.%2BM.%26atitle%3DThe%2520discovery%2520of%2520novel%2520calcium%2520sensing%2520receptor%2520negative%2520allosteric%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D12%26spage%3D3328%26epage%3D3332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Fitzpatrick, L. A.; Brennan, E.; Kumar, S.; Matheny, C.; Yi, B.; McLaughlin, M.; Phillips, J.; Skordos, L.; Ethgen, D.</span><span> </span><span class="NLM_article-title">Ronacaleret, a novel calcium-sensing receptor antagonist demonstrates potential as an oral bone-forming therapy in healthy postmenopausal women</span>. <span class="NLM_conf-name">ASBMR 30th Annual Meeting</span>, <span class="NLM_conf-loc">Montreal</span>, <span class="NLM_conf-date">2008</span>, Abstract 1174.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Fitzpatrick%2C+L.+A.%3B+Brennan%2C+E.%3B+Kumar%2C+S.%3B+Matheny%2C+C.%3B+Yi%2C+B.%3B+McLaughlin%2C+M.%3B+Phillips%2C+J.%3B+Skordos%2C+L.%3B+Ethgen%2C+D.+Ronacaleret%2C+a+novel+calcium-sensing+receptor+antagonist+demonstrates+potential+as+an+oral+bone-forming+therapy+in+healthy+postmenopausal+women.+ASBMR+30th+Annual+Meeting%2C+Montreal%2C+2008%2C+Abstract+1174."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DFitzpatrick%26aufirst%3DL.%2BA.%26atitle%3DRonacaleret%252C%2520a%2520novel%2520calcium-sensing%2520receptor%2520antagonist%2520demonstrates%2520potential%2520as%2520an%2520oral%2520bone-forming%2520therapy%2520in%2520healthy%2520postmenopausal%2520women" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Kirk, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arey, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feyen, J. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, J. K.</span><span> </span><span class="NLM_article-title">Discovery and structure−activity relationships of trisubstituted pyrimidines/pyridines as novel calcium-sensing receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1204</span><span class="NLM_x">–</span> <span class="NLM_lpage">1208</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801178c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1204-1208&issue=4&author=W.+Yangauthor=Z.+Ruanauthor=Y.+Wangauthor=K.+Van+Kirkauthor=Z.+Maauthor=B.+J.+Areyauthor=C.+B.+Cooperauthor=R.+Seethalaauthor=J.+H.+M.+Feyenauthor=J.+K.+Dickson&title=Discovery+and+structure%E2%88%92activity+relationships+of+trisubstituted+pyrimidines%2Fpyridines+as+novel+calcium-sensing+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1021%2Fjm801178c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801178c%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%26aulast%3DRuan%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DVan%2BKirk%26aufirst%3DK.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DArey%26aufirst%3DB.%2BJ.%26aulast%3DCooper%26aufirst%3DC.%2BB.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DFeyen%26aufirst%3DJ.%2BH.%2BM.%26aulast%3DDickson%26aufirst%3DJ.%2BK.%26atitle%3DDiscovery%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%2520trisubstituted%2520pyrimidines%252Fpyridines%2520as%2520novel%2520calcium-sensing%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D4%26spage%3D1204%26epage%3D1208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_contrib-group">Gavai, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkilineni, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberge, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corte, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednarz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feyen, J. H. M.</span><span> </span><span class="NLM_article-title">Discovery of novel 1-arylmethylpyrrolidin-2-ylethanolamines as calcium-sensing receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">5478</span><span class="NLM_x">–</span> <span class="NLM_lpage">5482</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=5478-5482&issue=24&author=A.+V.+Gavaiauthor=R.+J.+Vazauthor=A.+B.+Mikkilineniauthor=J.+Y.+Robergeauthor=Y.+Liuauthor=M+Lawrenceauthor=J.+R.+Corteauthor=W.+Yangauthor=M.+Bednarzauthor=J.+K.+Dicksonauthor=Z.+Maauthor=R.+Seethalaauthor=J.+H.+M.+Feyen&title=Discovery+of+novel+1-arylmethylpyrrolidin-2-ylethanolamines+as+calcium-sensing+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGavai%26aufirst%3DA.%2BV.%26aulast%3DVaz%26aufirst%3DR.%2BJ.%26aulast%3DMikkilineni%26aufirst%3DA.%2BB.%26aulast%3DRoberge%26aufirst%3DJ.%2BY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLawrence%26aufirst%3DM%26aulast%3DCorte%26aufirst%3DJ.%2BR.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DBednarz%26aufirst%3DM.%26aulast%3DDickson%26aufirst%3DJ.%2BK.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DFeyen%26aufirst%3DJ.%2BH.%2BM.%26atitle%3DDiscovery%2520of%2520novel%25201-arylmethylpyrrolidin-2-ylethanolamines%2520as%2520calcium-sensing%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26issue%3D24%26spage%3D5478%26epage%3D5482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9c"><span><span class="NLM_contrib-group">Arey, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swartz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feyen, J. H. M.</span><span> </span><span class="NLM_article-title">A novel calcium-sensing receptor antagonist transiently stimulates parathyroid hormone secretion in vivo</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">146</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">2015</span><span class="NLM_x">–</span> <span class="NLM_lpage">2022</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2005&pages=2015-2022&issue=4&author=B.+J.+Areyauthor=R.+Seethalaauthor=Z.+Maauthor=A.+Furaauthor=J.+Morinauthor=J.+Swartzauthor=V.+Vyasauthor=W.+Yangauthor=J.+Dicksonauthor=J.+H.+M.+Feyen&title=A+novel+calcium-sensing+receptor+antagonist+transiently+stimulates+parathyroid+hormone+secretion+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArey%26aufirst%3DB.%2BJ.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DMorin%26aufirst%3DJ.%26aulast%3DSwartz%26aufirst%3DJ.%26aulast%3DVyas%26aufirst%3DV.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DDickson%26aufirst%3DJ.%26aulast%3DFeyen%26aufirst%3DJ.%2BH.%2BM.%26atitle%3DA%2520novel%2520calcium-sensing%2520receptor%2520antagonist%2520transiently%2520stimulates%2520parathyroid%2520hormone%2520secretion%2520in%2520vivo%26jtitle%3DEndocrinology%26date%3D2005%26volume%3D146%26issue%3D4%26spage%3D2015%26epage%3D2022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9d"><span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberge, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotella, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feyen, J. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, J. K.</span><span> </span><span class="NLM_article-title">Discovery and structure−activity relationships of 2-benzylpyrrolidine-substituted aryloxypropanols as calcium-sensing receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1225</span><span class="NLM_x">–</span> <span class="NLM_lpage">1228</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1225-1228&issue=4&author=W.+Yangauthor=Y.+Wangauthor=J.+Y.+Robergeauthor=Z.+Maauthor=Y.+Liuauthor=R.+M.+Lawrenceauthor=D.+P.+Rotellaauthor=R.+Seethalaauthor=J.+H.+M.+Feyenauthor=J.+K.+Dickson&title=Discovery+and+structure%E2%88%92activity+relationships+of+2-benzylpyrrolidine-substituted+aryloxypropanols+as+calcium-sensing+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DRoberge%26aufirst%3DJ.%2BY.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLawrence%26aufirst%3DR.%2BM.%26aulast%3DRotella%26aufirst%3DD.%2BP.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DFeyen%26aufirst%3DJ.%2BH.%2BM.%26aulast%3DDickson%26aufirst%3DJ.%2BK.%26atitle%3DDiscovery%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%25202-benzylpyrrolidine-substituted%2520aryloxypropanols%2520as%2520calcium-sensing%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26issue%3D4%26spage%3D1225%26epage%3D1228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_contrib-group">Kessler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesario, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauban, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, R. H.</span><span> </span><span class="NLM_article-title"><i>N</i><sup>1</sup>-Benzoyl-<i>N</i><sup>2</sup>-[1-(1-naphthyl)ethyl]-<i>trans</i>-1,2-diaminocyclohexanes: Development of 4-chlorophenylcarboxamide (Calhex 231) as a new calcium sensing receptor ligand demonstrating potent calcilytic activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">5119</span><span class="NLM_x">–</span> <span class="NLM_lpage">5128</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051233%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5119-5128&issue=17&author=A.+Kesslerauthor=H.+Faureauthor=C.+Petrelauthor=D.+Rognanauthor=M.+Cesarioauthor=M.+Ruatauthor=P.+Daubanauthor=R.+H.+Dodd&title=N1-Benzoyl-N2-%5B1-%281-naphthyl%29ethyl%5D-trans-1%2C2-diaminocyclohexanes%3A+Development+of+4-chlorophenylcarboxamide+%28Calhex+231%29+as+a+new+calcium+sensing+receptor+ligand+demonstrating+potent+calcilytic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1021%2Fjm051233%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051233%252B%26sid%3Dliteratum%253Aachs%26aulast%3DKessler%26aufirst%3DA.%26aulast%3DFaure%26aufirst%3DH.%26aulast%3DPetrel%26aufirst%3DC.%26aulast%3DRognan%26aufirst%3DD.%26aulast%3DCesario%26aufirst%3DM.%26aulast%3DRuat%26aufirst%3DM.%26aulast%3DDauban%26aufirst%3DP.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DN1-Benzoyl-N2-%255B1-%25281-naphthyl%2529ethyl%255D-trans-1%252C2-diaminocyclohexanes%253A%2520Development%2520of%25204-chlorophenylcarboxamide%2520%2528Calhex%2520231%2529%2520as%2520a%2520new%2520calcium%2520sensing%2520receptor%2520ligand%2520demonstrating%2520potent%2520calcilytic%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D17%26spage%3D5119%26epage%3D5128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_contrib-group">Kessler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Césario, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauban, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, R. H.</span><span> </span><span class="NLM_article-title"><i>N</i><sup>2</sup>-Benzyl-<i>N</i><sup>1</sup>-(1-(1-naphthyl)ethyl)-3-phenylpropane-1,2-diamines and conformationally restrained indole analogues: development of calindol as a new calcimimetic acting at the calcium sensing receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3345</span><span class="NLM_x">–</span> <span class="NLM_lpage">3349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3345-3349&issue=12&author=A.+Kesslerauthor=H.+Faureauthor=C.+Petrelauthor=D.+Rognanauthor=M.+C%C3%A9sarioauthor=M.+Ruatauthor=P.+Daubanauthor=R.+H.+Dodd&title=N2-Benzyl-N1-%281-%281-naphthyl%29ethyl%29-3-phenylpropane-1%2C2-diamines+and+conformationally+restrained+indole+analogues%3A+development+of+calindol+as+a+new+calcimimetic+acting+at+the+calcium+sensing+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKessler%26aufirst%3DA.%26aulast%3DFaure%26aufirst%3DH.%26aulast%3DPetrel%26aufirst%3DC.%26aulast%3DRognan%26aufirst%3DD.%26aulast%3DC%25C3%25A9sario%26aufirst%3DM.%26aulast%3DRuat%26aufirst%3DM.%26aulast%3DDauban%26aufirst%3DP.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DN2-Benzyl-N1-%25281-%25281-naphthyl%2529ethyl%2529-3-phenylpropane-1%252C2-diamines%2520and%2520conformationally%2520restrained%2520indole%2520analogues%253A%2520development%2520of%2520calindol%2520as%2520a%2520new%2520calcimimetic%2520acting%2520at%2520the%2520calcium%2520sensing%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26issue%3D12%26spage%3D3345%26epage%3D3349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10c"><span><span class="NLM_contrib-group">Kessler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roussanne, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauban, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, R. H.</span><span> </span><span class="NLM_article-title"><i>N</i><sup>1</sup>-arylsulfonyl-<i>N</i><sup>2</sup>-(1-(1-naphthyl)ethyl)-1,2-diaminocyclohexanes: a new class of calcilytic agents acting at the calcium-sensing receptor</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1131</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=1131-1136&issue=8&author=A.+Kesslerauthor=H.+Faureauthor=M.+C.+Roussanneauthor=S.+Ferryauthor=M.+Ruatauthor=P.+Daubanauthor=R.+H.+Dodd&title=N1-arylsulfonyl-N2-%281-%281-naphthyl%29ethyl%29-1%2C2-diaminocyclohexanes%3A+a+new+class+of+calcilytic+agents+acting+at+the+calcium-sensing+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKessler%26aufirst%3DA.%26aulast%3DFaure%26aufirst%3DH.%26aulast%3DRoussanne%26aufirst%3DM.%2BC.%26aulast%3DFerry%26aufirst%3DS.%26aulast%3DRuat%26aufirst%3DM.%26aulast%3DDauban%26aufirst%3DP.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DN1-arylsulfonyl-N2-%25281-%25281-naphthyl%2529ethyl%2529-1%252C2-diaminocyclohexanes%253A%2520a%2520new%2520class%2520of%2520calcilytic%2520agents%2520acting%2520at%2520the%2520calcium-sensing%2520receptor%26jtitle%3DChemBioChem%26date%3D2004%26volume%3D5%26issue%3D8%26spage%3D1131%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10d"><span><span class="NLM_contrib-group">Petrel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauban, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span> </span><span class="NLM_article-title">Positive and negative allosteric modulators of the Ca<sup>2+</sup>-sensing receptor interact within overlapping but not identical binding sites in the transmembrane domain</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">18990</span><span class="NLM_x">–</span> <span class="NLM_lpage">18997</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=18990-18997&issue=18&author=C.+Petrelauthor=A.+Kesslerauthor=P.+Daubanauthor=R.+H.+Doddauthor=D.+Rognanauthor=M.+Ruat&title=Positive+and+negative+allosteric+modulators+of+the+Ca2%2B-sensing+receptor+interact+within+overlapping+but+not+identical+binding+sites+in+the+transmembrane+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetrel%26aufirst%3DC.%26aulast%3DKessler%26aufirst%3DA.%26aulast%3DDauban%26aufirst%3DP.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26aulast%3DRognan%26aufirst%3DD.%26aulast%3DRuat%26aufirst%3DM.%26atitle%3DPositive%2520and%2520negative%2520allosteric%2520modulators%2520of%2520the%2520Ca2%252B-sensing%2520receptor%2520interact%2520within%2520overlapping%2520but%2520not%2520identical%2520binding%2520sites%2520in%2520the%2520transmembrane%2520domain%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26issue%3D18%26spage%3D18990%26epage%3D18997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10e"><span><span class="NLM_contrib-group">Dauban, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, R. H.</span><span> </span><span class="NLM_article-title"><i>N</i><sup>1</sup>-Arylsulfonyl-<i>N</i><sup>2</sup>-(1-aryl)ethyl-3-phenylpropane-1,2-diamines as novel calcimimetics acting on the calcium sensing receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">2001</span><span class="NLM_x">–</span> <span class="NLM_lpage">2004</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=2001-2004&issue=17&author=P.+Daubanauthor=S.+Ferryauthor=H.+Faureauthor=M.+Ruatauthor=R.+H.+Dodd&title=N1-Arylsulfonyl-N2-%281-aryl%29ethyl-3-phenylpropane-1%2C2-diamines+as+novel+calcimimetics+acting+on+the+calcium+sensing+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDauban%26aufirst%3DP.%26aulast%3DFerry%26aufirst%3DS.%26aulast%3DFaure%26aufirst%3DH.%26aulast%3DRuat%26aufirst%3DM.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DN1-Arylsulfonyl-N2-%25281-aryl%2529ethyl-3-phenylpropane-1%252C2-diamines%2520as%2520novel%2520calcimimetics%2520acting%2520on%2520the%2520calcium%2520sensing%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26issue%3D17%26spage%3D2001%26epage%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_contrib-group">Shcherbakova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoffroy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swierczek, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balandrin, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, R. L.</span><span> </span><span class="NLM_article-title">Design, new synthesis, and calcilytic activity of substituted 3<i>H</i>-pyrimidin-4-ones</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">2537</span><span class="NLM_x">–</span> <span class="NLM_lpage">2540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2537-2540&issue=10&author=I.+Shcherbakovaauthor=G.+I.+Huangauthor=J.+Geoffroyauthor=S.+K.+Nairauthor=K.+Swierczekauthor=M.+F.+Balandrinauthor=J.+Foxauthor=W.+L.+Heatonauthor=R.+L.+Conklin&title=Design%2C+new+synthesis%2C+and+calcilytic+activity+of+substituted+3H-pyrimidin-4-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShcherbakova%26aufirst%3DI.%26aulast%3DHuang%26aufirst%3DG.%2BI.%26aulast%3DGeoffroy%26aufirst%3DJ.%26aulast%3DNair%26aufirst%3DS.%2BK.%26aulast%3DSwierczek%26aufirst%3DK.%26aulast%3DBalandrin%26aufirst%3DM.%2BF.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DHeaton%26aufirst%3DW.%2BL.%26aulast%3DConklin%26aufirst%3DR.%2BL.%26atitle%3DDesign%252C%2520new%2520synthesis%252C%2520and%2520calcilytic%2520activity%2520of%2520substituted%25203H-pyrimidin-4-ones%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26issue%3D10%26spage%3D2537%26epage%3D2540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_contrib-group">Shcherbakova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balandrin, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghatak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, R. L.</span><span> </span><span class="NLM_article-title">3<i>H</i>-Quinazolin-4-ones as a new calcilytic template for the potential treatment of osteoporosis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1557</span><span class="NLM_x">–</span> <span class="NLM_lpage">1560</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1557-1560&issue=6&author=I.+Shcherbakovaauthor=M.+F.+Balandrinauthor=J.+Foxauthor=A.+Ghatakauthor=W.+L.+Heatonauthor=R.+L.+Conklin&title=3H-Quinazolin-4-ones+as+a+new+calcilytic+template+for+the+potential+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShcherbakova%26aufirst%3DI.%26aulast%3DBalandrin%26aufirst%3DM.%2BF.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DGhatak%26aufirst%3DA.%26aulast%3DHeaton%26aufirst%3DW.%2BL.%26aulast%3DConklin%26aufirst%3DR.%2BL.%26atitle%3D3H-Quinazolin-4-ones%2520as%2520a%2520new%2520calcilytic%2520template%2520for%2520the%2520potential%2520treatment%2520of%2520osteoporosis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26issue%3D6%26spage%3D1557%26epage%3D1560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_contrib-group">Shinagawa, Y.; Inoue, T.; Kiguchi, T.; Ikenogami, T.; Ogawa, N.; Fukuda, K.; Nakagawa, T.; Shindo, M.; Soejima, Y.</span><span> </span><span class="NLM_article-title">CaSR antagonists</span>. Patent EP 1630157,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=Y.+Shinagawa&author=T.+Inoue&author=T.+Kiguchi&author=T.+Ikenogami&author=N.+Ogawa&author=K.+Fukuda&author=T.+Nakagawa&author=M.+Shindo&author=Y.+Soejima&title=CaSR+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShinagawa%26aufirst%3DY.%26atitle%3DCaSR%2520antagonists%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_contrib-group">Shinagawa, Y.; Inoue, T.; Kiguchi, T.; Ikenogami, T.; Ogawa, N.; Nakagawa, T.; Shindo, M.; Soejima, Y.</span><span> </span><span class="NLM_article-title">Preparation of 3-[[2-methyl-3-aryl-2-propyl]amino]-1,2-propanediol derivatives as calcium-sensing receptor (CaSR) antagonists</span>. Patent WO 2004106280,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=Y.+Shinagawa&author=T.+Inoue&author=T.+Kiguchi&author=T.+Ikenogami&author=N.+Ogawa&author=T.+Nakagawa&author=M.+Shindo&author=Y.+Soejima&title=Preparation+of+3-%5B%5B2-methyl-3-aryl-2-propyl%5Damino%5D-1%2C2-propanediol+derivatives+as+calcium-sensing+receptor+%28CaSR%29+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShinagawa%26aufirst%3DY.%26atitle%3DPreparation%2520of%25203-%255B%255B2-methyl-3-aryl-2-propyl%255Damino%255D-1%252C2-propanediol%2520derivatives%2520as%2520calcium-sensing%2520receptor%2520%2528CaSR%2529%2520antagonists%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_contrib-group">Gabka, J.</span><span> </span><span class="NLM_article-title">Analgesic and anti-inflammatory activity of Biarison. Clinical experimental studies</span> <span class="citation_source-journal">München Med. Wochen.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=1978&pages=331-334&issue=10&author=J.+Gabka&title=Analgesic+and+anti-inflammatory+activity+of+Biarison.+Clinical+experimental+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGabka%26aufirst%3DJ.%26atitle%3DAnalgesic%2520and%2520anti-inflammatory%2520activity%2520of%2520Biarison.%2520Clinical%2520experimental%2520studies%26jtitle%3DM%25C3%25BCnchen%2520Med.%2520Wochen.%26date%3D1978%26volume%3D120%26issue%3D10%26spage%3D331%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_contrib-group">Houlihan, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Bochoven, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takesue, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jukniewicz, E.</span><span> </span><span class="NLM_article-title">Anti-inflammatory properties of 8-aryl-5-isopropyl-2<i>H</i>-1,3-dioxolo[4,5-<i>g</i>]quinazolin-6(5<i>H</i>)-ones and -thiones</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1110</span><span class="NLM_x">–</span> <span class="NLM_lpage">1113</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00351a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1982&pages=1110-1113&issue=9&author=W.+J.+Houlihanauthor=G.+Cookeauthor=R.+Van+Bochovenauthor=J.+Perrineauthor=E.+I.+Takesueauthor=E.+Jukniewicz&title=Anti-inflammatory+properties+of+8-aryl-5-isopropyl-2H-1%2C3-dioxolo%5B4%2C5-g%5Dquinazolin-6%285H%29-ones+and+-thiones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Fjm00351a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00351a022%26sid%3Dliteratum%253Aachs%26aulast%3DHoulihan%26aufirst%3DW.%2BJ.%26aulast%3DCooke%26aufirst%3DG.%26aulast%3DVan%2BBochoven%26aufirst%3DR.%26aulast%3DPerrine%26aufirst%3DJ.%26aulast%3DTakesue%26aufirst%3DE.%2BI.%26aulast%3DJukniewicz%26aufirst%3DE.%26atitle%3DAnti-inflammatory%2520properties%2520of%25208-aryl-5-isopropyl-2H-1%252C3-dioxolo%255B4%252C5-g%255Dquinazolin-6%25285H%2529-ones%2520and%2520-thiones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1982%26volume%3D25%26issue%3D9%26spage%3D1110%26epage%3D1113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13c"><span><span class="NLM_contrib-group">Perrine, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houlihan, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takesue, E. I.</span><span> </span><span class="NLM_article-title">Anti-inflammatory and other pharmacodynamic properties of five members of the 4-aryl-1-isopropyl-2(1<i>H</i>)-quinazolinone series</span> <span class="citation_source-journal">Arzneim.-Forsch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">879</span><span class="NLM_x">–</span> <span class="NLM_lpage">885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=6333879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADyaL2cXlvVentLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1984&pages=879-885&issue=8&author=J.+W.+Perrineauthor=W.+J.+Houlihanauthor=E.+I.+Takesue&title=Anti-inflammatory+and+other+pharmacodynamic+properties+of+five+members+of+the+4-aryl-1-isopropyl-2%281H%29-quinazolinone+series"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13cR"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Antiinflammatory and other pharmacodynamic properties of five members of the 4-aryl-1-isopropyl-2(1H)-quinazolinone series</span></div><div class="casAuthors">Perrine, J. W.; Houlihan, W. J.; Takesue, E. I.</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel-Forschung</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">879-85</span>CODEN:
                <span class="NLM_cas:coden">ARZNAD</span>;
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    </div><div class="casAbstract">A series of five 4-aryl-1-isopropyl-2(1H)-quinazolinone analogs were examd. for their relative activities regarding analgesia, suppression of inflammation and pyrexia, and assocd. phenomena.  Two of these, SaH 43-715 proquazone(I)  [22760-18-5] and SaH 46-790 (fluproquazone(II)  [40507-23-1], are clin. effective anti-inflammatory and analgesic agents.  In general, substitutions in these 5 quinazolinone analogs produced noticeable changes in potency in several activities but changes of lesser degrees of others.  Compared to acetylsalicylic acid and phenylbutazone the quinazolinones exhibited better analgesic and related activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3VU9XcJG067Vg90H21EOLACvtfcHk0lj6DMaS_fnznw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXlvVentLk%253D&md5=5626bb72800d04da64ac527991368e91</span></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerrine%26aufirst%3DJ.%2BW.%26aulast%3DHoulihan%26aufirst%3DW.%2BJ.%26aulast%3DTakesue%26aufirst%3DE.%2BI.%26atitle%3DAnti-inflammatory%2520and%2520other%2520pharmacodynamic%2520properties%2520of%2520five%2520members%2520of%2520the%25204-aryl-1-isopropyl-2%25281H%2529-quinazolinone%2520series%26jtitle%3DArzneim.-Forsch.%26date%3D1984%26volume%3D34%26issue%3D8%26spage%3D879%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Houlihan, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoletti, J.</span><span> </span><span class="NLM_article-title">1-Alkyl-4-aryl-3,4-dihydro-2(1<i>H</i>)-quinazolinones and thiones. Synthesis and proton−NMR spectra</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1453</span><span class="NLM_x">–</span> <span class="NLM_lpage">1456</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1982&pages=1453-1456&issue=6&author=W.+J.+Houlihanauthor=G.+Cookeauthor=M.+Denzerauthor=J.+Nicoletti&title=1-Alkyl-4-aryl-3%2C4-dihydro-2%281H%29-quinazolinones+and+thiones.+Synthesis+and+proton%E2%88%92NMR+spectra"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoulihan%26aufirst%3DW.%2BJ.%26aulast%3DCooke%26aufirst%3DG.%26aulast%3DDenzer%26aufirst%3DM.%26aulast%3DNicoletti%26aufirst%3DJ.%26atitle%3D1-Alkyl-4-aryl-3%252C4-dihydro-2%25281H%2529-quinazolinones%2520and%2520thiones.%2520Synthesis%2520and%2520proton%25E2%2588%2592NMR%2520spectra%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1982%26volume%3D19%26issue%3D6%26spage%3D1453%26epage%3D1456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Wohnsland, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faller, B.</span><span> </span><span class="NLM_article-title">High throughput permeability pH profile and High throughput alkane/water log P with artificial membranes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">930</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm001020e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=923-930&author=F.+Wohnslandauthor=B.+Faller&title=High+throughput+permeability+pH+profile+and+High+throughput+alkane%2Fwater+log+P+with+artificial+membranes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm001020e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm001020e%26sid%3Dliteratum%253Aachs%26aulast%3DWohnsland%26aufirst%3DF.%26aulast%3DFaller%26aufirst%3DB.%26atitle%3DHigh%2520throughput%2520permeability%2520pH%2520profile%2520and%2520High%2520throughput%2520alkane%252Fwater%2520log%2520P%2520with%2520artificial%2520membranes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D923%26epage%3D930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Petrel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maslah, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauban, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span> </span><span class="NLM_article-title">Modeling and mutagenesis of the binding site of Calhex 231, a novel negative allosteric modulator of the extracellular Ca<sup>2+</sup>-sensing receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">49487</span><span class="NLM_x">–</span> <span class="NLM_lpage">49494</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=49487-49494&author=C.+Petrelauthor=A.+Kesslerauthor=F.+Maslahauthor=P.+Daubanauthor=R.+H.+Doddauthor=D.+Rognanauthor=M.+Ruat&title=Modeling+and+mutagenesis+of+the+binding+site+of+Calhex+231%2C+a+novel+negative+allosteric+modulator+of+the+extracellular+Ca2%2B-sensing+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetrel%26aufirst%3DC.%26aulast%3DKessler%26aufirst%3DA.%26aulast%3DMaslah%26aufirst%3DF.%26aulast%3DDauban%26aufirst%3DP.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26aulast%3DRognan%26aufirst%3DD.%26aulast%3DRuat%26aufirst%3DM.%26atitle%3DModeling%2520and%2520mutagenesis%2520of%2520the%2520binding%2520site%2520of%2520Calhex%2520231%252C%2520a%2520novel%2520negative%2520allosteric%2520modulator%2520of%2520the%2520extracellular%2520Ca2%252B-sensing%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D49487%26epage%3D49494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Miedlich, S. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gama, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seuwen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitwieser, G. E.</span><span> </span><span class="NLM_article-title">Homology modeling of the transmembrane domain of the human calcium sensing receptor and localization of an allosteric binding site</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">7254</span><span class="NLM_x">–</span> <span class="NLM_lpage">7263</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=7254-7263&author=S.+U.+Miedlichauthor=L.+Gamaauthor=K.+Seuwenauthor=R.+M.+Wolfauthor=G.+E.+Breitwieser&title=Homology+modeling+of+the+transmembrane+domain+of+the+human+calcium+sensing+receptor+and+localization+of+an+allosteric+binding+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiedlich%26aufirst%3DS.%2BU.%26aulast%3DGama%26aufirst%3DL.%26aulast%3DSeuwen%26aufirst%3DK.%26aulast%3DWolf%26aufirst%3DR.%2BM.%26aulast%3DBreitwieser%26aufirst%3DG.%2BE.%26atitle%3DHomology%2520modeling%2520of%2520the%2520transmembrane%2520domain%2520of%2520the%2520human%2520calcium%2520sensing%2520receptor%2520and%2520localization%2520of%2520an%2520allosteric%2520binding%2520site%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D7254%26epage%3D7263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Petrel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauban, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span> </span><span class="NLM_article-title">Positive and negative allosteric modulators of the Ca<sup>2+</sup>-sensing receptor interact within overlapping but not identical binding sites in the transmembrane domain</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">18990</span><span class="NLM_x">–</span> <span class="NLM_lpage">18997</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=18990-18997&author=C.+Petrelauthor=A.+Kesslerauthor=P.+Daubanauthor=R.+H.+Doddauthor=D.+Rognanauthor=M.+Ruat&title=Positive+and+negative+allosteric+modulators+of+the+Ca2%2B-sensing+receptor+interact+within+overlapping+but+not+identical+binding+sites+in+the+transmembrane+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetrel%26aufirst%3DC.%26aulast%3DKessler%26aufirst%3DA.%26aulast%3DDauban%26aufirst%3DP.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26aulast%3DRognan%26aufirst%3DD.%26aulast%3DRuat%26aufirst%3DM.%26atitle%3DPositive%2520and%2520negative%2520allosteric%2520modulators%2520of%2520the%2520Ca2%252B-sensing%2520receptor%2520interact%2520within%2520overlapping%2520but%2520not%2520identical%2520binding%2520sites%2520in%2520the%2520transmembrane%2520domain%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D18990%26epage%3D18997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Bu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, C. L.</span><span> </span><span class="NLM_article-title">Improved model building and assessment of the calcium-sensing receptor transmembrane domain</span> <span class="citation_source-journal">Proteins.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2008&pages=215-226&author=L.+Buauthor=M.+Michinoauthor=R.+M.+Wolfauthor=C.+L.+Brooks&title=Improved+model+building+and+assessment+of+the+calcium-sensing+receptor+transmembrane+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBu%26aufirst%3DL.%26aulast%3DMichino%26aufirst%3DM.%26aulast%3DWolf%26aufirst%3DR.%2BM.%26aulast%3DBrooks%26aufirst%3DC.%2BL.%26atitle%3DImproved%2520model%2520building%2520and%2520assessment%2520of%2520the%2520calcium-sensing%2520receptor%2520transmembrane%2520domain%26jtitle%3DProteins.%26date%3D2008%26volume%3D71%26spage%3D215%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Seuwen, K.; Halleux, C.; Bouhelal, R.; Kneissel, M.; Buhl, T.; Gamse, R.; Wolf, R. M.; Breitwieser, G.; Beerli, R.; Weiler, S.; Widler, L.</span><span> </span><span class="NLM_article-title">A new class of noncompetitive antagonists of the human calcium-sensing receptor releasing parathyroid hormone (PTH) from parathyroid glands</span>. Poster presented at the <span class="NLM_conf-name">26th Annual Meeting of the American Society of Bone and Mineral Research (ASBMR)</span>, <span class="NLM_conf-loc">Seattle, WA</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&conference=26th+Annual+Meeting+of+the+American+Society+of+Bone+and+Mineral+Research+%28ASBMR%29&author=K.+Seuwen&author=C.+Halleux&author=R.+Bouhelal&author=M.+Kneissel&author=T.+Buhl&author=R.+Gamse&author=R.+M.+Wolf&author=G.+Breitwieser&author=R.+Beerli&author=S.+Weiler&author=L.+Widler&title=A+new+class+of+noncompetitive+antagonists+of+the+human+calcium-sensing+receptor+releasing+parathyroid+hormone+%28PTH%29+from+parathyroid+glands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DSeuwen%26aufirst%3DK.%26atitle%3DA%2520new%2520class%2520of%2520noncompetitive%2520antagonists%2520of%2520the%2520human%2520calcium-sensing%2520receptor%2520releasing%2520parathyroid%2520hormone%2520%2528PTH%2529%2520from%2520parathyroid%2520glands%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">DeLano, W. L.</span> <span class="citation_source-book">The PyMOL Molecular Graphics System, version 1.0r2</span>; <span class="NLM_publisher-name">DeLano Scientific LLC</span>: <span class="NLM_publisher-loc">San Carlos, CA</span>; <a href="http://www.pymol.org" class="extLink">http://www.pymol.org</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=DeLano%2C+W.+L.The+PyMOL+Molecular+Graphics+System%2C+version+1.0r2%3B+DeLano+Scientific+LLC%3A+San+Carlos%2C+CA%3B+http%3A%2F%2Fwww.pymol.org."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDeLano%26aufirst%3DW.%2BL.%26btitle%3DThe%2520PyMOL%2520Molecular%2520Graphics%2520System%252C%2520version%25201.0r2%26pub%3DDeLano%2520Scientific%2520LLC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Duan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chowdhury, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cieplak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P.</span><span> </span><span class="NLM_article-title">A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1999</span><span class="NLM_x">–</span> <span class="NLM_lpage">2012</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1002%2Fjcc.10349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=14531054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVygsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=1999-2012&author=Y.+Duanauthor=C.+Wuauthor=S.+Chowdhuryauthor=M.+C.+Leeauthor=G.+Xiongauthor=W.+Zhangauthor=R.+Yangauthor=P.+Cieplakauthor=R.+Luoauthor=T.+Leeauthor=J.+Caldwellauthor=J.+Wangauthor=P.+Kollman&title=A+point-charge+force+field+for+molecular+mechanics+simulations+of+proteins+based+on+condensed-phase+quantum+mechanical+calculations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations</span></div><div class="casAuthors">Duan, Yong; Wu, Chun; Chowdhury, Shibasish; Lee, Mathew C.; Xiong, Guoming; Zhang, Wei; Yang, Rong; Cieplak, Piotr; Luo, Ray; Lee, Taisung; Caldwell, James; Wang, Junmei; Kollman, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1999-2012</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Mol. mechanics models have been applied extensively to study the dynamics of proteins and nucleic acids.  Here we report the development of a third-generation point-charge all-atom force field for proteins.  Following the earlier approach of Cornell et al., the charge set was obtained by fitting to the electrostatic potentials of dipeptides calcd. using B3LYP/cc-pVTZ/HF/6-31G** quantum mech. methods.  The main-chain torsion parameters were obtained by fitting to the energy profiles of Ace-Ala-Nme and Ace-Gly-Nme di-peptides calcd. using MP2/cc-pVTZ//HF/6-31G** quantum mech. methods.  All other parameters were taken from the existing AMBER data base.  The major departure from previous force fields is that all quantum mech. calcns. were done in the condensed phase with continuum solvent models and an effective dielec. const. of ε = 4.  We anticipate that this force field parameter set will address certain crit. short comings of previous force fields in condensed-phase simulations of proteins.  Initial tests on peptides demonstrated a high-degree of similarity between the calcd. and the statistically measured Ramanchandran maps for both Ace-Gly-Nme and Ace-Ala-Nme di-peptides.  Some highlights of our results include (1) well-preserved balance between the extended and helical region distributions, and (2) favorable type-II poly-proline helical region in agreement with recent expts.  Backward compatibility between the new and Cornell et al. charge sets, as judged by overall agreement between dipole moments, allows a smooth transition to the new force field in the area of ligand-binding calcns.  Test simulations on a large set of proteins are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAhPNmSr3iorVg90H21EOLACvtfcHk0licGaaHUbph6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVygsbc%253D&md5=b4531cbf2d90deb9a173ec314dfd7b5d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fjcc.10349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.10349%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DM.%2BC.%26aulast%3DXiong%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DR.%26aulast%3DCieplak%26aufirst%3DP.%26aulast%3DLuo%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DCaldwell%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKollman%26aufirst%3DP.%26atitle%3DA%2520point-charge%2520force%2520field%2520for%2520molecular%2520mechanics%2520simulations%2520of%2520proteins%2520based%2520on%2520condensed-phase%2520quantum%2520mechanical%2520calculations%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2003%26volume%3D24%26spage%3D1999%26epage%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Case, D. A.</span><span> </span><span class="NLM_article-title">Development and testing of a general amber force field</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1157</span><span class="NLM_x">–</span> <span class="NLM_lpage">1174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1002%2Fjcc.20035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=15116359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFakurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1157-1174&author=J.+Wangauthor=R.+M.+Wolfauthor=J.+W.+Caldwellauthor=P.+A.+Kollmanauthor=D.+A.+Case&title=Development+and+testing+of+a+general+amber+force+field"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Development and testing of a general Amber force field</span></div><div class="casAuthors">Wang, Junmei; Wolf, Romain M.; Caldwell, James W.; Kollman, Peter A.; Case, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1157-1174</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe here a general Amber force field (GAFF) for org. mols.  GAFF is designed to be compatible with existing Amber force fields for proteins and nucleic acids, and has parameters for most org. and pharmaceutical mols. that are composed of H, C, N, O, S, P, and halogens.  It uses a simple functional form and a limited no. of atom types, but incorporates both empirical and heuristic models to est. force consts. and partial at. charges.  The performance of GAFF in test cases is encouraging.  In test I, 74 crystallog. structures were compared to GAFF minimized structures, with a root-mean-square displacement of 0.26 Å, which is comparable to that of the Tripos 5.2 force field (0.25 Å) and better than those of MMFF 94 and CHARMm (0.47 and 0.44 Å, resp.).  In test II, gas phase minimizations were performed on 22 nucleic acid base pairs, and the minimized structures and intermol. energies were compared to MP2/6-31G* results.  The RMS of displacements and relative energies were 0.25 Å and 1.2 kcal/mol, resp.  These data are comparable to results from Parm99/RESP (0.16 Å and 1.18 kcal/mol, resp.), which were parameterized to these base pairs.  Test III looked at the relative energies of 71 conformational pairs that were used in development of the Parm99 force field.  The RMS error in relative energies (compared to expt.) is about 0.5 kcal/mol.  GAFF can be applied to wide range of mols. in an automatic fashion, making it suitable for rational drug design and database searching.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfW8Gsf8IiW7Vg90H21EOLACvtfcHk0licGaaHUbph6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFakurc%253D&md5=2992017a8cf51f89290ae2562403b115</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20035%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWolf%26aufirst%3DR.%2BM.%26aulast%3DCaldwell%26aufirst%3DJ.%2BW.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26aulast%3DCase%26aufirst%3DD.%2BA.%26atitle%3DDevelopment%2520and%2520testing%2520of%2520a%2520general%2520amber%2520force%2520field%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2004%26volume%3D25%26spage%3D1157%26epage%3D1174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><div class="note"><p class="first last">See, e.g.,</p></div><span class="NLM_contrib-group">Lennernaes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsson, B.</span><span> </span><span class="NLM_article-title">The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">285</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1211%2F0022357055263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=15807982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisFSqur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=273-285&issue=3&author=H.+Lennernaesauthor=B.+Abrahamsson&title=The+use+of+biopharmaceutic+classification+of+drugs+in+drug+discovery+and+development%3A+current+status+and+future+extension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension</span></div><div class="casAuthors">Lennernaes, Hans; Abrahamsson, Bertil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">273-285</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Press</span>)
        </div><div class="casAbstract">A review and discussion.  Bioavailability (BA) and bioequivalence (BE) play a central role in pharmaceutical product development and BE studies are presently being conducted for New Drug Applications (NDAs) of new compds., in supplementary NDAs for new medical indications and product line extensions, in Abbreviated New Drug Applications (ANDAs) of generic products and in applications for scale-up and post-approval changes.  The Biopharmaceutics Classification System (BCS) has been developed to provide a scientific approach for classifying drug compds. based on soly. as related to dose and intestinal permeability in combination with the dissoln. properties of the oral immediate-release (IR) dosage form.  The aim of the BCS is to provide a regulatory tool for replacing certain BE studies by accurate in-vitro dissoln. tests.  The aim of this review is to present the status of the BCS and discuss its future application in pharmaceutical product development.  The future application of the BCS is most likely increasingly important when the present framework gains increased recognition, which will probably be the case if the BCS borders for certain class II and III drugs are extended.  The future revision of the BCS guidelines by the regulatory agencies in communication with academic and industrial scientists is exciting and will hopefully result in an increased applicability in drug development.  Finally, the authors emphasize the great use of the BCS as a simple tool in early drug development to det. the rate-limiting step in the oral absorption process, which has facilitated the information between different experts involved in the overall drug development process.  This increased awareness of a proper biopharmaceutical characterization of new drugs may in the future result in drug mols. with a sufficiently high permeability, soly. and dissoln. rate, and that will automatically increase the importance of the BCS as a regulatory tool over time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG4DCZpL6kl7Vg90H21EOLACvtfcHk0lh9SHtcFt5mHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisFSqur4%253D&md5=26820123a6ad115d6fdfa8ef364ab39f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1211%2F0022357055263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252F0022357055263%26sid%3Dliteratum%253Aachs%26aulast%3DLennernaes%26aufirst%3DH.%26aulast%3DAbrahamsson%26aufirst%3DB.%26atitle%3DThe%2520use%2520of%2520biopharmaceutic%2520classification%2520of%2520drugs%2520in%2520drug%2520discovery%2520and%2520development%253A%2520current%2520status%2520and%2520future%2520extension%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2005%26volume%3D57%26issue%3D3%26spage%3D273%26epage%3D285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Bowden, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heilbron, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E. R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weedon, B. C. L.</span><span> </span><span class="NLM_article-title">Acetylenic compounds. I. Preparation of acetylenic ketones by oxidation of acetylenic carbinols and glycols</span> <span class="citation_source-journal">J. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1946</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1946&pages=39-45&author=K.+Bowdenauthor=I.+M.+Heilbronauthor=E.+R.+H.+Jonesauthor=B.+C.+L.+Weedon&title=Acetylenic+compounds.+I.+Preparation+of+acetylenic+ketones+by+oxidation+of+acetylenic+carbinols+and+glycols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBowden%26aufirst%3DK.%26aulast%3DHeilbron%26aufirst%3DI.%2BM.%26aulast%3DJones%26aufirst%3DE.%2BR.%2BH.%26aulast%3DWeedon%26aufirst%3DB.%2BC.%2BL.%26atitle%3DAcetylenic%2520compounds.%2520I.%2520Preparation%2520of%2520acetylenic%2520ketones%2520by%2520oxidation%2520of%2520acetylenic%2520carbinols%2520and%2520glycols%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1946%26spage%3D39%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c','cit1d','cit1e','cit1f','cit1g','cit1h','cit1i'],'ref2':['cit2a','cit2b','cit2c','cit2d','cit2e'],'ref3':['cit3a','cit3b'],'ref4':['cit4a','cit4b','cit4c'],'ref5':['cit5a','cit5b','cit5c'],'ref6':['cit6a','cit6b','cit6c','cit6d','cit6e'],'ref7':['cit7a','cit7b','cit7c'],'ref8':['cit8'],'ref9':['cit9a','cit9b','cit9c','cit9d'],'ref10':['cit10a','cit10b','cit10c','cit10d','cit10e'],'ref11':['cit11a','cit11b'],'ref12':['cit12a','cit12b'],'ref13':['cit13a','cit13b','cit13c'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 29 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jiayin Diao, Aaron DeBono, Tracy M. Josephs, Jane E. Bourke, Ben Capuano, Karen J. Gregory, <span class="NLM_string-name hlFld-ContribAuthor">Katie Leach</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Opportunities of Targeting Allosteric Binding Sites on the Calcium-Sensing Receptor. </span><span class="cited-content_cbyCitation_journal-name">ACS Pharmacology & Translational Science</span><span> <strong>2021,</strong> <em>4 </em>
                                    (2)
                                     , 666-679. <a href="https://doi.org/10.1021/acsptsci.1c00046" title="DOI URL">https://doi.org/10.1021/acsptsci.1c00046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsptsci.1c00046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsptsci.1c00046%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Pharmacology%2520%2526%2520Translational%2520Science%26atitle%3DTherapeutic%252BOpportunities%252Bof%252BTargeting%252BAllosteric%252BBinding%252BSites%252Bon%252Bthe%252BCalcium-Sensing%252BReceptor%26aulast%3DDiao%26aufirst%3DJiayin%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D04022021%26date%3D08032021%26volume%3D4%26issue%3D2%26spage%3D666%26epage%3D679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Tanaji T. Talele</span>. </span><span class="cited-content_cbyCitation_article-title">Acetylene Group, Friend or Foe in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (11)
                                     , 5625-5663. <a href="https://doi.org/10.1021/acs.jmedchem.9b01617" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01617</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01617%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAcetylene%252BGroup%25252C%252BFriend%252Bor%252BFoe%252Bin%252BMedicinal%252BChemistry%26aulast%3DTalele%26aufirst%3DTanaji%2BT.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D29092019%26date%3D19022020%26date%3D07022020%26volume%3D63%26issue%3D11%26spage%3D5625%26epage%3D5663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guo-Hai  Zhang</span>, <span class="hlFld-ContribAuthor ">Jing-Mei  Yuan</span>, <span class="hlFld-ContribAuthor ">Gang  Qian</span>, <span class="hlFld-ContribAuthor ">Chen-Xi  Gu</span>, <span class="hlFld-ContribAuthor ">Kai  Wei</span>, <span class="hlFld-ContribAuthor ">Dong-Liang  Mo</span>, <span class="hlFld-ContribAuthor ">Jiang-Ke  Qin</span>, <span class="hlFld-ContribAuthor ">Yan  Peng</span>, <span class="hlFld-ContribAuthor ">Zu-Ping  Zhou</span>, <span class="hlFld-ContribAuthor ">Cheng-Xue  Pan</span>, and <span class="hlFld-ContribAuthor ">Gui-Fa  Su</span>  . </span><span class="cited-content_cbyCitation_article-title">Phthalazino[1,2-b]quinazolinones as p53 Activators: Cell Cycle Arrest, Apoptotic Response and Bak–Bcl-xl Complex Reorganization in Bladder Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (16)
                                     , 6853-6866. <a href="https://doi.org/10.1021/acs.jmedchem.6b01769" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01769</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01769%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPhthalazino%25255B1%25252C2-b%25255Dquinazolinones%252Bas%252Bp53%252BActivators%25253A%252BCell%252BCycle%252BArrest%25252C%252BApoptotic%252BResponse%252Band%252BBak%2525E2%252580%252593Bcl-xl%252BComplex%252BReorganization%252Bin%252BBladder%252BCancer%252BCells%26aulast%3DZhang%26aufirst%3DGuo-Hai%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D04012017%26date%3D15082017%26date%3D24082017%26date%3D26072017%26volume%3D60%26issue%3D16%26spage%3D6853%26epage%3D6866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wayne P.  Kelley</span>, <span class="hlFld-ContribAuthor ">Shujun  Chen</span>, <span class="hlFld-ContribAuthor ">Philip D.  Floyd</span>, <span class="hlFld-ContribAuthor ">Ping  Hu</span>, <span class="hlFld-ContribAuthor ">Shiva G.  Kapsi</span>, <span class="hlFld-ContribAuthor ">Alireza S.  Kord</span>, <span class="hlFld-ContribAuthor ">Mingjiang  Sun</span>, and <span class="hlFld-ContribAuthor ">Frederick G.  Vogt</span>  . </span><span class="cited-content_cbyCitation_article-title">Analytical Characterization of an Orally-Delivered Peptide Pharmaceutical Product. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2012,</strong> <em>84 </em>
                                    (10)
                                     , 4357-4372. <a href="https://doi.org/10.1021/ac203478r" title="DOI URL">https://doi.org/10.1021/ac203478r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ac203478r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fac203478r%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DAnalytical%252BCharacterization%252Bof%252Ban%252BOrally-Delivered%252BPeptide%252BPharmaceutical%252BProduct%26aulast%3DKelley%26aufirst%3DWayne%2BP.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D28122011%26date%3D12042012%26date%3D27042012%26date%3D15052012%26date%3D12042012%26volume%3D84%26issue%3D10%26spage%3D4357%26epage%3D4372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiaxi  Cui</span>, <span class="hlFld-ContribAuthor ">Radu A.  Gropeanu</span>, <span class="hlFld-ContribAuthor ">David R.  Stevens</span>, <span class="hlFld-ContribAuthor ">Jens  Rettig</span>, and <span class="hlFld-ContribAuthor ">Aránzazu del  Campo</span>  . </span><span class="cited-content_cbyCitation_article-title">New Photolabile BAPTA-Based Ca2+ Cages with Improved Photorelease. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2012,</strong> <em>134 </em>
                                    (18)
                                     , 7733-7740. <a href="https://doi.org/10.1021/ja2115184" title="DOI URL">https://doi.org/10.1021/ja2115184</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja2115184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja2115184%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DNew%252BPhotolabile%252BBAPTA-Based%252BCa2%25252B%252BCages%252Bwith%252BImproved%252BPhotorelease%26aulast%3DCui%26aufirst%3DJiaxi%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D09122011%26date%3D01052012%26date%3D09052012%26date%3D22042012%26volume%3D134%26issue%3D18%26spage%3D7733%26epage%3D7740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuko  Shinagawa</span>, <span class="hlFld-ContribAuthor ">Teruhiko  Inoue</span>, <span class="hlFld-ContribAuthor ">Takeo  Katsushima</span>, <span class="hlFld-ContribAuthor ">Toshihiro  Kiguchi</span>, <span class="hlFld-ContribAuthor ">Taku  Ikenogami</span>, <span class="hlFld-ContribAuthor ">Naoki  Ogawa</span>, <span class="hlFld-ContribAuthor ">Kenji  Fukuda</span>, <span class="hlFld-ContribAuthor ">Kazuyuki  Hirata</span>, <span class="hlFld-ContribAuthor ">Kazuhito  Harada</span>, <span class="hlFld-ContribAuthor ">Masaki  Takagi</span>, <span class="hlFld-ContribAuthor ">Takashi  Nakagawa</span>, <span class="hlFld-ContribAuthor ">Shuichi  Kimura</span>, <span class="hlFld-ContribAuthor ">Yushi  Matsuo</span>, <span class="hlFld-ContribAuthor ">Mariko  Maekawa</span>, <span class="hlFld-ContribAuthor ">Mikio  Hayashi</span>, <span class="hlFld-ContribAuthor ">Yuki  Soejima</span>, <span class="hlFld-ContribAuthor ">Mitsuru  Takahashi</span>, <span class="hlFld-ContribAuthor ">Masanori  Shindo</span>, and <span class="hlFld-ContribAuthor ">Hiromasa  Hashimoto</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent and Short−Acting Oral Calcilytic with a Pulsatile Secretion of Parathyroid Hormone. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>2 </em>
                                    (3)
                                     , 238-242. <a href="https://doi.org/10.1021/ml100268k" title="DOI URL">https://doi.org/10.1021/ml100268k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml100268k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml100268k%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252Band%252BShort%2525E2%252588%252592Acting%252BOral%252BCalcilytic%252Bwith%252Ba%252BPulsatile%252BSecretion%252Bof%252BParathyroid%252BHormone%26aulast%3DShinagawa%26aufirst%3DYuko%26date%3D2011%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D09112010%26date%3D21122010%26date%3D29122010%26date%3D10032011%26volume%3D2%26issue%3D3%26spage%3D238%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed Hassen Shntaif</span>, <span class="hlFld-ContribAuthor ">Zahraa M.  Rashi</span>, <span class="hlFld-ContribAuthor ">Zaid H.  Al-Sawaff</span>, <span class="hlFld-ContribAuthor ">Fatma  Kandemirli</span>. </span><span class="cited-content_cbyCitation_article-title">Quantum Chemical Calculations on Two Compounds of Proquazone and Proquazone Type Calcites as a Calcium Sensing Receptor (CaSR) Inhibitory Profiles. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>47 </em>
                                    (3)
                                     , 777-783. <a href="https://doi.org/10.1134/S106816202103016X" title="DOI URL">https://doi.org/10.1134/S106816202103016X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S106816202103016X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS106816202103016X%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Bioorganic%2520Chemistry%26atitle%3DQuantum%252BChemical%252BCalculations%252Bon%252BTwo%252BCompounds%252Bof%252BProquazone%252Band%252BProquazone%252BType%252BCalcites%252Bas%252Ba%252BCalcium%252BSensing%252BReceptor%252B%252528CaSR%252529%252BInhibitory%252BProfiles%26aulast%3DAhmed%2BHassen%2BShntaif%26date%3D2021%26date%3D2021%26volume%3D47%26issue%3D3%26spage%3D777%26epage%3D783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonid G.  Menchikov</span>, <span class="hlFld-ContribAuthor ">Evgeny V.  Shulishov</span>, <span class="hlFld-ContribAuthor ">Yury V.  Tomilov</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the catalytic cyclopropanation of unsaturated compounds with diazomethane. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Reviews</span><span> <strong>2021,</strong> <em>90 </em>
                                    (2)
                                     , 199-230. <a href="https://doi.org/10.1070/RCR4982" title="DOI URL">https://doi.org/10.1070/RCR4982</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1070/RCR4982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1070%2FRCR4982%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Reviews%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bcatalytic%252Bcyclopropanation%252Bof%252Bunsaturated%252Bcompounds%252Bwith%252Bdiazomethane%26aulast%3DMenchikov%26aufirst%3DLeonid%2BG.%26date%3D2021%26volume%3D90%26issue%3D2%26spage%3D199%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yun-Sung  Lim</span>, <span class="hlFld-ContribAuthor ">Byung Hoon  You</span>, <span class="hlFld-ContribAuthor ">Hee-Bok  Kim</span>, <span class="hlFld-ContribAuthor ">So Hyun  Lim</span>, <span class="hlFld-ContribAuthor ">Jae Geun  Song</span>, <span class="hlFld-ContribAuthor ">Min Goo  Bae</span>, <span class="hlFld-ContribAuthor ">Hyo-Kyung  Han</span>, <span class="hlFld-ContribAuthor ">Young Hee  Choi</span>, <span class="hlFld-ContribAuthor ">Han Seok  Choi</span>. </span><span class="cited-content_cbyCitation_article-title">A New Therapeutic Approach Using a Calcilytic (AXT914) for Postsurgical Hypoparathyroidism in Female Rats. </span><span class="cited-content_cbyCitation_journal-name">Endocrinology</span><span> <strong>2020,</strong> <em>161 </em>
                                    (10)
                                     <a href="https://doi.org/10.1210/endocr/bqaa145" title="DOI URL">https://doi.org/10.1210/endocr/bqaa145</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1210/endocr/bqaa145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1210%2Fendocr%2Fbqaa145%26sid%3Dliteratum%253Aachs%26jtitle%3DEndocrinology%26atitle%3DA%252BNew%252BTherapeutic%252BApproach%252BUsing%252Ba%252BCalcilytic%252B%252528AXT914%252529%252Bfor%252BPostsurgical%252BHypoparathyroidism%252Bin%252BFemale%252BRats%26aulast%3DLim%26aufirst%3DYun-Sung%26date%3D2020%26date%3D2020%26volume%3D161%26issue%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shiyang  Zhou</span>, <span class="hlFld-ContribAuthor ">Gangliang  Huang</span>, <span class="hlFld-ContribAuthor ">Guangying  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological activities of drugs for the treatment of osteoporosis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>197 </em>, 112313. <a href="https://doi.org/10.1016/j.ejmech.2020.112313" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112313</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112313%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bactivities%252Bof%252Bdrugs%252Bfor%252Bthe%252Btreatment%252Bof%252Bosteoporosis%26aulast%3DZhou%26aufirst%3DShiyang%26date%3D2020%26volume%3D197%26spage%3D112313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tracy M.  Josephs</span>, <span class="hlFld-ContribAuthor ">Andrew N.  Keller</span>, <span class="hlFld-ContribAuthor ">Elham  Khajehali</span>, <span class="hlFld-ContribAuthor ">Aaron  DeBono</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Langmead</span>, <span class="hlFld-ContribAuthor ">Arthur D.  Conigrave</span>, <span class="hlFld-ContribAuthor ">Ben  Capuano</span>, <span class="hlFld-ContribAuthor ">Irina  Kufareva</span>, <span class="hlFld-ContribAuthor ">Karen J.  Gregory</span>, <span class="hlFld-ContribAuthor ">Katie  Leach</span>. </span><span class="cited-content_cbyCitation_article-title">Negative allosteric modulators of the human calcium‐sensing receptor bind to overlapping and distinct sites within the 7‐transmembrane domain. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2020,</strong> <em>177 </em>
                                    (8)
                                     , 1917-1930. <a href="https://doi.org/10.1111/bph.14961" title="DOI URL">https://doi.org/10.1111/bph.14961</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.14961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.14961%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DNegative%252Ballosteric%252Bmodulators%252Bof%252Bthe%252Bhuman%252Bcalcium%2525E2%252580%252590sensing%252Breceptor%252Bbind%252Bto%252Boverlapping%252Band%252Bdistinct%252Bsites%252Bwithin%252Bthe%252B7%2525E2%252580%252590transmembrane%252Bdomain%26aulast%3DJosephs%26aufirst%3DTracy%2BM.%26date%3D2020%26date%3D2020%26volume%3D177%26issue%3D8%26spage%3D1917%26epage%3D1930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rafaela  Teixeira</span>, <span class="hlFld-ContribAuthor ">Talita  Menengat</span>, <span class="hlFld-ContribAuthor ">Gabriel  Andrade</span>, <span class="hlFld-ContribAuthor ">Bruno  Cotrim</span>, <span class="hlFld-ContribAuthor ">Cristiano  Ponte</span>, <span class="hlFld-ContribAuthor ">Wilson C.  Santos</span>, <span class="hlFld-ContribAuthor ">Gabriel  Resende</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave Assisted Synthesis of 4-Phenylquinazolin-2(1H)-one Derivatives that Inhibit Vasopressor Tonus in Rat Thoracic Aorta. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (6)
                                     , 1467. <a href="https://doi.org/10.3390/molecules25061467" title="DOI URL">https://doi.org/10.3390/molecules25061467</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25061467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25061467%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DMicrowave%252BAssisted%252BSynthesis%252Bof%252B4-Phenylquinazolin-2%2525281H%252529-one%252BDerivatives%252Bthat%252BInhibit%252BVasopressor%252BTonus%252Bin%252BRat%252BThoracic%252BAorta%26aulast%3DTeixeira%26aufirst%3DRafaela%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D6%26spage%3D1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ilaria  Dal Prà</span>, <span class="hlFld-ContribAuthor ">Ubaldo  Armato</span>, <span class="hlFld-ContribAuthor ">Anna  Chiarini</span>. </span><span class="cited-content_cbyCitation_article-title">Family C G-Protein-Coupled Receptors in Alzheimer’s Disease and Therapeutic Implications. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2019,</strong> <em>10 </em><a href="https://doi.org/10.3389/fphar.2019.01282" title="DOI URL">https://doi.org/10.3389/fphar.2019.01282</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2019.01282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2019.01282%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DFamily%252BC%252BG-Protein-Coupled%252BReceptors%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%252Band%252BTherapeutic%252BImplications%26aulast%3DDal%2BPr%25C3%25A0%26aufirst%3DIlaria%26date%3D2019%26date%3D2019%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Grant B.  Frost</span>, <span class="hlFld-ContribAuthor ">Michaela N.  Mittelstaedt</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Douglas</span>. </span><span class="cited-content_cbyCitation_article-title">Chemoselectivity for Alkene Cleavage by Palladium-Catalyzed Intramolecular Diazo Group Transfer from Azide to Alkene. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2019,</strong> <em>25 </em>
                                    (7)
                                     , 1727-1732. <a href="https://doi.org/10.1002/chem.201805904" title="DOI URL">https://doi.org/10.1002/chem.201805904</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201805904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201805904%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DChemoselectivity%252Bfor%252BAlkene%252BCleavage%252Bby%252BPalladium-Catalyzed%252BIntramolecular%252BDiazo%252BGroup%252BTransfer%252Bfrom%252BAzide%252Bto%252BAlkene%26aulast%3DFrost%26aufirst%3DGrant%2BB.%26date%3D2019%26date%3D2019%26volume%3D25%26issue%3D7%26spage%3D1727%26epage%3D1732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Najwa  Sbei</span>, <span class="hlFld-ContribAuthor ">Belen  Batanero</span>, <span class="hlFld-ContribAuthor ">Fructuoso  Barba</span>, <span class="hlFld-ContribAuthor ">Beya  Haouas</span>, <span class="hlFld-ContribAuthor ">Mohamed Lamine  Benkhoud</span>, <span class="hlFld-ContribAuthor ">Isidoro  Barba</span>. </span><span class="cited-content_cbyCitation_article-title">Facile preparation of 3-substituted 2-quinazolinones via electrogenerated base. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2018,</strong> <em>74 </em>
                                    (16)
                                     , 2068-2072. <a href="https://doi.org/10.1016/j.tet.2018.03.010" title="DOI URL">https://doi.org/10.1016/j.tet.2018.03.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2018.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2018.03.010%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DFacile%252Bpreparation%252Bof%252B3-substituted%252B2-quinazolinones%252Bvia%252Belectrogenerated%252Bbase%26aulast%3DSbei%26aufirst%3DNajwa%26date%3D2018%26volume%3D74%26issue%3D16%26spage%3D2068%26epage%3D2072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edward F.  Nemeth</span>, <span class="hlFld-ContribAuthor ">Bradford C.  Van Wagenen</span>, <span class="hlFld-ContribAuthor ">Manuel F.  Balandrin</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Development of Calcimimetic and Calcilytic Compounds. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 1-86. <a href="https://doi.org/10.1016/bs.pmch.2017.12.001" title="DOI URL">https://doi.org/10.1016/bs.pmch.2017.12.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.pmch.2017.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.pmch.2017.12.001%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Band%252BDevelopment%252Bof%252BCalcimimetic%252Band%252BCalcilytic%252BCompounds%26aulast%3DNemeth%26aufirst%3DEdward%2BF.%26date%3D2018%26spage%3D1%26epage%3D86%26pub%3DElsevier%26date%3D2018%26volume%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gui-Bai  Liang</span>, <span class="hlFld-ContribAuthor ">Changyou  Zhou</span>, <span class="hlFld-ContribAuthor ">Xianghong  Huo</span>, <span class="hlFld-ContribAuthor ">Hank  Wang</span>, <span class="hlFld-ContribAuthor ">Xuelin  Yang</span>, <span class="hlFld-ContribAuthor ">Shaoqiang  Huang</span>, <span class="hlFld-ContribAuthor ">Haisheng  Wang</span>, <span class="hlFld-ContribAuthor ">Hilary  Wilkinson</span>, <span class="hlFld-ContribAuthor ">Lusong  Luo</span>, <span class="hlFld-ContribAuthor ">Wei  Tang</span>, <span class="hlFld-ContribAuthor ">David  Sutton</span>, <span class="hlFld-ContribAuthor ">Hong  Li</span>, <span class="hlFld-ContribAuthor ">Dennis  Zaller</span>, <span class="hlFld-ContribAuthor ">Peter T.  Meinke</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel dihydrobenzofuran cyclopropane carboxylic acid based calcium sensing receptor antagonists for the treatment of osteoporosis. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (16)
                                     , 4077-4080. <a href="https://doi.org/10.1016/j.bmcl.2016.06.073" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.06.073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.06.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.06.073%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnovel%252Bdihydrobenzofuran%252Bcyclopropane%252Bcarboxylic%252Bacid%252Bbased%252Bcalcium%252Bsensing%252Breceptor%252Bantagonists%252Bfor%252Bthe%252Btreatment%252Bof%252Bosteoporosis%26aulast%3DLiang%26aufirst%3DGui-Bai%26date%3D2016%26volume%3D26%26issue%3D16%26spage%3D4077%26epage%3D4080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Todd A.  Green</span>, <span class="hlFld-ContribAuthor ">Dennis J.  Chew</span>. </span><span class="cited-content_cbyCitation_article-title">Calcium Disorders. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 274-280. <a href="https://doi.org/10.1016/B978-1-4557-0306-7.00052-0" title="DOI URL">https://doi.org/10.1016/B978-1-4557-0306-7.00052-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-1-4557-0306-7.00052-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-1-4557-0306-7.00052-0%26sid%3Dliteratum%253Aachs%26atitle%3DCalcium%252BDisorders%26aulast%3DGreen%26aufirst%3DTodd%2BA.%26date%3D2015%26spage%3D274%26epage%3D280%26pub%3DElsevier%26atitle%3DSmall%252BAnimal%252BCritical%252BCare%252BMedicine%26date%3D2015%26volume%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ivo  Vranesic</span>, <span class="hlFld-ContribAuthor ">Silvio  Ofner</span>, <span class="hlFld-ContribAuthor ">Peter Josef  Flor</span>, <span class="hlFld-ContribAuthor ">Graeme  Bilbe</span>, <span class="hlFld-ContribAuthor ">Rochdi  Bouhelal</span>, <span class="hlFld-ContribAuthor ">Albert  Enz</span>, <span class="hlFld-ContribAuthor ">Sandrine  Desrayaud</span>, <span class="hlFld-ContribAuthor ">Kevin  McAllister</span>, <span class="hlFld-ContribAuthor ">Rainer  Kuhn</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Gasparini</span>. </span><span class="cited-content_cbyCitation_article-title">AFQ056/mavoglurant, a novel clinically effective mGluR5 antagonist: Identification, SAR and pharmacological characterization. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (21)
                                     , 5790-5803. <a href="https://doi.org/10.1016/j.bmc.2014.09.033" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.09.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.09.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.09.033%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DAFQ056%25252Fmavoglurant%25252C%252Ba%252Bnovel%252Bclinically%252Beffective%252BmGluR5%252Bantagonist%25253A%252BIdentification%25252C%252BSAR%252Band%252Bpharmacological%252Bcharacterization%26aulast%3DVranesic%26aufirst%3DIvo%26date%3D2014%26volume%3D22%26issue%3D21%26spage%3D5790%26epage%3D5803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniela  Riccardi</span>, <span class="hlFld-ContribAuthor ">Paul J.  Kemp</span>. </span><span class="cited-content_cbyCitation_article-title">The Calcium-Sensing Receptor Beyond Extracellular Calcium Homeostasis: Conception, Development, Adult Physiology, and Disease. </span><span class="cited-content_cbyCitation_journal-name">Annual Review of Physiology</span><span> <strong>2012,</strong> <em>74 </em>
                                    (1)
                                     , 271-297. <a href="https://doi.org/10.1146/annurev-physiol-020911-153318" title="DOI URL">https://doi.org/10.1146/annurev-physiol-020911-153318</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1146/annurev-physiol-020911-153318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1146%2Fannurev-physiol-020911-153318%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Review%2520of%2520Physiology%26atitle%3DThe%252BCalcium-Sensing%252BReceptor%252BBeyond%252BExtracellular%252BCalcium%252BHomeostasis%25253A%252BConception%25252C%252BDevelopment%25252C%252BAdult%252BPhysiology%25252C%252Band%252BDisease%26aulast%3DRiccardi%26aufirst%3DDaniela%26date%3D2012%26volume%3D74%26issue%3D1%26spage%3D271%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alice  Cavanaugh</span>, <span class="hlFld-ContribAuthor ">Ying  Huang</span>, <span class="hlFld-ContribAuthor ">Gerda E  Breitwieser</span>. </span><span class="cited-content_cbyCitation_article-title">Behind the curtain: cellular mechanisms for allosteric modulation of calcium-sensing receptors. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2012,</strong> <em>165 </em>
                                    (6)
                                     , 1670-1677. <a href="https://doi.org/10.1111/j.1476-5381.2011.01403.x" title="DOI URL">https://doi.org/10.1111/j.1476-5381.2011.01403.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1476-5381.2011.01403.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1476-5381.2011.01403.x%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DBehind%252Bthe%252Bcurtain%25253A%252Bcellular%252Bmechanisms%252Bfor%252Ballosteric%252Bmodulation%252Bof%252Bcalcium-sensing%252Breceptors%26aulast%3DCavanaugh%26aufirst%3DAlice%26date%3D2012%26date%3D2012%26volume%3D165%26issue%3D6%26spage%3D1670%26epage%3D1677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Donald T  Ward</span>, <span class="hlFld-ContribAuthor ">Daniela  Riccardi</span>. </span><span class="cited-content_cbyCitation_article-title">New concepts in calcium-sensing receptor pharmacology and signalling. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2012,</strong> <em>165 </em>
                                    (1)
                                     , 35-48. <a href="https://doi.org/10.1111/j.1476-5381.2011.01511.x" title="DOI URL">https://doi.org/10.1111/j.1476-5381.2011.01511.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1476-5381.2011.01511.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1476-5381.2011.01511.x%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DNew%252Bconcepts%252Bin%252Bcalcium-sensing%252Breceptor%252Bpharmacology%252Band%252Bsignalling%26aulast%3DWard%26aufirst%3DDonald%2BT%26date%3D2012%26date%3D2011%26volume%3D165%26issue%3D1%26spage%3D35%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. H.  Weston</span>, <span class="hlFld-ContribAuthor ">A.  Geraghty</span>, <span class="hlFld-ContribAuthor ">I.  Egner</span>, <span class="hlFld-ContribAuthor ">G.  Edwards</span>. </span><span class="cited-content_cbyCitation_article-title">The vascular extracellular calcium-sensing receptor: an update. </span><span class="cited-content_cbyCitation_journal-name">Acta Physiologica</span><span> <strong>2011,</strong> <em>203 </em>
                                    (1)
                                     , 127-137. <a href="https://doi.org/10.1111/j.1748-1716.2010.02249.x" title="DOI URL">https://doi.org/10.1111/j.1748-1716.2010.02249.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1748-1716.2010.02249.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1748-1716.2010.02249.x%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Physiologica%26atitle%3DThe%252Bvascular%252Bextracellular%252Bcalcium-sensing%252Breceptor%25253A%252Ban%252Bupdate%26aulast%3DWeston%26aufirst%3DA.%2BH.%26date%3D2011%26date%3D2011%26volume%3D203%26issue%3D1%26spage%3D127%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Markus R.  John</span>, <span class="hlFld-ContribAuthor ">Leo  Widler</span>, <span class="hlFld-ContribAuthor ">Rainer  Gamse</span>, <span class="hlFld-ContribAuthor ">Thomas  Buhl</span>, <span class="hlFld-ContribAuthor ">Klaus  Seuwen</span>, <span class="hlFld-ContribAuthor ">Werner  Breitenstein</span>, <span class="hlFld-ContribAuthor ">Gerard J.M.  Bruin</span>, <span class="hlFld-ContribAuthor ">Rossella  Belleli</span>, <span class="hlFld-ContribAuthor ">Lloyd B.  Klickstein</span>, <span class="hlFld-ContribAuthor ">Michaela  Kneissel</span>. </span><span class="cited-content_cbyCitation_article-title">ATF936, a novel oral calcilytic, increases bone mineral density in rats and transiently releases parathyroid hormone in humans. </span><span class="cited-content_cbyCitation_journal-name">Bone</span><span> <strong>2011,</strong> <em>49 </em>
                                    (2)
                                     , 233-241. <a href="https://doi.org/10.1016/j.bone.2011.04.007" title="DOI URL">https://doi.org/10.1016/j.bone.2011.04.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bone.2011.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bone.2011.04.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBone%26atitle%3DATF936%25252C%252Ba%252Bnovel%252Boral%252Bcalcilytic%25252C%252Bincreases%252Bbone%252Bmineral%252Bdensity%252Bin%252Brats%252Band%252Btransiently%252Breleases%252Bparathyroid%252Bhormone%252Bin%252Bhumans%26aulast%3DJohn%26aufirst%3DMarkus%2BR.%26date%3D2011%26volume%3D49%26issue%3D2%26spage%3D233%26epage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leo  Widler</span>. </span><span class="cited-content_cbyCitation_article-title">Calcilytics: antagonists of the calcium-sensing receptor for the treatment of osteoporosis. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2011,</strong> <em>3 </em>
                                    (5)
                                     , 535-547. <a href="https://doi.org/10.4155/fmc.11.17" title="DOI URL">https://doi.org/10.4155/fmc.11.17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.11.17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.11.17%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DCalcilytics%25253A%252Bantagonists%252Bof%252Bthe%252Bcalcium-sensing%252Breceptor%252Bfor%252Bthe%252Btreatment%252Bof%252Bosteoporosis%26aulast%3DWidler%26aufirst%3DLeo%26date%3D2011%26volume%3D3%26issue%3D5%26spage%3D535%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christofer S.  Tautermann</span>. </span><span class="cited-content_cbyCitation_article-title">The use of G-protein coupled receptor models in lead optimization. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2011,</strong> <em>3 </em>
                                    (6)
                                     , 709-721. <a href="https://doi.org/10.4155/fmc.11.24" title="DOI URL">https://doi.org/10.4155/fmc.11.24</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.11.24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.11.24%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DThe%252Buse%252Bof%252BG-protein%252Bcoupled%252Breceptor%252Bmodels%252Bin%252Blead%252Boptimization%26aulast%3DTautermann%26aufirst%3DChristofer%2BS.%26date%3D2011%26volume%3D3%26issue%3D6%26spage%3D709%26epage%3D721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephan  Urwyler</span>, . </span><span class="cited-content_cbyCitation_article-title">Allosteric Modulation of Family C G-Protein-Coupled Receptors: from Molecular Insights to Therapeutic Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reviews</span><span> <strong>2011,</strong> <em>63 </em>
                                    (1)
                                     , 59-126. <a href="https://doi.org/10.1124/pr.109.002501" title="DOI URL">https://doi.org/10.1124/pr.109.002501</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/pr.109.002501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fpr.109.002501%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reviews%26atitle%3DAllosteric%252BModulation%252Bof%252BFamily%252BC%252BG-Protein-Coupled%252BReceptors%25253A%252Bfrom%252BMolecular%252BInsights%252Bto%252BTherapeutic%252BPerspectives%26aulast%3DUrwyler%26aufirst%3DStephan%26date%3D2011%26date%3D2011%26volume%3D63%26issue%3D1%26spage%3D59%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masato  Yoshida</span>, <span class="hlFld-ContribAuthor ">Akira  Mori</span>, <span class="hlFld-ContribAuthor ">Atsuhiro  Inaba</span>, <span class="hlFld-ContribAuthor ">Masahiro  Oka</span>, <span class="hlFld-ContribAuthor ">Haruhiko  Makino</span>, <span class="hlFld-ContribAuthor ">Masashi  Yamaguchi</span>, <span class="hlFld-ContribAuthor ">Hisashi  Fujita</span>, <span class="hlFld-ContribAuthor ">Tomohiro  Kawamoto</span>, <span class="hlFld-ContribAuthor ">Mika  Goto</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Kimura</span>, <span class="hlFld-ContribAuthor ">Atsuo  Baba</span>, <span class="hlFld-ContribAuthor ">Tsuneo  Yasuma</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and structure–activity relationship of tetrahydropyrazolopyrimidine derivatives—A novel structural class of potent calcium-sensing receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2010,</strong> <em>18 </em>
                                    (24)
                                     , 8501-8511. <a href="https://doi.org/10.1016/j.bmc.2010.10.035" title="DOI URL">https://doi.org/10.1016/j.bmc.2010.10.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2010.10.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2010.10.035%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Bof%252Btetrahydropyrazolopyrimidine%252Bderivatives%2525E2%252580%252594A%252Bnovel%252Bstructural%252Bclass%252Bof%252Bpotent%252Bcalcium-sensing%252Breceptor%252Bantagonists%26aulast%3DYoshida%26aufirst%3DMasato%26date%3D2010%26volume%3D18%26issue%3D24%26spage%3D8501%26epage%3D8511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marc  Gerspacher</span>, <span class="hlFld-ContribAuthor ">Eva  Altmann</span>, <span class="hlFld-ContribAuthor ">René  Beerli</span>, <span class="hlFld-ContribAuthor ">Thomas  Buhl</span>, <span class="hlFld-ContribAuthor ">Ralf  Endres</span>, <span class="hlFld-ContribAuthor ">Rainer  Gamse</span>, <span class="hlFld-ContribAuthor ">Jacques  Kameni-Tcheudji</span>, <span class="hlFld-ContribAuthor ">Michaela  Kneissel</span>, <span class="hlFld-ContribAuthor ">Karl Heinz  Krawinkler</span>, <span class="hlFld-ContribAuthor ">Martin  Missbach</span>, <span class="hlFld-ContribAuthor ">Alfred  Schmidt</span>, <span class="hlFld-ContribAuthor ">Klaus  Seuwen</span>, <span class="hlFld-ContribAuthor ">Sven  Weiler</span>, <span class="hlFld-ContribAuthor ">Leo  Widler</span>. </span><span class="cited-content_cbyCitation_article-title">Penta-substituted benzimidazoles as potent antagonists of the calcium-sensing receptor (CaSR-antagonists). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (17)
                                     , 5161-5164. <a href="https://doi.org/10.1016/j.bmcl.2010.07.016" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.07.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.07.016%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPenta-substituted%252Bbenzimidazoles%252Bas%252Bpotent%252Bantagonists%252Bof%252Bthe%252Bcalcium-sensing%252Breceptor%252B%252528CaSR-antagonists%252529%26aulast%3DGerspacher%26aufirst%3DMarc%26date%3D2010%26volume%3D20%26issue%3D17%26spage%3D5161%26epage%3D5164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of calcilytics <b>1a</b> and <b>1b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of lead compound <b>2a</b> and Proquazone.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0010.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 1-Isopropyl-4-(4-isopropyl-phenyl)-6-methoxy-1<i>H</i>-quinazolin-2-one<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) methyl iodide, K<sub>2</sub>CO<sub>3</sub>, DMF, rt, 12 h; (b) 4-isopropyl-phenyl-magnesium bromide, THF; −78 °C, 2 h; (c) (i) Jones-reagent; acetone, 0 °C, 1 h, (ii) H<sub>2</sub>, RaNi, rt, atmospheric pressure, MeOH/THF 1:1; (d) isopropyl iodide, K<sub>2</sub>CO<sub>3</sub>, 110 °C, 48 h; (e) sodium cyanate, AcOH, rt, overnight.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0011.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Modification of the Ether Functionality<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BBr<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1 h; (b) R<sup>1</sup>-Br, Cs<sub>2</sub>CO<sub>3</sub>, DMEU, rt, 18 h.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0012.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 1-Benzyl-4-(4-isopropyl-phenyl)-6-propargyloxy-1<i>H</i>-quinazolin-2-ones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Huenig’s base, 1.4-dioxane, 100 °C; (a′) NaB(OAc)<sub>3</sub>H/CH<sub>2</sub>Cl<sub>2</sub> or NaCNBH<sub>3</sub>/MeOH, rt; (b) sodium cyanate, AcOH, rt; (c) benzoyl isothiocyanate, THF, rt.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0013.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 6-Amino-4-(4-isopropyl-phenyl)-1-isopropyl-1<i>H</i>-quinazolin-2-one<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 4-isopropyl-phenyl-magnesium bromide, THF; −75 °C → rt, 3 h; (b) Jones reagent; acetone, 0 °C; (c) isopropyl amine, 65 °C, 10 h; (d) chlorosulfonyl isocyanate, 0 °C; (e) H<sub>2</sub>, Ra−Ni, EtOH/THF; (f) cf. <a class="ref internalNav" href="#sec4" aria-label="Experimental Procedures">Experimental Procedures</a> below.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0014.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of 6-Hydroxy-1<i>H</i>-quinazolin-2-ones<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) autoclave, DMEU/water, 165 °C, 48 h or microwave, 180 °C (small scale); (b) benzaldehyde, sodium cyanoborohydride, AcOH/CH<sub>2</sub>Cl<sub>2</sub>, rt; (c) sodium cyanate, AcOH, rt, overnight; (d) H<sub>2</sub>, Ra−Ni, rt, 2 h; (e) diazomethane, Pd(II)acetate, rt, 16 h.</p></p></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0020.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Proposed binding mode for <b>10a</b> (top view, from the extracellular area into the receptor). In red W818 (TM6) and Y825 (TM6) mutations, both of which affect the interactions with quinazolinone-type ligands; in yellow E837 (TM7), R680 (TM3), I841 (TM7), and F668 (TM2), which do not seem to be involved in binding of this type of ligands but clearly interfere with compounds like <b>1a</b>; in orange F684 (TM3) and F688 (TM3), which are supposed to interact with both types of ligands. (Figure made with PyMOL<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0021.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Side view of binding site (extracellular region on top). The ligand <b>10a</b> is represented in green, see Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> and text for the further color coding. (Figure made with PyMOL<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0001.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Correlation between in vitro and in vivo iv potency.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0002.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Comparison of blood levels of <b>7h</b> in rats after 3 mg/kg po administration using EtOH/corn oil or a microemulsion formulation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0003.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Plasma and bioactive parathyroid hormone (PTH, expressed as human PTH equivalents) levels after oral administration of a microemulsion formulation of <b>7h</b> at a dose of 10 and 30 mg/kg to rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0004.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Plasma levels and bioactive parathyroid hormone (PTH, expressed as human PTH equivalents) after oral administration of a microemulsion formulation of <b>7h</b> at a dose of 30 mg per dog.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0005.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Plasma levels and bioactive parathyroid hormone (PTH, expressed as human PTH equivalents) after oral administration of a microemulsion formulation of <b>11m</b> at a dose of 1 and 3 mg/kg to rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/medium/jm-2009-01811v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0006.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Plasma levels of PTH and of parent compound <b>11m</b> after oral administration of 3 mg/dog (ca. 0.3 mg/kg) in a microemulsion formulation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-5/jm901811v/production/images/large/jm-2009-01811v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901811v&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i56">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46202" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46202" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 25 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_contrib-group">Bodenner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggs, A.</span><span> </span><span class="NLM_article-title">Teriparatide in the management of osteoporosis</span> <span class="citation_source-journal">Clin. Interventions Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">499</span><span class="NLM_x">–</span> <span class="NLM_lpage">507</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=18225450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1ejsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=499-507&author=D.+Bodennerauthor=C.+Redmannauthor=A.+Riggs&title=Teriparatide+in+the+management+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Teriparatide in the management of osteoporosis</span></div><div class="casAuthors">Bodenner, Donald; Redman, Carolyn; Riggs, Ann</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Interventions in Aging</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">499-507</span>CODEN:
                <span class="NLM_cas:coden">CIALBC</span>;
        ISSN:<span class="NLM_cas:issn">1176-9092</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  Fracture of the hip is frequently a catastrophic event in the elderly, often resulting in death within a year and of the survivors, few regain pre-fracture quality of life.  Although less appreciated, fractures of the spine result in significant morbidity and are also assocd. with increased mortality compared with individuals without a fracture.  In recent years there has been an explosion in the development of new drugs for the treatment of osteoporosis.  Recombinant human parathyroid hormone (1-34) (20 μg/day) is a recent addn. to this armamentarium with a novel mechanism of action, which was approved by the US FDA for the treatment of postmenopausal osteoporosis and male osteoporosis secondary to hypogonadism in Nov. 2002.  It is the first osteoporosis treatment that leads to the formation of new bone with architecture similar to normal bone.  Intense efforts have been made to understand the effect of teriparatide on antiresorptive therapy and vice versa.  Although these relationships are not completely understood, the results of recent studies allow clinicians to begin to optimize therapeutic gains in bone mineral d. and improve anti-fracture efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoah_3atunqZbVg90H21EOLACvtfcHk0lhWPc5Gi8e6XA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1ejsb4%253D&md5=ce7b8894f61d7d67e2e83b9fd03c0520</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBodenner%26aufirst%3DD.%26aulast%3DRedmann%26aufirst%3DC.%26aulast%3DRiggs%26aufirst%3DA.%26atitle%3DTeriparatide%2520in%2520the%2520management%2520of%2520osteoporosis%26jtitle%3DClin.%2520Interventions%2520Aging%26date%3D2007%26volume%3D2%26spage%3D499%26epage%3D507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_contrib-group">Bilezikian, J. P.</span><span> </span><span class="NLM_article-title">Anabolic therapy for osteoporosis</span> <span class="citation_source-journal">Women’s Health</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.2217%2F17455057.3.2.243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit12qtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=243-253&author=J.+P.+Bilezikian&title=Anabolic+therapy+for+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Anabolic therapy for osteoporosis</span></div><div class="casAuthors">Bilezikian, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Women's Health</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">243-253</span>CODEN:
                <span class="NLM_cas:coden">WHOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1745-5057</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Antiresorptive agents for osteoporosis are a cornerstone of therapy, but anabolic drugs have recently increased our options.  By directly stimulating bone formation, anabolic agents reduce fracture incidence by improving bone qualities as well as increasing bone mass.  The anabolic agent currently approved for osteoporosis, teriparatide (recombinant human parathyroid hormone[1-34]), has emerged as a major approach for selected patients with osteoporosis.  Parathyroid hormone(1-84) is also available in Europe.  Teriparatide increases bone d. and bone turnover, improves microarchitecture and changes bone size.  The incidence of vertebral and nonvertebral fractures is reduced.  A current concept in the mechanism of teriparatide action is related to its effect of stimulating processes assocd. with bone formation before processes assocd. with bone resorption.  This sequence of events has led to the concept of the anabolic window, the period of time when teriparatide is maximally anabolic.  Newer approaches to the use of teriparatide alone and in combination with antiresorptive agents has led to ways in which the anabolic window can be expanded.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKC2jWx9LbarVg90H21EOLACvtfcHk0litbIXnifipEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit12qtL0%253D&md5=2e26b6931f831f63477e2f9a8d5f2042</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.2217%2F17455057.3.2.243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252F17455057.3.2.243%26sid%3Dliteratum%253Aachs%26aulast%3DBilezikian%26aufirst%3DJ.%2BP.%26atitle%3DAnabolic%2520therapy%2520for%2520osteoporosis%26jtitle%3DWomen%25E2%2580%2599s%2520Health%26date%3D2007%26volume%3D3%26spage%3D243%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_contrib-group">Girotra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilezikian, J. P.</span><span> </span><span class="NLM_article-title">The use of parathyroid hormone in the treatment of osteoporosis</span> <span class="citation_source-journal">Rev. Endocrinol. Metab. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1007%2Fs11154-006-9007-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=17043762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12lsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=113-121&author=M.+Girotraauthor=M.+R.+Rubinauthor=J.+P.+Bilezikian&title=The+use+of+parathyroid+hormone+in+the+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The use of parathyroid hormone in the treatment of osteoporosis</span></div><div class="casAuthors">Girotra, Monica; Rubin, Mishaela R.; Bilezikian, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in Endocrine & Metabolic Disorders</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">113-121</span>CODEN:
                <span class="NLM_cas:coden">REMDCG</span>;
        ISSN:<span class="NLM_cas:issn">1389-9155</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Anabolic skeletal agents have recently broadened our therapeutic options for osteoporosis.  By directly stimulating bone formation, they reduce fracture incidence by improving bone qualities in addn. to increasing bone mass.  Teriparatide [recombinant human parathyroid hormone(1-34)], the only anabolic agent currently approved in the United States for osteoporosis, has emerged as a major therapeutic approach to selected patients with osteoporosis.  Teriparatide is approved for both postmenopausal women and men with osteoporosis who are at high risk for fracture.  With the use of this anabolic agent, bone d. and bone turnover increase, microarchitecture improves, and bone size is beneficially altered.  The incidence of vertebral and nonvertebral fractures is reduced with teriparatide use.  Combination therapy with parathyroid hormone and an antiresorptive does not appear to offer definitive advantages over the use of PTH or an antiresorptive alone, although recent ideas about combining these agents may offer new insights.  In order to maintain increases in bone d. acquired during PTH therapy, it is important to follow its use with an antiresorptive agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgHX2PVm7hELVg90H21EOLACvtfcHk0litbIXnifipEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12lsg%253D%253D&md5=2c3c9d800f166a7236c3314a6730ad79</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1007%2Fs11154-006-9007-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11154-006-9007-z%26sid%3Dliteratum%253Aachs%26aulast%3DGirotra%26aufirst%3DM.%26aulast%3DRubin%26aufirst%3DM.%2BR.%26aulast%3DBilezikian%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520use%2520of%2520parathyroid%2520hormone%2520in%2520the%2520treatment%2520of%2520osteoporosis%26jtitle%3DRev.%2520Endocrinol.%2520Metab.%2520Disord.%26date%3D2006%26volume%3D7%26spage%3D113%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1d"><span><span class="NLM_contrib-group">Rubin, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilezikian, J. P.</span><span> </span><span class="NLM_article-title">Parathyroid hormone as an anabolic skeletal therapy</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">2481</span><span class="NLM_x">–</span> <span class="NLM_lpage">2498</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=2481-2498&issue=17&author=M.+R.+Rubinauthor=J.+P.+Bilezikian&title=Parathyroid+hormone+as+an+anabolic+skeletal+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRubin%26aufirst%3DM.%2BR.%26aulast%3DBilezikian%26aufirst%3DJ.%2BP.%26atitle%3DParathyroid%2520hormone%2520as%2520an%2520anabolic%2520skeletal%2520therapy%26jtitle%3DDrugs%26date%3D2005%26volume%3D65%26issue%3D17%26spage%3D2481%26epage%3D2498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1e"><span><span class="NLM_contrib-group">Rubin, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilezikan, J. P.</span><span> </span><span class="NLM_article-title">The anabolic effects of parathyroid hormone</span> <span class="citation_source-journal">Osteoporosis Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1007%2Fs001980200026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=12030541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1e&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFWjt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2002&pages=267-277&author=M.+R.+Rubinauthor=F.+Cosmanauthor=R.+Lindsayauthor=J.+P.+Bilezikan&title=The+anabolic+effects+of+parathyroid+hormone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1eR"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The anabolic effects of parathyroid hormone</span></div><div class="casAuthors">Rubin, M. R.; Cosman, F.; Lindsay, R.; Bilezikian, J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Osteoporosis International</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">267-277</span>CODEN:
                <span class="NLM_cas:coden">OSINEP</span>;
        ISSN:<span class="NLM_cas:issn">0937-941X</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag London Ltd.</span>)
        </div><div class="casAbstract">A review discusses animal and human data indicating the potential of parathyroid hormone as an anabolic agent for osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqMEj9nk-hg7Vg90H21EOLACvtfcHk0litbIXnifipEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFWjt70%253D&md5=ede19e4982006206a511e3bed09274b8</span></div><a href="/servlet/linkout?suffix=cit1e&amp;dbid=16384&amp;doi=10.1007%2Fs001980200026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs001980200026%26sid%3Dliteratum%253Aachs%26aulast%3DRubin%26aufirst%3DM.%2BR.%26aulast%3DCosman%26aufirst%3DF.%26aulast%3DLindsay%26aufirst%3DR.%26aulast%3DBilezikan%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520anabolic%2520effects%2520of%2520parathyroid%2520hormone%26jtitle%3DOsteoporosis%2520Int.%26date%3D2002%26volume%3D13%26spage%3D267%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1f"><span><span class="NLM_contrib-group">Compston, J.</span><span> </span><span class="NLM_article-title">Recombinant parathyroid hormone in the management of osteoporosis</span> <span class="citation_source-journal">Calcif. Tissue Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1f&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1007%2Fs00223-005-0012-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1f&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=16059774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1f&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFant7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2005&pages=65-71&issue=2&author=J.+Compston&title=Recombinant+parathyroid+hormone+in+the+management+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1fR"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Recombinant parathyroid hormone in the management of osteoporosis</span></div><div class="casAuthors">Compston, J.</div><div class="citationInfo"><span class="NLM_cas:title">Calcified Tissue International</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">65-71</span>CODEN:
                <span class="NLM_cas:coden">CTINDZ</span>;
        ISSN:<span class="NLM_cas:issn">0171-967X</span>.
    
            (<span class="NLM_cas:orgname">Springer Science+Business Media, Inc.</span>)
        </div><div class="casAbstract">A review.  Although the observation that injections of parathyroid hormone (PTH) ext. could increase bone mineral d. was first made in 1929, it was not until nearly 90 yr later that the 1-34 peptide of PTH became approved as a treatment for postmenopausal osteoporosis.  The checkered career of PTH as a treatment for osteoporosis has been recounted in detail previously; however, today it provides an exciting new addn. to our armamentarium of therapies.  This review considers the evidence for efficacy of recombinant human PTH 1-34 (teriparatide) in the prevention of osteoporotic fractures and discusses its positioning among other available interventions.  Studies with other PTH peptides are also discussed with respect to combination therapy, sequential therapy, and prevention of glucocorticoid-induced osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKP0lqJnWTUbVg90H21EOLACvtfcHk0ljvYtEYBnPXGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFant7nF&md5=0f5e6499ef0ba5bdac28adcdbdd714e1</span></div><a href="/servlet/linkout?suffix=cit1f&amp;dbid=16384&amp;doi=10.1007%2Fs00223-005-0012-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00223-005-0012-0%26sid%3Dliteratum%253Aachs%26aulast%3DCompston%26aufirst%3DJ.%26atitle%3DRecombinant%2520parathyroid%2520hormone%2520in%2520the%2520management%2520of%2520osteoporosis%26jtitle%3DCalcif.%2520Tissue%2520Int.%26date%3D2005%26volume%3D77%26issue%3D2%26spage%3D65%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1g"><span><span class="NLM_contrib-group">Eriksen, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, D. A.</span><span> </span><span class="NLM_article-title">Teriparatide: a bone formation treatment for osteoporosis</span> <span class="citation_source-journal">Drugs Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">935</span><span class="NLM_x">–</span> <span class="NLM_lpage">948</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1g&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1358%2Fdot.2004.40.11.872582" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1g&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVSksbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2004&pages=935-948&author=E.+F.+Eriksenauthor=D.+A.+Robins&title=Teriparatide%3A+a+bone+formation+treatment+for+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1gR"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">TERIPARATIDE: A bone formation treatment for osteoporosis</span></div><div class="casAuthors">Eriksen, Erik F.; Robins, Deborah A.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of Today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">935-948</span>CODEN:
                <span class="NLM_cas:coden">MDACAP</span>;
        ISSN:<span class="NLM_cas:issn">0025-7656</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Teriparatide is the recombinant human N-terminal fragment (1-34) of endogenous human parathyroid hormone, and it is the first bone anabolic agent for the treatment of osteoporosis.  When given as once-daily s.c. injections, teriparatide can reverse the course of osteoporosis by stimulating formation of new bone and restoring lost architecture.  Teriparatide (20 μg) treatment of osteoporosis in postmenopausal women rapidly increased markers of bone formation and reduced the incidence of vertebral fractures by 65% and of nonvertebral fragility fractures by 53%.  In addn., treatment with this compd. increased spine bone mineral d. by 10% and hip bone mineral d. by 3% at study endpoint.  Teriparatide is well tolerated and is not assocd. with any serious side effects.  The compd. has been approved in Europe and in the US for the treatment of osteoporosis.  Duration of treatment is 18-24 mo and the dose does not need to be adjusted for age or gender.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1JIdWJtTLw7Vg90H21EOLACvtfcHk0ljvYtEYBnPXGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVSksbs%253D&md5=636570477d27ee584bc02ce954ecee68</span></div><a href="/servlet/linkout?suffix=cit1g&amp;dbid=16384&amp;doi=10.1358%2Fdot.2004.40.11.872582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdot.2004.40.11.872582%26sid%3Dliteratum%253Aachs%26aulast%3DEriksen%26aufirst%3DE.%2BF.%26aulast%3DRobins%26aufirst%3DD.%2BA.%26atitle%3DTeriparatide%253A%2520a%2520bone%2520formation%2520treatment%2520for%2520osteoporosis%26jtitle%3DDrugs%2520Today%26date%3D2004%26volume%3D40%26spage%3D935%26epage%3D948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1h"><span><span class="NLM_contrib-group">Hodsman, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dempster, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanley, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendler, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClung, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olszynski, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orwoll, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuen, C. K.</span><span> </span><span class="NLM_article-title">Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">688</span><span class="NLM_x">–</span> <span class="NLM_lpage">703</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1h&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1210%2Fer.2004-0006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1h&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=15769903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1h&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXps1Kit7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=688-703&issue=5&author=A.+B.+Hodsmanauthor=D.+C.+Bauerauthor=D.+W.+Dempsterauthor=L.+Dianauthor=D.+A.+Hanleyauthor=S.+T.+Harrisauthor=D.+L.+Kendlerauthor=M.+R.+McClungauthor=P.+D.+Millerauthor=W.+P.+Olszynskiauthor=E.+Orwollauthor=C.+K.+Yuen&title=Parathyroid+hormone+and+teriparatide+for+the+treatment+of+osteoporosis%3A+a+review+of+the+evidence+and+suggested+guidelines+for+its+use"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1hR"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Parathyroid hormone and teriparatide for the treatment of osteoporosis: A review of the evidence and suggested guidelines for its use</span></div><div class="casAuthors">Hodsman, Anthony B.; Bauer, Douglas C.; Dempster, David W.; Dian, Larry; Hanley, David A.; Harris, Steven T.; Kendler, David L.; McClung, Michael R.; Miller, Paul D.; Olszynski, Wojciech P.; Orwoll, Eric; Yuen, Chui Kin</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">688-703</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  All therapies currently recommended for the management of osteoporosis act mainly to inhibit bone resorption and reduce bone remodeling.  PTH and its analog, teriparatide [recombinant human PTH(1-34)], represent a new class of anabolic therapies for the treatment of severe osteoporosis, having the potential to improve skeletal microarchitecture.  Significant redns. in both vertebral and appendicular fracture rates have been demonstrated in the phase III trial of teriparatide, involving elderly women with at least one prevalent vertebral fracture before the onset of therapy.  However, there is as yet no evidence that the antifracture efficacy of PTH will be superior to the bisphosphonates, whereas cost-utility ests. suggest that teriparatide is significantly more expensive.  Teriparatide should be considered as treatment for post-menopausal women and men with severe osteoporosis, as well as for patients with established glucocorticoid-induced osteoporosis who require long-term steroid treatment.  Teriparatide should also be considered for the management of individuals at particularly high risk for fractures, including subjects who are younger than age 65 and who have particularly low bone mineral d. measurements (T scores ≤ 3.5).  Teriparatide therapy is not recommended for more than 2 yr, based, in part, on the induction of osteosarcoma in a rat model of carcinogenicity.  Total daily calcium intake from both supplements and dietary sources should be limited to 1500 mg together with adequate vitamin D intake (≤1000 U/d).  Monitoring of serum calcium may be safely limited to measurement after 1 mo of treatment; mild hypercalcemia may be treated by withdrawing dietary calcium supplements, reducing the dosing frequency of PTH, or both.  At present, concurrent therapy with antiresorptive therapy, particularly bisphosphonates, should be avoided, although sequential therapy with such agents may consolidate the beneficial effects upon the skeleton after PTH is discontinued.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7Er5Z7BfgdbVg90H21EOLACvtfcHk0ljvYtEYBnPXGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXps1Kit7g%253D&md5=a0d06328df9dff668e76699719ae02ac</span></div><a href="/servlet/linkout?suffix=cit1h&amp;dbid=16384&amp;doi=10.1210%2Fer.2004-0006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2004-0006%26sid%3Dliteratum%253Aachs%26aulast%3DHodsman%26aufirst%3DA.%2BB.%26aulast%3DBauer%26aufirst%3DD.%2BC.%26aulast%3DDempster%26aufirst%3DD.%2BW.%26aulast%3DDian%26aufirst%3DL.%26aulast%3DHanley%26aufirst%3DD.%2BA.%26aulast%3DHarris%26aufirst%3DS.%2BT.%26aulast%3DKendler%26aufirst%3DD.%2BL.%26aulast%3DMcClung%26aufirst%3DM.%2BR.%26aulast%3DMiller%26aufirst%3DP.%2BD.%26aulast%3DOlszynski%26aufirst%3DW.%2BP.%26aulast%3DOrwoll%26aufirst%3DE.%26aulast%3DYuen%26aufirst%3DC.%2BK.%26atitle%3DParathyroid%2520hormone%2520and%2520teriparatide%2520for%2520the%2520treatment%2520of%2520osteoporosis%253A%2520a%2520review%2520of%2520the%2520evidence%2520and%2520suggested%2520guidelines%2520for%2520its%2520use%26jtitle%3DEndocr.%2520Rev.%26date%3D2005%26volume%3D26%26issue%3D5%26spage%3D688%26epage%3D703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1i"><span><span class="NLM_contrib-group">Hodsman, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanley, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ettinger, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognese, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalfe, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsay, R.</span><span> </span><span class="NLM_article-title">Efficacy and safety of human parathyroid hormone-(1−84) in increasing bone mineral density in postmenopausal osteoporosis</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">5212</span><span class="NLM_x">–</span> <span class="NLM_lpage">5220</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1i&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1210%2Fjc.2003-030768" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1i&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=14602752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1i&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptVyns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2003&pages=5212-5220&issue=11&author=A.+B.+Hodsmanauthor=D.+A.+Hanleyauthor=M.+P.+Ettingerauthor=M.+A.+Bologneseauthor=J.+Foxauthor=A.+J.+Metcalfeauthor=R.+Lindsay&title=Efficacy+and+safety+of+human+parathyroid+hormone-%281%E2%88%9284%29+in+increasing+bone+mineral+density+in+postmenopausal+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1iR"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of human parathyroid hormone-(1-84) in increasing bone mineral density in postmenopausal osteoporosis</span></div><div class="casAuthors">Hodsman, Anthony B.; Hanley, David A.; Ettinger, Mark P.; Bolognese, Michael A.; Fox, John; Metcalfe, Anna J.; Lindsay, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5212-5220</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Daily s.c. injections of N-terminal analogs of PTH increase bone mass and decrease fractures in osteoporotic women.  We investigated the efficacy and safety of human PTH-(1-84) (full-length PTH) in the treatment of postmenopausal osteoporosis in a double-blind, placebo-controlled study.  The women (n = 50-53/group) self-administered PTH (50, 75, or 100 μg) or placebo by daily s.c. injection for 12 mo.  PTH treatment induced time- and dose-related increases in lumbar spine bone mineral d. (BMD).  The 100-μg dose increased BMD significantly at 3 mo (+2.0%) and 12 mo (+7.8%).  BMD underestimated the anabolic effect of PTH in lumbar spine (bone mineral content, +10.0%) because bone area increased significantly (+2.0%).  A nonsignificant decrease (-0.9%) in total hip BMD occurred during the first 6 mo with the 100-μg dose, but this trend reversed (+1.6%) during the second 6 mo.  Bone turnover markers increased during the first half of the study and were maintained at elevated levels during the second 6 mo.  Protocol compliance was excellent (95-98%), and treatment was generally safe and well tolerated.  Dose-related incidences of transient hypercalcemia occurred, but only one patient (100-μg group) was withdrawn because of repeated hypercalcemia.  Thus, full-length PTH was efficacious and safe over 12 mo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9JUuh11mAhrVg90H21EOLACvtfcHk0lj9a4dln6ZMTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptVyns7k%253D&md5=97c1f6be416d744473dcd5dc0acb0b2a</span></div><a href="/servlet/linkout?suffix=cit1i&amp;dbid=16384&amp;doi=10.1210%2Fjc.2003-030768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2003-030768%26sid%3Dliteratum%253Aachs%26aulast%3DHodsman%26aufirst%3DA.%2BB.%26aulast%3DHanley%26aufirst%3DD.%2BA.%26aulast%3DEttinger%26aufirst%3DM.%2BP.%26aulast%3DBolognese%26aufirst%3DM.%2BA.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DMetcalfe%26aufirst%3DA.%2BJ.%26aulast%3DLindsay%26aufirst%3DR.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520human%2520parathyroid%2520hormone-%25281%25E2%2588%259284%2529%2520in%2520increasing%2520bone%2520mineral%2520density%2520in%2520postmenopausal%2520osteoporosis%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2003%26volume%3D88%26issue%3D11%26spage%3D5212%26epage%3D5220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_contrib-group">Trivedi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mithal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chattopadhyay, N.</span><span> </span><span class="NLM_article-title">Recent updates on the calcium-sensing receptor as a drug target</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">178</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.2174%2F092986708783330601" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=18220773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVyisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=178-186&issue=2&author=R.+Trivediauthor=A.+Mithalauthor=N.+Chattopadhyay&title=Recent+updates+on+the+calcium-sensing+receptor+as+a+drug+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Recent updates on the calcium-sensing receptor as a drug target</span></div><div class="casAuthors">Trivedi, Ritu; Mithal, Ambrish; Chattopadhyay, Naibedya</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">178-186</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Parathyroid hormone (PTH) secreted from parathyroid cells is a key regulator of circulating levels of calcium ion, which is maintained within a narrow physiol. range mainly by the action of a cell surface Ca2+-sensing receptor (CaSR) residing on parathyroid cells.  The CaSR belongs to the family C of G-protein-coupled receptors (GPCRs), all members of which have a large extra cellular domain called Venus flytrap, akin to bacterial nutrient sensor.  Promiscuity of the CaSR is reflected in its binding to several physiol. relevant di- or polyvalent cations that could elicit cellular signaling, yet the ligand specificity remains poor.  This problem has been circumvented by the discovery of calcimimetics, the pos. allosteric modulators of the CaSR that activate the CaSR on parathyroid cells, immediately suppressing PTH secretion.  Out of several small mols. that act as calcimimetics, cinacalcet is the most extensively studied.  The discovery of the CaSR and these specific agonists provides important insights into the discovery of new drugs that will be discussed in this review from the perspective of their structure-activity relationship.  The calcimimetic compd. cinacalcet has obtained regulatory approval for the treatment of hyperparathyroidism and is the first pos. allosteric modulator of any GPCR to reach the market.  It has other important uses in dialysis patients with end-stage renal disease, in whom it decreases Ca × P product.  Pharmaceutically converse to calcimimetics are calcilytic compds., which antagonize parathyroid CaSR and stimulate PTH secretion.  Antagonism of the CaSR has the potential to yield an anabolic therapy for osteoporosis that awaits clin. validation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuFmI3kGSesbVg90H21EOLACvtfcHk0lj9a4dln6ZMTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVyisro%253D&md5=cea967bc7042aa21177bd11638da8d50</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.2174%2F092986708783330601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986708783330601%26sid%3Dliteratum%253Aachs%26aulast%3DTrivedi%26aufirst%3DR.%26aulast%3DMithal%26aufirst%3DA.%26aulast%3DChattopadhyay%26aufirst%3DN.%26atitle%3DRecent%2520updates%2520on%2520the%2520calcium-sensing%2520receptor%2520as%2520a%2520drug%2520target%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2008%26volume%3D15%26issue%3D2%26spage%3D178%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_contrib-group">Brown, E. M.</span><span> </span><span class="NLM_article-title">The calcium-sensing receptor: physiology, pathophysiology and CaR-based therapeutics</span> <span class="citation_source-journal">Subcell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1007%2F978-1-4020-6191-2_6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=18193637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A280%3ADC%252BD1c%252FktVahtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2007&pages=139-165&author=E.+M.+Brown&title=The+calcium-sensing+receptor%3A+physiology%2C+pathophysiology+and+CaR-based+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The calcium-sensing receptor: physiology, pathophysiology and CaR-based therapeutics</span></div><div class="casAuthors">Brown E M</div><div class="citationInfo"><span class="NLM_cas:title">Sub-cellular biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">139-67</span>
        ISSN:<span class="NLM_cas:issn">0306-0225</span>.
    </div><div class="casAbstract">The extracellular calcium (Ca(o)2+)-sensing receptor (CaR) enables the parathyroid glands and other CaR-expressing cells to sense alterations in the level of Ca(o)2+ and to respond with changes in function that are directed at normalizing the blood calcium concentration.  In addition to the parathyroid gland, the kidney is a key site for Ca(o)2(+)-sensing that enables it to make physiologically relevant alterations in divalent cation and water metabolism.  Several disorders of Ca(o)2(+)-sensing arise from inherited or acquired abnormalities that "reset" the serum calcium concentration upward or downward.  Inactivating mutations produce a benign form of hypercalcemia when present in the heterozygous state, termed Familial Hypocalciuric Hypercalcemia (FHH), while homozygous mutations produce a much more severe hypercalcemic disorder resulting from marked hyperparathyroidism, called Neonatal Severe Hyperparathyroidism (NSHPT).  Activating mutations cause a hypocalcemic syndrome of varying severity, termed autosomal dominant hypocalcemia or hypoparathyroidism.  Inactivating or activating antibodies directed at the CaR produce the expected hyper- or hypocalcemic syndromes, respectively. "Calcimimetic" CaR activators and "calcilytic" CaR antagonists have been developed.  The calcimimetics are currently in use for controlling severe hyperparathyroidism in patients receiving dialysis treatment for end stage renal disease or with parathyroid cancer.  Calcilytics are being evaluated as a means of inducing a "pulse" in the circulating parathyroid hormone (PTH) concentration, which would mimic that resulting from injection of PTH, an established anabolic form of treatment for osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8IqdjdhC4Am52AMpI4GK2fW6udTcc2ebZ6pZq4JhM9Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c%252FktVahtQ%253D%253D&md5=efb4412b5755168f5433ee1f034cd934</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1007%2F978-1-4020-6191-2_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4020-6191-2_6%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DE.%2BM.%26atitle%3DThe%2520calcium-sensing%2520receptor%253A%2520physiology%252C%2520pathophysiology%2520and%2520CaR-based%2520therapeutics%26jtitle%3DSubcell.%2520Biochem.%26date%3D2007%26volume%3D45%26spage%3D139%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_contrib-group">Brown, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacLeod, R. J.</span><span> </span><span class="NLM_article-title">Extracellular calcium sensing and extracellular calcium signaling</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1152%2Fphysrev.2001.81.1.239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=11152759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitV2ktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2001&pages=239-297&author=E.+M.+Brownauthor=R.+J.+MacLeod&title=Extracellular+calcium+sensing+and+extracellular+calcium+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular calcium sensing and extracellular calcium signaling</span></div><div class="casAuthors">Brown, Edward M.; MacLeod, R. John</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">239-297</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review, with 481 refs.  The cloning of a G protein-coupled extracellular Ca2+ (Cao2+)-sensing receptor (CaR) has elucidated the mol. basis for many of the previously recognized effects of Cao2+ on tissues that maintain systemic Cao2+ homeostasis, esp. parathyroid chief cells and several cells in the kidney.  The availability of the cloned CaR enabled the development of DNA and antibody probes for identifying the CaR's mRNA and protein, resp., within these and other tissues.  It also permitted the identification of human diseases resulting from inactivating or activating mutations of the CaR gene and the subsequent generation of mice with targeted disruption of the CaR gene.  The characteristic alterations in parathyroid and renal function in these patients and in the mice with knockout of the CaR gene have provided valuable information on the CaR's physiol. roles in these tissues participating in mineral ion homeostasis.  Nevertheless, relatively little is known about how the CaR regulates other tissues involved in systemic Cao2+ homeostasis, particularly bone and intestine.  Moreover, there is evidence that addnl. Cao2+ sensors may exist in bone cells that mediate some or even all of the known effects of Cao2+ on these cells.  Even more remains to be learned about the CaR's function in the rapidly growing list of cells that express it but are uninvolved in systemic Cao2+ metab.  Available data suggest that the receptor serves numerous roles outside of systemic mineral ion homeostasis, ranging from the regulation of hormonal secretion and the activities of various ion channels to the longer term control of gene expression, programmed cell death (apoptosis), and cellular proliferation.  In some cases, the CaR on these non-homeostatic cells responds to local changes in Cao2+ taking place within compartments of the extracellular fluid (ECF) that communicate with the outside environment (e.g., the gastrointestinal tract).  In others, localized changes in Cao2+ within the ECF can originate from several mechanisms, including fluxes of calcium ions into or out of cellular or extracellular stores or across epithelium that absorb or secrete Ca2+.  In any event, the CaR and other receptors/sensors for Cao2+ and probably for other extracellular ions represent versatile regulators of numerous cellular functions and may serve as important therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6uGVgKVIQybVg90H21EOLACvtfcHk0lj9a4dln6ZMTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitV2ktLo%253D&md5=bdaf576fbde7255da389eb9fa0d84823</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.2001.81.1.239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.2001.81.1.239%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DE.%2BM.%26aulast%3DMacLeod%26aufirst%3DR.%2BJ.%26atitle%3DExtracellular%2520calcium%2520sensing%2520and%2520extracellular%2520calcium%2520signaling%26jtitle%3DPhysiol.%2520Rev.%26date%3D2001%26volume%3D81%26spage%3D239%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2d"><span><span class="NLM_contrib-group">Brown, E. M.</span><span> </span><span class="NLM_article-title">Extracellular Ca<sup>2+</sup> sensing, regulation of parathyroid cell function, and role of Ca<sup>2+</sup> and other ions as extracellular (first) messengers</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">411</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1991&pages=371-411&author=E.+M.+Brown&title=Extracellular+Ca2%2B+sensing%2C+regulation+of+parathyroid+cell+function%2C+and+role+of+Ca2%2B+and+other+ions+as+extracellular+%28first%29+messengers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DE.%2BM.%26atitle%3DExtracellular%2520Ca2%252B%2520sensing%252C%2520regulation%2520of%2520parathyroid%2520cell%2520function%252C%2520and%2520role%2520of%2520Ca2%252B%2520and%2520other%2520ions%2520as%2520extracellular%2520%2528first%2529%2520messengers%26jtitle%3DPhysiol.%2520Rev.%26date%3D1991%26volume%3D71%26spage%3D371%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2e"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span> </span><span class="NLM_article-title">Calcium receptor-dependent regulation of cellular functions</span> <span class="citation_source-journal">News Physiol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2e&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADyaK2MXkslequ7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1995&pages=1-5&author=E.+F.+Nemeth&title=Calcium+receptor-dependent+regulation+of+cellular+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2eR"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Ca2+ receptor-dependent regulation of cellular functions</span></div><div class="casAuthors">Nemeth, Edward F.</div><div class="citationInfo"><span class="NLM_cas:title">News in Physiological Sciences</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">Feb.</span>),
    <span class="NLM_cas:pages">1-5</span>CODEN:
                <span class="NLM_cas:coden">NEPSEY</span>;
        ISSN:<span class="NLM_cas:issn">0886-1714</span>.
    </div><div class="casAbstract">A review, with 15 refs.  A cell-surface Ca2+ receptor enables parathyroid cells to detect and respond to extracellular Ca2+.  The recent cloning of a G protein-coupled Ca2+ receptor solidifies this view.  Ca2+ receptors regulate the activity of various cells and provide novel mol. targets for new pharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmAYKq3zbA7LVg90H21EOLACvtfcHk0lj-ajBGddkkBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXkslequ7g%253D&md5=5c0358f59bb52230ca313049fa647144</span></div><a href="/servlet/linkout?suffix=cit2e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26atitle%3DCalcium%2520receptor-dependent%2520regulation%2520of%2520cellular%2520functions%26jtitle%3DNews%2520Physiol.%2520Sci.%26date%3D1995%26volume%3D10%26spage%3D1%26epage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_contrib-group">Steddon, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, J.</span><span> </span><span class="NLM_article-title">Calcimimetics and calcilytics−fooling the calcium receptor</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">365</span><span class="NLM_x"> (</span><span class="NLM_issue">9478</span><span class="NLM_x">) </span> <span class="NLM_fpage">2237</span><span class="NLM_x">–</span> <span class="NLM_lpage">2239</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2005&pages=2237-2239&issue=9478&author=S.+J.+Steddonauthor=J.+Cunningham&title=Calcimimetics+and+calcilytics%E2%88%92fooling+the+calcium+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSteddon%26aufirst%3DS.%2BJ.%26aulast%3DCunningham%26aufirst%3DJ.%26atitle%3DCalcimimetics%2520and%2520calcilytics%25E2%2588%2592fooling%2520the%2520calcium%2520receptor%26jtitle%3DLancet%26date%3D2005%26volume%3D365%26issue%3D9478%26spage%3D2237%26epage%3D2239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_contrib-group">Jensen, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brauner-Osborne, H.</span><span> </span><span class="NLM_article-title">Allosteric modulation of the calcium-sensing receptor</span> <span class="citation_source-journal">Curr. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">180</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.2174%2F157015907781695982" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=19305800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKqsLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=180-186&issue=3&author=A.+A.+Jensenauthor=H.+Brauner-Osborne&title=Allosteric+modulation+of+the+calcium-sensing+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulation of the calcium-sensing receptor</span></div><div class="casAuthors">Jensen, Anders A.; Brauner-Osborne, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">180-186</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1570-159X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The calcium (Ca2+)-sensing receptor (CaR) belongs to family C of the G-protein coupled receptors (GPCRs).  The receptor is activated by physiol. levels of Ca2+ (and Mg2+) and pos. modulated by a range of proteinogenic L-α-amino acids.  Recently, several synthetic allosteric modulators of the receptor have been developed, which either act as pos. modulators (termed calcimimetics) or neg. modulators (termed calcilytics).  These ligands do not activate the wild-type receptor directly, but rather shift the concn.-response curves of Ca2+ to the left or right, resp.  Like other family C GPCRs, the CaR contains a large amino-terminal domain and a 7-transmembrane domain.  Whereas the endogenous ligands for the receptor, Ca2+, Mg2+ and the L-α-amino acids, bind to the amino-terminal domain, most if not all of the synthetic modulators published so far bind to the 7-transmembrane domain.  The most prominent physiol. function of the CaR is to maintain the extracellular Ca2+ level in a very tight range via control of secretion of parathyroid hormone (PTH).  Influence on e.g. secretion of calcitonin from thyroid C-cells and direct action on the tubule of the kidney also contribute to the control of the extracellular Ca2+ level.  This control over PTH and Ca2+ levels is partially lost in patients suffering from primary and secondary hyperparathyroidism.  The perspectives in CaR as a therapeutic target have been underlined by the recent approval of the calcimimetic cinacalcet for the treatment of certain forms of primary and secondary hyperparathyroidism.  Cinacalcet is the first clin. administered allosteric modulator acting on a GPCR, and thus the compd. constitutes an important proof-of-concept for future development of allosteric modulators on other GPCR drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGKZ6YylvnSLVg90H21EOLACvtfcHk0lj-ajBGddkkBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKqsLnJ&md5=2cfbaaea96ba8f4ef1c9119bff0b6207</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.2174%2F157015907781695982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157015907781695982%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DBrauner-Osborne%26aufirst%3DH.%26atitle%3DAllosteric%2520modulation%2520of%2520the%2520calcium-sensing%2520receptor%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2007%26volume%3D5%26issue%3D3%26spage%3D180%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_contrib-group">Dobnig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R. T.</span><span> </span><span class="NLM_article-title">The effects of programmed administration of human parathyroid hormone fragment (1−34) on bone histomorphometry and serum chemistry in rats</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">4607</span><span class="NLM_x">–</span> <span class="NLM_lpage">4612</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=1997&pages=4607-4612&issue=11&author=H.+Dobnigauthor=R.+T.+Turner&title=The+effects+of+programmed+administration+of+human+parathyroid+hormone+fragment+%281%E2%88%9234%29+on+bone+histomorphometry+and+serum+chemistry+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDobnig%26aufirst%3DH.%26aulast%3DTurner%26aufirst%3DR.%2BT.%26atitle%3DThe%2520effects%2520of%2520programmed%2520administration%2520of%2520human%2520parathyroid%2520hormone%2520fragment%2520%25281%25E2%2588%259234%2529%2520on%2520bone%2520histomorphometry%2520and%2520serum%2520chemistry%2520in%2520rats%26jtitle%3DEndocrinology%26date%3D1997%26volume%3D138%26issue%3D11%26spage%3D4607%26epage%3D4612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_contrib-group">Frolik, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cain, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satterwhite, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown-Augsburger, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hock, J. M.</span><span> </span><span class="NLM_article-title">Anabolic and catabolic bone effects of human parathyroid hormone (1−34) are predicted by duration of hormone exposure</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">372</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2003&pages=372-379&author=C.+A.+Frolikauthor=E.+C.+Blackauthor=R.+L.+Cainauthor=J.+H.+Satterwhiteauthor=P.+L.+Brown-Augsburgerauthor=M.+Sataauthor=J.+M.+Hock&title=Anabolic+and+catabolic+bone+effects+of+human+parathyroid+hormone+%281%E2%88%9234%29+are+predicted+by+duration+of+hormone+exposure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrolik%26aufirst%3DC.%2BA.%26aulast%3DBlack%26aufirst%3DE.%2BC.%26aulast%3DCain%26aufirst%3DR.%2BL.%26aulast%3DSatterwhite%26aufirst%3DJ.%2BH.%26aulast%3DBrown-Augsburger%26aufirst%3DP.%2BL.%26aulast%3DSata%26aufirst%3DM.%26aulast%3DHock%26aufirst%3DJ.%2BM.%26atitle%3DAnabolic%2520and%2520catabolic%2520bone%2520effects%2520of%2520human%2520parathyroid%2520hormone%2520%25281%25E2%2588%259234%2529%2520are%2520predicted%2520by%2520duration%2520of%2520hormone%2520exposure%26jtitle%3DBone%26date%3D2003%26volume%3D33%26spage%3D372%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_contrib-group">Onyia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helvering, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbert, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dow, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotinun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halladay, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miles, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambrose, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frolik, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R. T.</span><span> </span><span class="NLM_article-title">Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: An analysis of DNA microarray</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">418</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2005&pages=403-418&author=J.+E.+Onyiaauthor=L.+M.+Helveringauthor=L.+Gelbertauthor=T.+Weiauthor=S.+Huangauthor=P.+Chenauthor=E.+R.+Dowauthor=A.+Maranauthor=M.+Zhangauthor=S.+Lotinunauthor=X.+Linauthor=D.+L.+Halladayauthor=R.+R.+Milesauthor=N.+H.+Kulkarniauthor=E.+M.+Ambroseauthor=Y.+L.+Maauthor=C.+A.+Frolikauthor=M.+Satoauthor=H.+U.+Bryantauthor=R.+T.+Turner&title=Molecular+profile+of+catabolic+versus+anabolic+treatment+regimens+of+parathyroid+hormone+%28PTH%29+in+rat+bone%3A+An+analysis+of+DNA+microarray"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOnyia%26aufirst%3DJ.%2BE.%26aulast%3DHelvering%26aufirst%3DL.%2BM.%26aulast%3DGelbert%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DDow%26aufirst%3DE.%2BR.%26aulast%3DMaran%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DLotinun%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DHalladay%26aufirst%3DD.%2BL.%26aulast%3DMiles%26aufirst%3DR.%2BR.%26aulast%3DKulkarni%26aufirst%3DN.%2BH.%26aulast%3DAmbrose%26aufirst%3DE.%2BM.%26aulast%3DMa%26aufirst%3DY.%2BL.%26aulast%3DFrolik%26aufirst%3DC.%2BA.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DBryant%26aufirst%3DH.%2BU.%26aulast%3DTurner%26aufirst%3DR.%2BT.%26atitle%3DMolecular%2520profile%2520of%2520catabolic%2520versus%2520anabolic%2520treatment%2520regimens%2520of%2520parathyroid%2520hormone%2520%2528PTH%2529%2520in%2520rat%2520bone%253A%2520An%2520analysis%2520of%2520DNA%2520microarray%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2005%26volume%3D95%26spage%3D403%26epage%3D418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_contrib-group">Messa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfieri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brezzi, B.</span><span> </span><span class="NLM_article-title">Cinacalcet: pharmacological and clinical aspects</span> <span class="citation_source-journal">Expert Opin. Drug Metabol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1551</span><span class="NLM_x">–</span> <span class="NLM_lpage">1560</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1517%2F17425250802587017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=19040330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVent7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=1551-1560&issue=12&author=P.+Messaauthor=C.+Alfieriauthor=B.+Brezzi&title=Cinacalcet%3A+pharmacological+and+clinical+aspects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Cinacalcet: pharmacological and clinical aspects</span></div><div class="casAuthors">Messa, Piergiorgio; Alfieri, Carlo; Brezzi, Brigida</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1551-1560</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The calcium sensing receptor (CaSR) is expressed in cells secreting calcium-regulating hormones, in cells involved in calcium transport and in many other tissues, with an as yet not completely defined role.  In parathyroid cells, the CaSR stimulation inhibits parathyroid hormone (PTH) secretion, synthesis and parathyroid cell proliferation.  Cinacalcet belongs to calcimimetic type II compds. that can interact with CaSR, increasing its affinity for calcium.  Clin. studies have proved cinacalcet to be effective in reducing calcium and PTH levels in primary hyperparathyroidism and in reducing PTH, calcium and phosphate in patients with secondary hyperparathyroidism owing to chronic renal failure, with a relatively safe profile, the only reported adverse events being hypocalcemia and gastrointestinal symptoms.  However, though calcimimetics do represent a real advancement in the field of the treatment of PTH secretion disturbances, there is a need for clin. trials, which should aim to demonstrate that a better control of biochem. parameters is also matched with better clin. outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphrPY0-n5eq7Vg90H21EOLACvtfcHk0li5uI8p8Zoovg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVent7zP&md5=c0bbe83dc845e72b2d1a1f41a05ce025</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1517%2F17425250802587017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425250802587017%26sid%3Dliteratum%253Aachs%26aulast%3DMessa%26aufirst%3DP.%26aulast%3DAlfieri%26aufirst%3DC.%26aulast%3DBrezzi%26aufirst%3DB.%26atitle%3DCinacalcet%253A%2520pharmacological%2520and%2520clinical%2520aspects%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metabol.%2520Toxicol.%26date%3D2008%26volume%3D4%26issue%3D12%26spage%3D1551%26epage%3D1560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_contrib-group">Kebig, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, K.</span><span> </span><span class="NLM_article-title">Cinacalcet−an allosteric enhancer at the Ca<sup>2+</sup>-receptor</span> <span class="citation_source-journal">Dtsch. Med. Wochenschr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x"> (</span><span class="NLM_issue">33</span><span class="NLM_x">) </span> <span class="NLM_fpage">1681</span><span class="NLM_x">–</span> <span class="NLM_lpage">1683</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1055%2Fs-0028-1082785" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=18661462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2008&pages=1681-1683&issue=33&author=A.+Kebigauthor=K.+Mohr&title=Cinacalcet%E2%88%92an+allosteric+enhancer+at+the+Ca2%2B-receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Cinacalcet - an allosteric enhancer at the Ca2+-receptor</span></div><div class="casAuthors">Kebig, A.; Mohr, K.</div><div class="citationInfo"><span class="NLM_cas:title">Deutsche Medizinische Wochenschrift</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">1681-1683</span>CODEN:
                <span class="NLM_cas:coden">DMWOAX</span>;
        ISSN:<span class="NLM_cas:issn">0012-0472</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">A review on the mode of action, indications, dosing, intake, pharmacokinetics, undesired drug effects, therapy control, efficacy in clin. studies, and evaluation of cinacalcet, an allosteric enhancer at the Ca2+ receptor.  Treatment is discussed of secondary hyperparathyroidism with the calcimimetic agent cinacalcet.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxhY4OdWKgYbVg90H21EOLACvtfcHk0li5uI8p8Zoovg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsrnN&md5=8b8497eaca38aa31529a43c1274bbcf0</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1055%2Fs-0028-1082785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0028-1082785%26sid%3Dliteratum%253Aachs%26aulast%3DKebig%26aufirst%3DA.%26aulast%3DMohr%26aufirst%3DK.%26atitle%3DCinacalcet%25E2%2588%2592an%2520allosteric%2520enhancer%2520at%2520the%2520Ca2%252B-receptor%26jtitle%3DDtsch.%2520Med.%2520Wochenschr.%26date%3D2008%26volume%3D133%26issue%3D33%26spage%3D1681%26epage%3D1683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_contrib-group">Harrington, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fotsch, C.</span><span> </span><span class="NLM_article-title">Calcium sensing receptor activators: Calcimimetics</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">28</span><span class="NLM_x">) </span> <span class="NLM_fpage">3027</span><span class="NLM_x">–</span> <span class="NLM_lpage">3034</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.2174%2F092986707782794096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=18220738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlSrs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=3027-3034&issue=28&author=P.+Harringtonauthor=C.+Fotsch&title=Calcium+sensing+receptor+activators%3A+Calcimimetics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium sensing receptor activators: calcimimetics</span></div><div class="casAuthors">Harrington, Paul E.; Fotsch, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">3027-3034</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The calcium sensing receptor (CaR) is a G protein-coupled receptor (GPCR) that plays a fundamental role in serum calcium homeostasis.  The CaR is expressed on the chief cells of the parathyroid gland and is responsible for controlling the secretion of parathyroid hormone (PTH).  PTH acts on several organs including the bone, kidney, and intestine to tightly regulate the concn. of serum calcium.  Substances other than calcium that activate the CaR are referred to as calcimimetics.  Calcimimetics that bind to the CaR as agonists are referred to as type I.  Type II calcimimetics bind to a site that is distinct from the physiol. ligand and function as pos. allosteric modulators of the CaR.  Type II calcimimetics amplify the sensitivity of the CaR to serum calcium and are thus able to lower the concn. of serum PTH.  Calcimimetics are being pursued as therapeutics for the treatment of disorders that are characterized by elevated levels of PTH such as primary and secondary hyperparathyroidism (primary HPT and secondary HPT).  In this review, we provide an overview of key results in the discovery of cinacalcet HCl (Sensipar in the US, Mimpara in Europe).  In addn., other recently disclosed type II calcimimetics are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBRgBPKixE4rVg90H21EOLACvtfcHk0li5uI8p8Zoovg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlSrs7Y%253D&md5=7f519dd21f377ef76af4a43c722206f8</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.2174%2F092986707782794096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986707782794096%26sid%3Dliteratum%253Aachs%26aulast%3DHarrington%26aufirst%3DP.%26aulast%3DFotsch%26aufirst%3DC.%26atitle%3DCalcium%2520sensing%2520receptor%2520activators%253A%2520Calcimimetics%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2007%26volume%3D14%26issue%3D28%26spage%3D3027%26epage%3D3034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_contrib-group">Marquis, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lago, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee Trout, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DelMar, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Wagenen, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roethke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, P.</span><span> </span><span class="NLM_article-title">Antagonists of the Calcium Receptor I. Amino Alcohol-Based Parathyroid Hormone Secretagogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">3982</span><span class="NLM_x">–</span> <span class="NLM_lpage">3993</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900364m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3982-3993&issue=13&author=R.+W.+Marquisauthor=A.+M.+Lagoauthor=J.+F.+Callahanauthor=R.+E.+Lee+Troutauthor=M.+Gowenauthor=E.+G.+DelMarauthor=B.+C.+Van+Wagenenauthor=S.+Loganauthor=S.+Shimizuauthor=J.+Foxauthor=E.+F.+Nemethauthor=Z.+Yangauthor=T.+Roethkeauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=J.+Leeauthor=R.+M.+Keenanauthor=P.+Bhatnagar&title=Antagonists+of+the+Calcium+Receptor+I.+Amino+Alcohol-Based+Parathyroid+Hormone+Secretagogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1021%2Fjm900364m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900364m%26sid%3Dliteratum%253Aachs%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DLago%26aufirst%3DA.%2BM.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DLee%2BTrout%26aufirst%3DR.%2BE.%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DDelMar%26aufirst%3DE.%2BG.%26aulast%3DVan%2BWagenen%26aufirst%3DB.%2BC.%26aulast%3DLogan%26aufirst%3DS.%26aulast%3DShimizu%26aufirst%3DS.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DRoethke%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DKeenan%26aufirst%3DR.%2BM.%26aulast%3DBhatnagar%26aufirst%3DP.%26atitle%3DAntagonists%2520of%2520the%2520Calcium%2520Receptor%2520I.%2520Amino%2520Alcohol-Based%2520Parathyroid%2520Hormone%2520Secretagogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D13%26spage%3D3982%26epage%3D3993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroup, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodds, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Votta, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lago, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DelMar, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span> </span><span class="NLM_article-title">Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1595</span><span class="NLM_x">–</span> <span class="NLM_lpage">1604</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2000&pages=1595-1604&issue=11&author=M.+Gowenauthor=G.+B.+Stroupauthor=R.+A.+Doddsauthor=I.+E.+Jamesauthor=B.+J.+Vottaauthor=B.+R.+Smithauthor=P.+K.+Bhatnagarauthor=A.+M.+Lagoauthor=J.+F.+Callahanauthor=E.+G.+DelMarauthor=M.+A.+Millerauthor=E.+F.+Nemethauthor=J.+Fox&title=Antagonizing+the+parathyroid+calcium+receptor+stimulates+parathyroid+hormone+secretion+and+bone+formation+in+osteopenic+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DStroup%26aufirst%3DG.%2BB.%26aulast%3DDodds%26aufirst%3DR.%2BA.%26aulast%3DJames%26aufirst%3DI.%2BE.%26aulast%3DVotta%26aufirst%3DB.%2BJ.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DBhatnagar%26aufirst%3DP.%2BK.%26aulast%3DLago%26aufirst%3DA.%2BM.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DDelMar%26aufirst%3DE.%2BG.%26aulast%3DMiller%26aufirst%3DM.%2BA.%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DFox%26aufirst%3DJ.%26atitle%3DAntagonizing%2520the%2520parathyroid%2520calcium%2520receptor%2520stimulates%2520parathyroid%2520hormone%2520secretion%2520and%2520bone%2520formation%2520in%2520osteopenic%2520rats%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2000%26volume%3D105%26issue%3D11%26spage%3D1595%26epage%3D1604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delmar, E:G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleason, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span> </span><span class="NLM_article-title">Calcilytic compounds: potent and selective Ca<sup>2+</sup> receptor antagonists that stimulate secretion of parathyroid hormone</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=11561095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntFWltbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2001&pages=323-331&issue=1&author=E.+F.+Nemethauthor=E%3AG.+Delmarauthor=W.+L.+Heatonauthor=M.+A.+Millerauthor=L.+D.+Lambertauthor=R.+L.+Conklinauthor=M.+Gowenauthor=J.+G.+Gleasonauthor=P.+K.+Bhatnagarauthor=J.+Fox&title=Calcilytic+compounds%3A+potent+and+selective+Ca2%2B+receptor+antagonists+that+stimulate+secretion+of+parathyroid+hormone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Calcilytic compounds: potent and selective Ca2+ receptor antagonists that stimulate secretion of parathyroid hormone</span></div><div class="casAuthors">Nemeth, Edward F.; Delmar, Eric G.; Heaton, William L.; Miller, Michael A.; Lambert, Lyssa D.; Conklin, Rebecca L.; Gowen, Maxine; Gleason, John G.; Bhatnagar, Pradip K.; Fox, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">323-331</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Despite the discovery of many ions and mols. that activate the Ca2+ receptor, there are no known ligands that block this receptor.  Reported here are the pharmacodynamic properties of a small mol., NPS 2143, which acts as an antagonist at the Ca2+ receptor.  This compd. blocked (IC50 of 43 nM) increases in cytoplasmic Ca2+ concns. [Ca2+]i elicited by activating the Ca2+ receptor in HEK 293 cells expressing the human Ca2+ receptor.  NPS 2143, even when tested at much higher concns. (3 μM), did not affect the activity of a no. of other G protein-coupled receptors, including those most structurally homologous to the Ca2+ receptor.  NPS 2143 stimulated parathyroid hormone (PTH) secretion from bovine parathyroid cells (EC50 of 41 nM) over a range of extracellular Ca2+ concns. and reversed the effects of the calcimimetic compd. NPS R-467 on [Ca2+]i and on secretion of PTH.  When infused i.v. in normal rats, NPS 2143 caused a rapid and large increase in plasma levels of PTH.  Ca2+ receptor antagonists are termed calcilytics and NPS 2143 is the first substance (either at. or mol.) shown to possess such activity.  The pharmacodynamic properties of NPS 2143 together with the recently demonstrated effects of this compd. on bone formation support the view that orally active calcilytic compds. might provide a novel anabolic therapy for osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5irxzzwLOvbVg90H21EOLACvtfcHk0lhH60j_Cn8LHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntFWltbk%253D&md5=14cedbe167bc3f0de96cec16d9ce73b4</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DDelmar%26aufirst%3DE%253AG.%26aulast%3DHeaton%26aufirst%3DW.%2BL.%26aulast%3DMiller%26aufirst%3DM.%2BA.%26aulast%3DLambert%26aufirst%3DL.%2BD.%26aulast%3DConklin%26aufirst%3DR.%2BL.%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DGleason%26aufirst%3DJ.%2BG.%26aulast%3DBhatnagar%26aufirst%3DP.%2BK.%26aulast%3DFox%26aufirst%3DJ.%26atitle%3DCalcilytic%2520compounds%253A%2520potent%2520and%2520selective%2520Ca2%252B%2520receptor%2520antagonists%2520that%2520stimulate%2520secretion%2520of%2520parathyroid%2520hormone%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D299%26issue%3D1%26spage%3D323%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6d"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span> </span><span class="NLM_article-title">The search for calcium receptor antagonists (calcilytics)</span> <span class="citation_source-journal">J. Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1677%2Fjme.0.0290015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=12200226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD38XmvFOhu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2002&pages=15-21&issue=1&author=E.+F.+Nemeth&title=The+search+for+calcium+receptor+antagonists+%28calcilytics%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6dR"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The search for calcium receptor antagonists (calcilytics)</span></div><div class="casAuthors">Nemeth, E. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-21</span>CODEN:
                <span class="NLM_cas:coden">JMLEEI</span>;
        ISSN:<span class="NLM_cas:issn">0952-5041</span>.
    
            (<span class="NLM_cas:orgname">Society for Endocrinology</span>)
        </div><div class="casAbstract">A review.  The Ca2+ receptor on the surface of parathyroid cells is the primary mol. entity regulating secretion of parathyroid hormone (PTH).  Because of this, it is a particularly appealing target for new drugs intended to increase or decrease circulating levels of PTH.  Calcilytic compds. are Ca2+ receptor antagonists which increase the secretion of PTH.  The first reported calcilytic compd. was NPS 2143, an orally active mol. which elicits rapid, 3- to 4-fold increases in circulating levels of PTH.  These rapid changes in plasma PTH levels are sufficient to increase bone turnover in ovariectomized, osteopenic rats.  When administered together with an antiresorptive agent (estradiol), NPS 2143 causes an increase in trabecular bone vol. and bone mineral d. in osteopenic rats.  The magnitude of these changes are far in excess of those caused by estradiol alone and are comparable with those achieved by daily administration of PTH or a peptide analog.  These anabolic effects of NPS 2143 on bone are not assocd. with hyperplasia of the parathyroid glands.  Calcilytic compds. can increase endogenous levels of circulating PTH to an extent that stimulates new bone formation.  Such compds. could replace the use of exogenous PTH or its peptide fragments in treating osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQAkcwwkiwrrVg90H21EOLACvtfcHk0lhH60j_Cn8LHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmvFOhu7o%253D&md5=e2836d11c306172c2a209df996ee5cea</span></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.1677%2Fjme.0.0290015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252Fjme.0.0290015%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26atitle%3DThe%2520search%2520for%2520calcium%2520receptor%2520antagonists%2520%2528calcilytics%2529%26jtitle%3DJ.%2520Mol.%2520Endocrinol.%26date%3D2002%26volume%3D29%26issue%3D1%26spage%3D15%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6e"><span><span class="NLM_contrib-group">Doggrell, S. A.; Del Fresno, M.; Castaner, J.</span> NPS - 2143.  <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span>),  <span class="NLM_fpage">140</span>− <span class="NLM_lpage">142</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1358%2Fdof.2002.027.02.656406" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD38Xkt1Shsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Doggrell%2C+S.+A.%3B+Del+Fresno%2C+M.%3B+Castaner%2C+J.+NPS+-+2143.+Drugs+Future+2002%2C+27+%282%29%2C+140%E2%88%92142."target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6eR"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">NPS-2143</span></div><div class="casAuthors">Doggrell, Sheila A.; Del Fresno, M.; Castaner, J.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">140-142</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Efforts to discover new treatments for osteoporosis led to the identification of the potent and selective, small-mol. calcium receptor antagonist NPS-2143.  NPS-2143 is the prototype calcilytic drug, designed to act on calcium receptors on the surface of parathyroid glands, stimulating the release of the body's own stores of native parathyroid hormone (PTH).  In osteopenic ovariectomized rats, daily oral administration of NPS-2143 resulted in moderate but sustained increases in plasma PTH levels and marked increases in bone formation and resorption, with no net bone gain or loss.  The combination of NPS-2143 and estrogen increases bone formation and d. to a greater extent than either agent alone.  These results suggest that NPS-2143 may be useful in the treatment of established osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9khiVRdE9nLVg90H21EOLACvtfcHk0lgbWYaiRkI4tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xkt1Shsb0%253D&md5=e306314807d368de4a1c9e023dc36885</span></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=10.1358%2Fdof.2002.027.02.656406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2002.027.02.656406%26sid%3Dliteratum%253Aachs%26aulast%3DDoggrell%26aufirst%3DS.%2BA.%26jtitle%3DDrugs%2520Future%26date%3D2002%26volume%3D27%26issue%3D2%26spage%3D140%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_contrib-group">Marquis, R. W.; Ramanjulu, J. M.; Casillas, L. N.</span><span> </span><span class="NLM_article-title">Preparation of acyloxy-amino-functionalized-aromatic carboxy compounds as calcilytic compounds useful against bone and mineral diseases</span>. Patent WO 2005077886,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=R.+W.+Marquis&author=J.+M.+Ramanjulu&author=L.+N.+Casillas&title=Preparation+of+acyloxy-amino-functionalized-aromatic+carboxy+compounds+as+calcilytic+compounds+useful+against+bone+and+mineral+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26atitle%3DPreparation%2520of%2520acyloxy-amino-functionalized-aromatic%2520carboxy%2520compounds%2520as%2520calcilytic%2520compounds%2520useful%2520against%2520bone%2520and%2520mineral%2520diseases%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_contrib-group">Marquis, R. W.; Casillas, L. N.; Ramanjulu, J. M.; Callahan, J. F.</span><span> </span><span class="NLM_article-title">Preparation of phenylalkanoic acids as calcilytic compounds</span>. Patent WO 200404775,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=R.+W.+Marquis&author=L.+N.+Casillas&author=J.+M.+Ramanjulu&author=J.+F.+Callahan&title=Preparation+of+phenylalkanoic+acids+as+calcilytic+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26atitle%3DPreparation%2520of%2520phenylalkanoic%2520acids%2520as%2520calcilytic%2520compounds%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_contrib-group">Balan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castrodad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healy, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphries, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapinos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khot, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarra, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neagu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piotrowski, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paralkar, V. M.</span><span> </span><span class="NLM_article-title">The discovery of novel calcium sensing receptor negative allosteric modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3328</span><span class="NLM_x">–</span> <span class="NLM_lpage">3332</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3328-3332&issue=12&author=G.+Balanauthor=J.+Baumanauthor=S.+Bhattacharyaauthor=M.+Castrodadauthor=D.+R.+Healyauthor=M.+Herrauthor=P.+Humphriesauthor=S.+Jenningsauthor=A.+S.+Kalgutkarauthor=B.+Kapinosauthor=V.+Khotauthor=K.+Lazarraauthor=M.+Liauthor=Y.+Liauthor=C.+Neaguauthor=R.+Oliverauthor=D.+W.+Piotrowskiauthor=D.+Priceauthor=H.+Qiauthor=H.+A.+Simmonsauthor=J.+Southersauthor=L.+Weiauthor=Y.+Zhangauthor=V.+M.+Paralkar&title=The+discovery+of+novel+calcium+sensing+receptor+negative+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBalan%26aufirst%3DG.%26aulast%3DBauman%26aufirst%3DJ.%26aulast%3DBhattacharya%26aufirst%3DS.%26aulast%3DCastrodad%26aufirst%3DM.%26aulast%3DHealy%26aufirst%3DD.%2BR.%26aulast%3DHerr%26aufirst%3DM.%26aulast%3DHumphries%26aufirst%3DP.%26aulast%3DJennings%26aufirst%3DS.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKapinos%26aufirst%3DB.%26aulast%3DKhot%26aufirst%3DV.%26aulast%3DLazarra%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DNeagu%26aufirst%3DC.%26aulast%3DOliver%26aufirst%3DR.%26aulast%3DPiotrowski%26aufirst%3DD.%2BW.%26aulast%3DPrice%26aufirst%3DD.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DSimmons%26aufirst%3DH.%2BA.%26aulast%3DSouthers%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DParalkar%26aufirst%3DV.%2BM.%26atitle%3DThe%2520discovery%2520of%2520novel%2520calcium%2520sensing%2520receptor%2520negative%2520allosteric%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D12%26spage%3D3328%26epage%3D3332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Fitzpatrick, L. A.; Brennan, E.; Kumar, S.; Matheny, C.; Yi, B.; McLaughlin, M.; Phillips, J.; Skordos, L.; Ethgen, D.</span><span> </span><span class="NLM_article-title">Ronacaleret, a novel calcium-sensing receptor antagonist demonstrates potential as an oral bone-forming therapy in healthy postmenopausal women</span>. <span class="NLM_conf-name">ASBMR 30th Annual Meeting</span>, <span class="NLM_conf-loc">Montreal</span>, <span class="NLM_conf-date">2008</span>, Abstract 1174.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Fitzpatrick%2C+L.+A.%3B+Brennan%2C+E.%3B+Kumar%2C+S.%3B+Matheny%2C+C.%3B+Yi%2C+B.%3B+McLaughlin%2C+M.%3B+Phillips%2C+J.%3B+Skordos%2C+L.%3B+Ethgen%2C+D.+Ronacaleret%2C+a+novel+calcium-sensing+receptor+antagonist+demonstrates+potential+as+an+oral+bone-forming+therapy+in+healthy+postmenopausal+women.+ASBMR+30th+Annual+Meeting%2C+Montreal%2C+2008%2C+Abstract+1174."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DFitzpatrick%26aufirst%3DL.%2BA.%26atitle%3DRonacaleret%252C%2520a%2520novel%2520calcium-sensing%2520receptor%2520antagonist%2520demonstrates%2520potential%2520as%2520an%2520oral%2520bone-forming%2520therapy%2520in%2520healthy%2520postmenopausal%2520women" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Kirk, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arey, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feyen, J. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, J. K.</span><span> </span><span class="NLM_article-title">Discovery and structure−activity relationships of trisubstituted pyrimidines/pyridines as novel calcium-sensing receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1204</span><span class="NLM_x">–</span> <span class="NLM_lpage">1208</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801178c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1204-1208&issue=4&author=W.+Yangauthor=Z.+Ruanauthor=Y.+Wangauthor=K.+Van+Kirkauthor=Z.+Maauthor=B.+J.+Areyauthor=C.+B.+Cooperauthor=R.+Seethalaauthor=J.+H.+M.+Feyenauthor=J.+K.+Dickson&title=Discovery+and+structure%E2%88%92activity+relationships+of+trisubstituted+pyrimidines%2Fpyridines+as+novel+calcium-sensing+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1021%2Fjm801178c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801178c%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%26aulast%3DRuan%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DVan%2BKirk%26aufirst%3DK.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DArey%26aufirst%3DB.%2BJ.%26aulast%3DCooper%26aufirst%3DC.%2BB.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DFeyen%26aufirst%3DJ.%2BH.%2BM.%26aulast%3DDickson%26aufirst%3DJ.%2BK.%26atitle%3DDiscovery%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%2520trisubstituted%2520pyrimidines%252Fpyridines%2520as%2520novel%2520calcium-sensing%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D4%26spage%3D1204%26epage%3D1208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_contrib-group">Gavai, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkilineni, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberge, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corte, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednarz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feyen, J. H. M.</span><span> </span><span class="NLM_article-title">Discovery of novel 1-arylmethylpyrrolidin-2-ylethanolamines as calcium-sensing receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">5478</span><span class="NLM_x">–</span> <span class="NLM_lpage">5482</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=5478-5482&issue=24&author=A.+V.+Gavaiauthor=R.+J.+Vazauthor=A.+B.+Mikkilineniauthor=J.+Y.+Robergeauthor=Y.+Liuauthor=M+Lawrenceauthor=J.+R.+Corteauthor=W.+Yangauthor=M.+Bednarzauthor=J.+K.+Dicksonauthor=Z.+Maauthor=R.+Seethalaauthor=J.+H.+M.+Feyen&title=Discovery+of+novel+1-arylmethylpyrrolidin-2-ylethanolamines+as+calcium-sensing+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGavai%26aufirst%3DA.%2BV.%26aulast%3DVaz%26aufirst%3DR.%2BJ.%26aulast%3DMikkilineni%26aufirst%3DA.%2BB.%26aulast%3DRoberge%26aufirst%3DJ.%2BY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLawrence%26aufirst%3DM%26aulast%3DCorte%26aufirst%3DJ.%2BR.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DBednarz%26aufirst%3DM.%26aulast%3DDickson%26aufirst%3DJ.%2BK.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DFeyen%26aufirst%3DJ.%2BH.%2BM.%26atitle%3DDiscovery%2520of%2520novel%25201-arylmethylpyrrolidin-2-ylethanolamines%2520as%2520calcium-sensing%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26issue%3D24%26spage%3D5478%26epage%3D5482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9c"><span><span class="NLM_contrib-group">Arey, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swartz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feyen, J. H. M.</span><span> </span><span class="NLM_article-title">A novel calcium-sensing receptor antagonist transiently stimulates parathyroid hormone secretion in vivo</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">146</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">2015</span><span class="NLM_x">–</span> <span class="NLM_lpage">2022</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2005&pages=2015-2022&issue=4&author=B.+J.+Areyauthor=R.+Seethalaauthor=Z.+Maauthor=A.+Furaauthor=J.+Morinauthor=J.+Swartzauthor=V.+Vyasauthor=W.+Yangauthor=J.+Dicksonauthor=J.+H.+M.+Feyen&title=A+novel+calcium-sensing+receptor+antagonist+transiently+stimulates+parathyroid+hormone+secretion+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArey%26aufirst%3DB.%2BJ.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DMorin%26aufirst%3DJ.%26aulast%3DSwartz%26aufirst%3DJ.%26aulast%3DVyas%26aufirst%3DV.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DDickson%26aufirst%3DJ.%26aulast%3DFeyen%26aufirst%3DJ.%2BH.%2BM.%26atitle%3DA%2520novel%2520calcium-sensing%2520receptor%2520antagonist%2520transiently%2520stimulates%2520parathyroid%2520hormone%2520secretion%2520in%2520vivo%26jtitle%3DEndocrinology%26date%3D2005%26volume%3D146%26issue%3D4%26spage%3D2015%26epage%3D2022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9d"><span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberge, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotella, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feyen, J. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, J. K.</span><span> </span><span class="NLM_article-title">Discovery and structure−activity relationships of 2-benzylpyrrolidine-substituted aryloxypropanols as calcium-sensing receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1225</span><span class="NLM_x">–</span> <span class="NLM_lpage">1228</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1225-1228&issue=4&author=W.+Yangauthor=Y.+Wangauthor=J.+Y.+Robergeauthor=Z.+Maauthor=Y.+Liuauthor=R.+M.+Lawrenceauthor=D.+P.+Rotellaauthor=R.+Seethalaauthor=J.+H.+M.+Feyenauthor=J.+K.+Dickson&title=Discovery+and+structure%E2%88%92activity+relationships+of+2-benzylpyrrolidine-substituted+aryloxypropanols+as+calcium-sensing+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DRoberge%26aufirst%3DJ.%2BY.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLawrence%26aufirst%3DR.%2BM.%26aulast%3DRotella%26aufirst%3DD.%2BP.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DFeyen%26aufirst%3DJ.%2BH.%2BM.%26aulast%3DDickson%26aufirst%3DJ.%2BK.%26atitle%3DDiscovery%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%25202-benzylpyrrolidine-substituted%2520aryloxypropanols%2520as%2520calcium-sensing%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26issue%3D4%26spage%3D1225%26epage%3D1228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_contrib-group">Kessler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesario, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauban, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, R. H.</span><span> </span><span class="NLM_article-title"><i>N</i><sup>1</sup>-Benzoyl-<i>N</i><sup>2</sup>-[1-(1-naphthyl)ethyl]-<i>trans</i>-1,2-diaminocyclohexanes: Development of 4-chlorophenylcarboxamide (Calhex 231) as a new calcium sensing receptor ligand demonstrating potent calcilytic activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">5119</span><span class="NLM_x">–</span> <span class="NLM_lpage">5128</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051233%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5119-5128&issue=17&author=A.+Kesslerauthor=H.+Faureauthor=C.+Petrelauthor=D.+Rognanauthor=M.+Cesarioauthor=M.+Ruatauthor=P.+Daubanauthor=R.+H.+Dodd&title=N1-Benzoyl-N2-%5B1-%281-naphthyl%29ethyl%5D-trans-1%2C2-diaminocyclohexanes%3A+Development+of+4-chlorophenylcarboxamide+%28Calhex+231%29+as+a+new+calcium+sensing+receptor+ligand+demonstrating+potent+calcilytic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1021%2Fjm051233%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051233%252B%26sid%3Dliteratum%253Aachs%26aulast%3DKessler%26aufirst%3DA.%26aulast%3DFaure%26aufirst%3DH.%26aulast%3DPetrel%26aufirst%3DC.%26aulast%3DRognan%26aufirst%3DD.%26aulast%3DCesario%26aufirst%3DM.%26aulast%3DRuat%26aufirst%3DM.%26aulast%3DDauban%26aufirst%3DP.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DN1-Benzoyl-N2-%255B1-%25281-naphthyl%2529ethyl%255D-trans-1%252C2-diaminocyclohexanes%253A%2520Development%2520of%25204-chlorophenylcarboxamide%2520%2528Calhex%2520231%2529%2520as%2520a%2520new%2520calcium%2520sensing%2520receptor%2520ligand%2520demonstrating%2520potent%2520calcilytic%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D17%26spage%3D5119%26epage%3D5128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_contrib-group">Kessler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Césario, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauban, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, R. H.</span><span> </span><span class="NLM_article-title"><i>N</i><sup>2</sup>-Benzyl-<i>N</i><sup>1</sup>-(1-(1-naphthyl)ethyl)-3-phenylpropane-1,2-diamines and conformationally restrained indole analogues: development of calindol as a new calcimimetic acting at the calcium sensing receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3345</span><span class="NLM_x">–</span> <span class="NLM_lpage">3349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3345-3349&issue=12&author=A.+Kesslerauthor=H.+Faureauthor=C.+Petrelauthor=D.+Rognanauthor=M.+C%C3%A9sarioauthor=M.+Ruatauthor=P.+Daubanauthor=R.+H.+Dodd&title=N2-Benzyl-N1-%281-%281-naphthyl%29ethyl%29-3-phenylpropane-1%2C2-diamines+and+conformationally+restrained+indole+analogues%3A+development+of+calindol+as+a+new+calcimimetic+acting+at+the+calcium+sensing+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKessler%26aufirst%3DA.%26aulast%3DFaure%26aufirst%3DH.%26aulast%3DPetrel%26aufirst%3DC.%26aulast%3DRognan%26aufirst%3DD.%26aulast%3DC%25C3%25A9sario%26aufirst%3DM.%26aulast%3DRuat%26aufirst%3DM.%26aulast%3DDauban%26aufirst%3DP.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DN2-Benzyl-N1-%25281-%25281-naphthyl%2529ethyl%2529-3-phenylpropane-1%252C2-diamines%2520and%2520conformationally%2520restrained%2520indole%2520analogues%253A%2520development%2520of%2520calindol%2520as%2520a%2520new%2520calcimimetic%2520acting%2520at%2520the%2520calcium%2520sensing%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26issue%3D12%26spage%3D3345%26epage%3D3349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_contrib-group">Kessler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roussanne, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauban, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, R. H.</span><span> </span><span class="NLM_article-title"><i>N</i><sup>1</sup>-arylsulfonyl-<i>N</i><sup>2</sup>-(1-(1-naphthyl)ethyl)-1,2-diaminocyclohexanes: a new class of calcilytic agents acting at the calcium-sensing receptor</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1131</span><span class="NLM_x">–</span> <span class="NLM_lpage">1136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=1131-1136&issue=8&author=A.+Kesslerauthor=H.+Faureauthor=M.+C.+Roussanneauthor=S.+Ferryauthor=M.+Ruatauthor=P.+Daubanauthor=R.+H.+Dodd&title=N1-arylsulfonyl-N2-%281-%281-naphthyl%29ethyl%29-1%2C2-diaminocyclohexanes%3A+a+new+class+of+calcilytic+agents+acting+at+the+calcium-sensing+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKessler%26aufirst%3DA.%26aulast%3DFaure%26aufirst%3DH.%26aulast%3DRoussanne%26aufirst%3DM.%2BC.%26aulast%3DFerry%26aufirst%3DS.%26aulast%3DRuat%26aufirst%3DM.%26aulast%3DDauban%26aufirst%3DP.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DN1-arylsulfonyl-N2-%25281-%25281-naphthyl%2529ethyl%2529-1%252C2-diaminocyclohexanes%253A%2520a%2520new%2520class%2520of%2520calcilytic%2520agents%2520acting%2520at%2520the%2520calcium-sensing%2520receptor%26jtitle%3DChemBioChem%26date%3D2004%26volume%3D5%26issue%3D8%26spage%3D1131%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10d"><span><span class="NLM_contrib-group">Petrel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauban, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span> </span><span class="NLM_article-title">Positive and negative allosteric modulators of the Ca<sup>2+</sup>-sensing receptor interact within overlapping but not identical binding sites in the transmembrane domain</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">18990</span><span class="NLM_x">–</span> <span class="NLM_lpage">18997</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=18990-18997&issue=18&author=C.+Petrelauthor=A.+Kesslerauthor=P.+Daubanauthor=R.+H.+Doddauthor=D.+Rognanauthor=M.+Ruat&title=Positive+and+negative+allosteric+modulators+of+the+Ca2%2B-sensing+receptor+interact+within+overlapping+but+not+identical+binding+sites+in+the+transmembrane+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetrel%26aufirst%3DC.%26aulast%3DKessler%26aufirst%3DA.%26aulast%3DDauban%26aufirst%3DP.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26aulast%3DRognan%26aufirst%3DD.%26aulast%3DRuat%26aufirst%3DM.%26atitle%3DPositive%2520and%2520negative%2520allosteric%2520modulators%2520of%2520the%2520Ca2%252B-sensing%2520receptor%2520interact%2520within%2520overlapping%2520but%2520not%2520identical%2520binding%2520sites%2520in%2520the%2520transmembrane%2520domain%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26issue%3D18%26spage%3D18990%26epage%3D18997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10e"><span><span class="NLM_contrib-group">Dauban, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faure, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, R. H.</span><span> </span><span class="NLM_article-title"><i>N</i><sup>1</sup>-Arylsulfonyl-<i>N</i><sup>2</sup>-(1-aryl)ethyl-3-phenylpropane-1,2-diamines as novel calcimimetics acting on the calcium sensing receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">2001</span><span class="NLM_x">–</span> <span class="NLM_lpage">2004</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=2001-2004&issue=17&author=P.+Daubanauthor=S.+Ferryauthor=H.+Faureauthor=M.+Ruatauthor=R.+H.+Dodd&title=N1-Arylsulfonyl-N2-%281-aryl%29ethyl-3-phenylpropane-1%2C2-diamines+as+novel+calcimimetics+acting+on+the+calcium+sensing+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDauban%26aufirst%3DP.%26aulast%3DFerry%26aufirst%3DS.%26aulast%3DFaure%26aufirst%3DH.%26aulast%3DRuat%26aufirst%3DM.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DN1-Arylsulfonyl-N2-%25281-aryl%2529ethyl-3-phenylpropane-1%252C2-diamines%2520as%2520novel%2520calcimimetics%2520acting%2520on%2520the%2520calcium%2520sensing%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26issue%3D17%26spage%3D2001%26epage%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_contrib-group">Shcherbakova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoffroy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swierczek, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balandrin, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, R. L.</span><span> </span><span class="NLM_article-title">Design, new synthesis, and calcilytic activity of substituted 3<i>H</i>-pyrimidin-4-ones</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">2537</span><span class="NLM_x">–</span> <span class="NLM_lpage">2540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2537-2540&issue=10&author=I.+Shcherbakovaauthor=G.+I.+Huangauthor=J.+Geoffroyauthor=S.+K.+Nairauthor=K.+Swierczekauthor=M.+F.+Balandrinauthor=J.+Foxauthor=W.+L.+Heatonauthor=R.+L.+Conklin&title=Design%2C+new+synthesis%2C+and+calcilytic+activity+of+substituted+3H-pyrimidin-4-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShcherbakova%26aufirst%3DI.%26aulast%3DHuang%26aufirst%3DG.%2BI.%26aulast%3DGeoffroy%26aufirst%3DJ.%26aulast%3DNair%26aufirst%3DS.%2BK.%26aulast%3DSwierczek%26aufirst%3DK.%26aulast%3DBalandrin%26aufirst%3DM.%2BF.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DHeaton%26aufirst%3DW.%2BL.%26aulast%3DConklin%26aufirst%3DR.%2BL.%26atitle%3DDesign%252C%2520new%2520synthesis%252C%2520and%2520calcilytic%2520activity%2520of%2520substituted%25203H-pyrimidin-4-ones%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26issue%3D10%26spage%3D2537%26epage%3D2540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_contrib-group">Shcherbakova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balandrin, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghatak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, R. L.</span><span> </span><span class="NLM_article-title">3<i>H</i>-Quinazolin-4-ones as a new calcilytic template for the potential treatment of osteoporosis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1557</span><span class="NLM_x">–</span> <span class="NLM_lpage">1560</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1557-1560&issue=6&author=I.+Shcherbakovaauthor=M.+F.+Balandrinauthor=J.+Foxauthor=A.+Ghatakauthor=W.+L.+Heatonauthor=R.+L.+Conklin&title=3H-Quinazolin-4-ones+as+a+new+calcilytic+template+for+the+potential+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShcherbakova%26aufirst%3DI.%26aulast%3DBalandrin%26aufirst%3DM.%2BF.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DGhatak%26aufirst%3DA.%26aulast%3DHeaton%26aufirst%3DW.%2BL.%26aulast%3DConklin%26aufirst%3DR.%2BL.%26atitle%3D3H-Quinazolin-4-ones%2520as%2520a%2520new%2520calcilytic%2520template%2520for%2520the%2520potential%2520treatment%2520of%2520osteoporosis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26issue%3D6%26spage%3D1557%26epage%3D1560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_contrib-group">Shinagawa, Y.; Inoue, T.; Kiguchi, T.; Ikenogami, T.; Ogawa, N.; Fukuda, K.; Nakagawa, T.; Shindo, M.; Soejima, Y.</span><span> </span><span class="NLM_article-title">CaSR antagonists</span>. Patent EP 1630157,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=Y.+Shinagawa&author=T.+Inoue&author=T.+Kiguchi&author=T.+Ikenogami&author=N.+Ogawa&author=K.+Fukuda&author=T.+Nakagawa&author=M.+Shindo&author=Y.+Soejima&title=CaSR+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShinagawa%26aufirst%3DY.%26atitle%3DCaSR%2520antagonists%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_contrib-group">Shinagawa, Y.; Inoue, T.; Kiguchi, T.; Ikenogami, T.; Ogawa, N.; Nakagawa, T.; Shindo, M.; Soejima, Y.</span><span> </span><span class="NLM_article-title">Preparation of 3-[[2-methyl-3-aryl-2-propyl]amino]-1,2-propanediol derivatives as calcium-sensing receptor (CaSR) antagonists</span>. Patent WO 2004106280,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=Y.+Shinagawa&author=T.+Inoue&author=T.+Kiguchi&author=T.+Ikenogami&author=N.+Ogawa&author=T.+Nakagawa&author=M.+Shindo&author=Y.+Soejima&title=Preparation+of+3-%5B%5B2-methyl-3-aryl-2-propyl%5Damino%5D-1%2C2-propanediol+derivatives+as+calcium-sensing+receptor+%28CaSR%29+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShinagawa%26aufirst%3DY.%26atitle%3DPreparation%2520of%25203-%255B%255B2-methyl-3-aryl-2-propyl%255Damino%255D-1%252C2-propanediol%2520derivatives%2520as%2520calcium-sensing%2520receptor%2520%2528CaSR%2529%2520antagonists%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_contrib-group">Gabka, J.</span><span> </span><span class="NLM_article-title">Analgesic and anti-inflammatory activity of Biarison. Clinical experimental studies</span> <span class="citation_source-journal">München Med. Wochen.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">334</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=1978&pages=331-334&issue=10&author=J.+Gabka&title=Analgesic+and+anti-inflammatory+activity+of+Biarison.+Clinical+experimental+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGabka%26aufirst%3DJ.%26atitle%3DAnalgesic%2520and%2520anti-inflammatory%2520activity%2520of%2520Biarison.%2520Clinical%2520experimental%2520studies%26jtitle%3DM%25C3%25BCnchen%2520Med.%2520Wochen.%26date%3D1978%26volume%3D120%26issue%3D10%26spage%3D331%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_contrib-group">Houlihan, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Bochoven, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takesue, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jukniewicz, E.</span><span> </span><span class="NLM_article-title">Anti-inflammatory properties of 8-aryl-5-isopropyl-2<i>H</i>-1,3-dioxolo[4,5-<i>g</i>]quinazolin-6(5<i>H</i>)-ones and -thiones</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1110</span><span class="NLM_x">–</span> <span class="NLM_lpage">1113</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00351a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1982&pages=1110-1113&issue=9&author=W.+J.+Houlihanauthor=G.+Cookeauthor=R.+Van+Bochovenauthor=J.+Perrineauthor=E.+I.+Takesueauthor=E.+Jukniewicz&title=Anti-inflammatory+properties+of+8-aryl-5-isopropyl-2H-1%2C3-dioxolo%5B4%2C5-g%5Dquinazolin-6%285H%29-ones+and+-thiones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Fjm00351a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00351a022%26sid%3Dliteratum%253Aachs%26aulast%3DHoulihan%26aufirst%3DW.%2BJ.%26aulast%3DCooke%26aufirst%3DG.%26aulast%3DVan%2BBochoven%26aufirst%3DR.%26aulast%3DPerrine%26aufirst%3DJ.%26aulast%3DTakesue%26aufirst%3DE.%2BI.%26aulast%3DJukniewicz%26aufirst%3DE.%26atitle%3DAnti-inflammatory%2520properties%2520of%25208-aryl-5-isopropyl-2H-1%252C3-dioxolo%255B4%252C5-g%255Dquinazolin-6%25285H%2529-ones%2520and%2520-thiones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1982%26volume%3D25%26issue%3D9%26spage%3D1110%26epage%3D1113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13c"><span><span class="NLM_contrib-group">Perrine, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houlihan, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takesue, E. I.</span><span> </span><span class="NLM_article-title">Anti-inflammatory and other pharmacodynamic properties of five members of the 4-aryl-1-isopropyl-2(1<i>H</i>)-quinazolinone series</span> <span class="citation_source-journal">Arzneim.-Forsch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">879</span><span class="NLM_x">–</span> <span class="NLM_lpage">885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=6333879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADyaL2cXlvVentLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1984&pages=879-885&issue=8&author=J.+W.+Perrineauthor=W.+J.+Houlihanauthor=E.+I.+Takesue&title=Anti-inflammatory+and+other+pharmacodynamic+properties+of+five+members+of+the+4-aryl-1-isopropyl-2%281H%29-quinazolinone+series"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13cR"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Antiinflammatory and other pharmacodynamic properties of five members of the 4-aryl-1-isopropyl-2(1H)-quinazolinone series</span></div><div class="casAuthors">Perrine, J. W.; Houlihan, W. J.; Takesue, E. I.</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel-Forschung</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">879-85</span>CODEN:
                <span class="NLM_cas:coden">ARZNAD</span>;
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    </div><div class="casAbstract">A series of five 4-aryl-1-isopropyl-2(1H)-quinazolinone analogs were examd. for their relative activities regarding analgesia, suppression of inflammation and pyrexia, and assocd. phenomena.  Two of these, SaH 43-715 proquazone(I)  [22760-18-5] and SaH 46-790 (fluproquazone(II)  [40507-23-1], are clin. effective anti-inflammatory and analgesic agents.  In general, substitutions in these 5 quinazolinone analogs produced noticeable changes in potency in several activities but changes of lesser degrees of others.  Compared to acetylsalicylic acid and phenylbutazone the quinazolinones exhibited better analgesic and related activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3VU9XcJG067Vg90H21EOLACvtfcHk0lilYBqzOVi9tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXlvVentLk%253D&md5=5626bb72800d04da64ac527991368e91</span></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerrine%26aufirst%3DJ.%2BW.%26aulast%3DHoulihan%26aufirst%3DW.%2BJ.%26aulast%3DTakesue%26aufirst%3DE.%2BI.%26atitle%3DAnti-inflammatory%2520and%2520other%2520pharmacodynamic%2520properties%2520of%2520five%2520members%2520of%2520the%25204-aryl-1-isopropyl-2%25281H%2529-quinazolinone%2520series%26jtitle%3DArzneim.-Forsch.%26date%3D1984%26volume%3D34%26issue%3D8%26spage%3D879%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Houlihan, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoletti, J.</span><span> </span><span class="NLM_article-title">1-Alkyl-4-aryl-3,4-dihydro-2(1<i>H</i>)-quinazolinones and thiones. Synthesis and proton−NMR spectra</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1453</span><span class="NLM_x">–</span> <span class="NLM_lpage">1456</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1982&pages=1453-1456&issue=6&author=W.+J.+Houlihanauthor=G.+Cookeauthor=M.+Denzerauthor=J.+Nicoletti&title=1-Alkyl-4-aryl-3%2C4-dihydro-2%281H%29-quinazolinones+and+thiones.+Synthesis+and+proton%E2%88%92NMR+spectra"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoulihan%26aufirst%3DW.%2BJ.%26aulast%3DCooke%26aufirst%3DG.%26aulast%3DDenzer%26aufirst%3DM.%26aulast%3DNicoletti%26aufirst%3DJ.%26atitle%3D1-Alkyl-4-aryl-3%252C4-dihydro-2%25281H%2529-quinazolinones%2520and%2520thiones.%2520Synthesis%2520and%2520proton%25E2%2588%2592NMR%2520spectra%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1982%26volume%3D19%26issue%3D6%26spage%3D1453%26epage%3D1456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Wohnsland, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faller, B.</span><span> </span><span class="NLM_article-title">High throughput permeability pH profile and High throughput alkane/water log P with artificial membranes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">930</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm001020e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=923-930&author=F.+Wohnslandauthor=B.+Faller&title=High+throughput+permeability+pH+profile+and+High+throughput+alkane%2Fwater+log+P+with+artificial+membranes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm001020e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm001020e%26sid%3Dliteratum%253Aachs%26aulast%3DWohnsland%26aufirst%3DF.%26aulast%3DFaller%26aufirst%3DB.%26atitle%3DHigh%2520throughput%2520permeability%2520pH%2520profile%2520and%2520High%2520throughput%2520alkane%252Fwater%2520log%2520P%2520with%2520artificial%2520membranes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D923%26epage%3D930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Petrel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maslah, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauban, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span> </span><span class="NLM_article-title">Modeling and mutagenesis of the binding site of Calhex 231, a novel negative allosteric modulator of the extracellular Ca<sup>2+</sup>-sensing receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">49487</span><span class="NLM_x">–</span> <span class="NLM_lpage">49494</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=49487-49494&author=C.+Petrelauthor=A.+Kesslerauthor=F.+Maslahauthor=P.+Daubanauthor=R.+H.+Doddauthor=D.+Rognanauthor=M.+Ruat&title=Modeling+and+mutagenesis+of+the+binding+site+of+Calhex+231%2C+a+novel+negative+allosteric+modulator+of+the+extracellular+Ca2%2B-sensing+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetrel%26aufirst%3DC.%26aulast%3DKessler%26aufirst%3DA.%26aulast%3DMaslah%26aufirst%3DF.%26aulast%3DDauban%26aufirst%3DP.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26aulast%3DRognan%26aufirst%3DD.%26aulast%3DRuat%26aufirst%3DM.%26atitle%3DModeling%2520and%2520mutagenesis%2520of%2520the%2520binding%2520site%2520of%2520Calhex%2520231%252C%2520a%2520novel%2520negative%2520allosteric%2520modulator%2520of%2520the%2520extracellular%2520Ca2%252B-sensing%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D49487%26epage%3D49494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Miedlich, S. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gama, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seuwen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitwieser, G. E.</span><span> </span><span class="NLM_article-title">Homology modeling of the transmembrane domain of the human calcium sensing receptor and localization of an allosteric binding site</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">7254</span><span class="NLM_x">–</span> <span class="NLM_lpage">7263</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=7254-7263&author=S.+U.+Miedlichauthor=L.+Gamaauthor=K.+Seuwenauthor=R.+M.+Wolfauthor=G.+E.+Breitwieser&title=Homology+modeling+of+the+transmembrane+domain+of+the+human+calcium+sensing+receptor+and+localization+of+an+allosteric+binding+site"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiedlich%26aufirst%3DS.%2BU.%26aulast%3DGama%26aufirst%3DL.%26aulast%3DSeuwen%26aufirst%3DK.%26aulast%3DWolf%26aufirst%3DR.%2BM.%26aulast%3DBreitwieser%26aufirst%3DG.%2BE.%26atitle%3DHomology%2520modeling%2520of%2520the%2520transmembrane%2520domain%2520of%2520the%2520human%2520calcium%2520sensing%2520receptor%2520and%2520localization%2520of%2520an%2520allosteric%2520binding%2520site%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D7254%26epage%3D7263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Petrel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauban, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rognan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruat, M.</span><span> </span><span class="NLM_article-title">Positive and negative allosteric modulators of the Ca<sup>2+</sup>-sensing receptor interact within overlapping but not identical binding sites in the transmembrane domain</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">18990</span><span class="NLM_x">–</span> <span class="NLM_lpage">18997</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=18990-18997&author=C.+Petrelauthor=A.+Kesslerauthor=P.+Daubanauthor=R.+H.+Doddauthor=D.+Rognanauthor=M.+Ruat&title=Positive+and+negative+allosteric+modulators+of+the+Ca2%2B-sensing+receptor+interact+within+overlapping+but+not+identical+binding+sites+in+the+transmembrane+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetrel%26aufirst%3DC.%26aulast%3DKessler%26aufirst%3DA.%26aulast%3DDauban%26aufirst%3DP.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26aulast%3DRognan%26aufirst%3DD.%26aulast%3DRuat%26aufirst%3DM.%26atitle%3DPositive%2520and%2520negative%2520allosteric%2520modulators%2520of%2520the%2520Ca2%252B-sensing%2520receptor%2520interact%2520within%2520overlapping%2520but%2520not%2520identical%2520binding%2520sites%2520in%2520the%2520transmembrane%2520domain%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D18990%26epage%3D18997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Bu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, C. L.</span><span> </span><span class="NLM_article-title">Improved model building and assessment of the calcium-sensing receptor transmembrane domain</span> <span class="citation_source-journal">Proteins.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2008&pages=215-226&author=L.+Buauthor=M.+Michinoauthor=R.+M.+Wolfauthor=C.+L.+Brooks&title=Improved+model+building+and+assessment+of+the+calcium-sensing+receptor+transmembrane+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBu%26aufirst%3DL.%26aulast%3DMichino%26aufirst%3DM.%26aulast%3DWolf%26aufirst%3DR.%2BM.%26aulast%3DBrooks%26aufirst%3DC.%2BL.%26atitle%3DImproved%2520model%2520building%2520and%2520assessment%2520of%2520the%2520calcium-sensing%2520receptor%2520transmembrane%2520domain%26jtitle%3DProteins.%26date%3D2008%26volume%3D71%26spage%3D215%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Seuwen, K.; Halleux, C.; Bouhelal, R.; Kneissel, M.; Buhl, T.; Gamse, R.; Wolf, R. M.; Breitwieser, G.; Beerli, R.; Weiler, S.; Widler, L.</span><span> </span><span class="NLM_article-title">A new class of noncompetitive antagonists of the human calcium-sensing receptor releasing parathyroid hormone (PTH) from parathyroid glands</span>. Poster presented at the <span class="NLM_conf-name">26th Annual Meeting of the American Society of Bone and Mineral Research (ASBMR)</span>, <span class="NLM_conf-loc">Seattle, WA</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&conference=26th+Annual+Meeting+of+the+American+Society+of+Bone+and+Mineral+Research+%28ASBMR%29&author=K.+Seuwen&author=C.+Halleux&author=R.+Bouhelal&author=M.+Kneissel&author=T.+Buhl&author=R.+Gamse&author=R.+M.+Wolf&author=G.+Breitwieser&author=R.+Beerli&author=S.+Weiler&author=L.+Widler&title=A+new+class+of+noncompetitive+antagonists+of+the+human+calcium-sensing+receptor+releasing+parathyroid+hormone+%28PTH%29+from+parathyroid+glands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DSeuwen%26aufirst%3DK.%26atitle%3DA%2520new%2520class%2520of%2520noncompetitive%2520antagonists%2520of%2520the%2520human%2520calcium-sensing%2520receptor%2520releasing%2520parathyroid%2520hormone%2520%2528PTH%2529%2520from%2520parathyroid%2520glands%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">DeLano, W. L.</span> <span class="citation_source-book">The PyMOL Molecular Graphics System, version 1.0r2</span>; <span class="NLM_publisher-name">DeLano Scientific LLC</span>: <span class="NLM_publisher-loc">San Carlos, CA</span>; <a href="http://www.pymol.org" class="extLink">http://www.pymol.org</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=DeLano%2C+W.+L.The+PyMOL+Molecular+Graphics+System%2C+version+1.0r2%3B+DeLano+Scientific+LLC%3A+San+Carlos%2C+CA%3B+http%3A%2F%2Fwww.pymol.org."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DDeLano%26aufirst%3DW.%2BL.%26btitle%3DThe%2520PyMOL%2520Molecular%2520Graphics%2520System%252C%2520version%25201.0r2%26pub%3DDeLano%2520Scientific%2520LLC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Duan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chowdhury, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cieplak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P.</span><span> </span><span class="NLM_article-title">A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1999</span><span class="NLM_x">–</span> <span class="NLM_lpage">2012</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1002%2Fjcc.10349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=14531054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVygsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=1999-2012&author=Y.+Duanauthor=C.+Wuauthor=S.+Chowdhuryauthor=M.+C.+Leeauthor=G.+Xiongauthor=W.+Zhangauthor=R.+Yangauthor=P.+Cieplakauthor=R.+Luoauthor=T.+Leeauthor=J.+Caldwellauthor=J.+Wangauthor=P.+Kollman&title=A+point-charge+force+field+for+molecular+mechanics+simulations+of+proteins+based+on+condensed-phase+quantum+mechanical+calculations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations</span></div><div class="casAuthors">Duan, Yong; Wu, Chun; Chowdhury, Shibasish; Lee, Mathew C.; Xiong, Guoming; Zhang, Wei; Yang, Rong; Cieplak, Piotr; Luo, Ray; Lee, Taisung; Caldwell, James; Wang, Junmei; Kollman, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1999-2012</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Mol. mechanics models have been applied extensively to study the dynamics of proteins and nucleic acids.  Here we report the development of a third-generation point-charge all-atom force field for proteins.  Following the earlier approach of Cornell et al., the charge set was obtained by fitting to the electrostatic potentials of dipeptides calcd. using B3LYP/cc-pVTZ/HF/6-31G** quantum mech. methods.  The main-chain torsion parameters were obtained by fitting to the energy profiles of Ace-Ala-Nme and Ace-Gly-Nme di-peptides calcd. using MP2/cc-pVTZ//HF/6-31G** quantum mech. methods.  All other parameters were taken from the existing AMBER data base.  The major departure from previous force fields is that all quantum mech. calcns. were done in the condensed phase with continuum solvent models and an effective dielec. const. of ε = 4.  We anticipate that this force field parameter set will address certain crit. short comings of previous force fields in condensed-phase simulations of proteins.  Initial tests on peptides demonstrated a high-degree of similarity between the calcd. and the statistically measured Ramanchandran maps for both Ace-Gly-Nme and Ace-Ala-Nme di-peptides.  Some highlights of our results include (1) well-preserved balance between the extended and helical region distributions, and (2) favorable type-II poly-proline helical region in agreement with recent expts.  Backward compatibility between the new and Cornell et al. charge sets, as judged by overall agreement between dipole moments, allows a smooth transition to the new force field in the area of ligand-binding calcns.  Test simulations on a large set of proteins are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAhPNmSr3iorVg90H21EOLACvtfcHk0lgYn4-VRGIaGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVygsbc%253D&md5=b4531cbf2d90deb9a173ec314dfd7b5d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fjcc.10349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.10349%26sid%3Dliteratum%253Aachs%26aulast%3DDuan%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DM.%2BC.%26aulast%3DXiong%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DR.%26aulast%3DCieplak%26aufirst%3DP.%26aulast%3DLuo%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DCaldwell%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DKollman%26aufirst%3DP.%26atitle%3DA%2520point-charge%2520force%2520field%2520for%2520molecular%2520mechanics%2520simulations%2520of%2520proteins%2520based%2520on%2520condensed-phase%2520quantum%2520mechanical%2520calculations%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2003%26volume%3D24%26spage%3D1999%26epage%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Case, D. A.</span><span> </span><span class="NLM_article-title">Development and testing of a general amber force field</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1157</span><span class="NLM_x">–</span> <span class="NLM_lpage">1174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1002%2Fjcc.20035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=15116359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFakurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1157-1174&author=J.+Wangauthor=R.+M.+Wolfauthor=J.+W.+Caldwellauthor=P.+A.+Kollmanauthor=D.+A.+Case&title=Development+and+testing+of+a+general+amber+force+field"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Development and testing of a general Amber force field</span></div><div class="casAuthors">Wang, Junmei; Wolf, Romain M.; Caldwell, James W.; Kollman, Peter A.; Case, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1157-1174</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe here a general Amber force field (GAFF) for org. mols.  GAFF is designed to be compatible with existing Amber force fields for proteins and nucleic acids, and has parameters for most org. and pharmaceutical mols. that are composed of H, C, N, O, S, P, and halogens.  It uses a simple functional form and a limited no. of atom types, but incorporates both empirical and heuristic models to est. force consts. and partial at. charges.  The performance of GAFF in test cases is encouraging.  In test I, 74 crystallog. structures were compared to GAFF minimized structures, with a root-mean-square displacement of 0.26 Å, which is comparable to that of the Tripos 5.2 force field (0.25 Å) and better than those of MMFF 94 and CHARMm (0.47 and 0.44 Å, resp.).  In test II, gas phase minimizations were performed on 22 nucleic acid base pairs, and the minimized structures and intermol. energies were compared to MP2/6-31G* results.  The RMS of displacements and relative energies were 0.25 Å and 1.2 kcal/mol, resp.  These data are comparable to results from Parm99/RESP (0.16 Å and 1.18 kcal/mol, resp.), which were parameterized to these base pairs.  Test III looked at the relative energies of 71 conformational pairs that were used in development of the Parm99 force field.  The RMS error in relative energies (compared to expt.) is about 0.5 kcal/mol.  GAFF can be applied to wide range of mols. in an automatic fashion, making it suitable for rational drug design and database searching.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfW8Gsf8IiW7Vg90H21EOLACvtfcHk0lhtpYbPHMeRww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFakurc%253D&md5=2992017a8cf51f89290ae2562403b115</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20035%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWolf%26aufirst%3DR.%2BM.%26aulast%3DCaldwell%26aufirst%3DJ.%2BW.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26aulast%3DCase%26aufirst%3DD.%2BA.%26atitle%3DDevelopment%2520and%2520testing%2520of%2520a%2520general%2520amber%2520force%2520field%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2004%26volume%3D25%26spage%3D1157%26epage%3D1174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><div class="note"><p class="first last">See, e.g.,</p></div><span class="NLM_contrib-group">Lennernaes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsson, B.</span><span> </span><span class="NLM_article-title">The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">273</span><span class="NLM_x">–</span> <span class="NLM_lpage">285</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm901811v&amp;key=10.1211%2F0022357055263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm901811v&amp;key=15807982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm901811v&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisFSqur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=273-285&issue=3&author=H.+Lennernaesauthor=B.+Abrahamsson&title=The+use+of+biopharmaceutic+classification+of+drugs+in+drug+discovery+and+development%3A+current+status+and+future+extension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension</span></div><div class="casAuthors">Lennernaes, Hans; Abrahamsson, Bertil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">273-285</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Press</span>)
        </div><div class="casAbstract">A review and discussion.  Bioavailability (BA) and bioequivalence (BE) play a central role in pharmaceutical product development and BE studies are presently being conducted for New Drug Applications (NDAs) of new compds., in supplementary NDAs for new medical indications and product line extensions, in Abbreviated New Drug Applications (ANDAs) of generic products and in applications for scale-up and post-approval changes.  The Biopharmaceutics Classification System (BCS) has been developed to provide a scientific approach for classifying drug compds. based on soly. as related to dose and intestinal permeability in combination with the dissoln. properties of the oral immediate-release (IR) dosage form.  The aim of the BCS is to provide a regulatory tool for replacing certain BE studies by accurate in-vitro dissoln. tests.  The aim of this review is to present the status of the BCS and discuss its future application in pharmaceutical product development.  The future application of the BCS is most likely increasingly important when the present framework gains increased recognition, which will probably be the case if the BCS borders for certain class II and III drugs are extended.  The future revision of the BCS guidelines by the regulatory agencies in communication with academic and industrial scientists is exciting and will hopefully result in an increased applicability in drug development.  Finally, the authors emphasize the great use of the BCS as a simple tool in early drug development to det. the rate-limiting step in the oral absorption process, which has facilitated the information between different experts involved in the overall drug development process.  This increased awareness of a proper biopharmaceutical characterization of new drugs may in the future result in drug mols. with a sufficiently high permeability, soly. and dissoln. rate, and that will automatically increase the importance of the BCS as a regulatory tool over time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG4DCZpL6kl7Vg90H21EOLACvtfcHk0lhtpYbPHMeRww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisFSqur4%253D&md5=26820123a6ad115d6fdfa8ef364ab39f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1211%2F0022357055263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252F0022357055263%26sid%3Dliteratum%253Aachs%26aulast%3DLennernaes%26aufirst%3DH.%26aulast%3DAbrahamsson%26aufirst%3DB.%26atitle%3DThe%2520use%2520of%2520biopharmaceutic%2520classification%2520of%2520drugs%2520in%2520drug%2520discovery%2520and%2520development%253A%2520current%2520status%2520and%2520future%2520extension%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2005%26volume%3D57%26issue%3D3%26spage%3D273%26epage%3D285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Bowden, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heilbron, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E. R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weedon, B. C. L.</span><span> </span><span class="NLM_article-title">Acetylenic compounds. I. Preparation of acetylenic ketones by oxidation of acetylenic carbinols and glycols</span> <span class="citation_source-journal">J. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1946</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1946&pages=39-45&author=K.+Bowdenauthor=I.+M.+Heilbronauthor=E.+R.+H.+Jonesauthor=B.+C.+L.+Weedon&title=Acetylenic+compounds.+I.+Preparation+of+acetylenic+ketones+by+oxidation+of+acetylenic+carbinols+and+glycols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBowden%26aufirst%3DK.%26aulast%3DHeilbron%26aufirst%3DI.%2BM.%26aulast%3DJones%26aufirst%3DE.%2BR.%2BH.%26aulast%3DWeedon%26aufirst%3DB.%2BC.%2BL.%26atitle%3DAcetylenic%2520compounds.%2520I.%2520Preparation%2520of%2520acetylenic%2520ketones%2520by%2520oxidation%2520of%2520acetylenic%2520carbinols%2520and%2520glycols%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1946%26spage%3D39%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i55"><a href="/doi/suppl/10.1021/jm901811v">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_27016"></div></div></div></div></div><hr /></hr><p class="last">Experimental information on synthetic preparation and analytical data of compounds <b>2b</b>−<b>2e</b>, <b>2g</b>−<b>2j</b>, <b>7b</b>−<b>7e</b>, <b>7g</b>−<b>7i</b>, <b>8</b>, <b>10b</b>−<b>10l</b>, <b>16a</b>−<b>16d</b>, <b>16f</b>, <b>16g</b>, <b>16i</b>, <b>21a</b>, and <b>21c</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm901811v/suppl_file/jm901811v_si_001.pdf">jm901811v_si_001.pdf (82.93 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm901811v&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm901811v%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-5%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm901811v" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679910ba5ece1949","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
